0001683168-24-003236.txt : 20240510 0001683168-24-003236.hdr.sgml : 20240510 20240510163032 ACCESSION NUMBER: 0001683168-24-003236 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 39 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240510 DATE AS OF CHANGE: 20240510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NeoVolta Inc. CENTRAL INDEX KEY: 0001748137 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 825299263 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41447 FILM NUMBER: 24935430 BUSINESS ADDRESS: STREET 1: 13651 DANIELSON STREET STREET 2: SUITE A CITY: POWAY STATE: CA ZIP: 92064 BUSINESS PHONE: 800-364-5464 MAIL ADDRESS: STREET 1: 13651 DANIELSON STREET STREET 2: SUITE A CITY: POWAY STATE: CA ZIP: 92064 FORMER COMPANY: FORMER CONFORMED NAME: NeoVolta, Inc. DATE OF NAME CHANGE: 20220613 FORMER COMPANY: FORMER CONFORMED NAME: NeoVolta Inc. DATE OF NAME CHANGE: 20180725 10-Q 1 neovolta_i10q-033124.htm FORM 10-Q FOR 3-31-24 NeoVolta, Inc. Form 10-Q
false --06-30 2024 Q3 0001748137 0001748137 2023-07-01 2024-03-31 0001748137 NEOV:CommonStockParValue0.001PerShareMember 2023-07-01 2024-03-31 0001748137 NEOV:WarrantsEachWarrantExercisableForOneShareOfCommonStockMember 2023-07-01 2024-03-31 0001748137 2024-05-10 0001748137 2024-03-31 0001748137 2023-06-30 0001748137 2024-01-01 2024-03-31 0001748137 2023-01-01 2023-03-31 0001748137 2022-07-01 2023-03-31 0001748137 us-gaap:CommonStockMember 2023-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001748137 us-gaap:RetainedEarningsMember 2023-06-30 0001748137 us-gaap:CommonStockMember 2023-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001748137 us-gaap:RetainedEarningsMember 2023-09-30 0001748137 2023-09-30 0001748137 us-gaap:CommonStockMember 2023-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001748137 us-gaap:RetainedEarningsMember 2023-12-31 0001748137 2023-12-31 0001748137 us-gaap:CommonStockMember 2022-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001748137 us-gaap:RetainedEarningsMember 2022-06-30 0001748137 2022-06-30 0001748137 us-gaap:CommonStockMember 2022-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001748137 us-gaap:RetainedEarningsMember 2022-09-30 0001748137 2022-09-30 0001748137 us-gaap:CommonStockMember 2022-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001748137 us-gaap:RetainedEarningsMember 2022-12-31 0001748137 2022-12-31 0001748137 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001748137 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001748137 2023-07-01 2023-09-30 0001748137 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0001748137 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0001748137 2023-10-01 2023-12-31 0001748137 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001748137 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001748137 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001748137 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001748137 2022-07-01 2022-09-30 0001748137 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001748137 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001748137 2022-10-01 2022-12-31 0001748137 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001748137 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001748137 us-gaap:CommonStockMember 2024-03-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001748137 us-gaap:RetainedEarningsMember 2024-03-31 0001748137 us-gaap:CommonStockMember 2023-03-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001748137 us-gaap:RetainedEarningsMember 2023-03-31 0001748137 2023-03-31 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:OneDealerMember 2023-07-01 2024-03-31 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:SecondDealerMember 2023-07-01 2024-03-31 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:ThirdDealerMember 2023-07-01 2024-03-31 0001748137 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember NEOV:OneDealerMember 2023-07-01 2024-03-31 0001748137 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember NEOV:SecondDealerMember 2023-07-01 2024-03-31 0001748137 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember NEOV:ThirdDealerMember 2023-07-01 2024-03-31 0001748137 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember NEOV:FourthDealerMember 2023-07-01 2024-03-31 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:OneDealerMember 2022-07-01 2023-03-31 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:SecondDealerMember 2022-07-01 2023-03-31 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:ThirdDealerMember 2022-07-01 2023-03-31 0001748137 us-gaap:CommonStockMember 2023-07-01 2024-03-31 0001748137 NEOV:InvestorWarrantsMember 2023-07-01 2024-03-31 0001748137 NEOV:UnderwriterWarrantsMember 2023-07-01 2024-03-31 0001748137 NEOV:RestrictedStockUnitsMember 2023-07-01 2024-03-31 0001748137 NEOV:UnderwrittenPublicOfferingMember NEOV:UnitsMember 2022-08-01 2022-08-31 0001748137 NEOV:UnderwrittenPublicOfferingMember NEOV:UnderwriterMember NEOV:NonTradeableWarrantsMember 2022-08-31 0001748137 NEOV:AugustPublicOfferingMember NEOV:May2018NotesPayableMember 2022-08-01 2022-08-31 0001748137 NEOV:AugustPublicOfferingMember NEOV:October2021NotesPayableMember 2022-08-01 2022-08-31 0001748137 srt:ChiefExecutiveOfficerMember NEOV:Milestone1Member 2022-07-01 2022-12-31 0001748137 srt:ChiefFinancialOfficerMember NEOV:Milestone1Member 2022-07-01 2022-12-31 0001748137 us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2024-03-31 0001748137 us-gaap:RestrictedStockUnitsRSUMember 2022-07-01 2023-03-31 0001748137 NEOV:ThreeIndependentDirectorsMember 2024-03-31 0001748137 NEOV:AmortizedValueOfRSUsGrantedMember 2023-07-01 2024-03-31 0001748137 NEOV:IndependentDirectorsMember 2023-07-01 2024-03-31 0001748137 NEOV:AmortizedValueOfSharesGrantedToVariousAdvisorsMember 2023-07-01 2024-03-31 0001748137 NEOV:FairValueOfIncentiveSharesWholesaleDealerMember 2023-07-01 2024-03-31 0001748137 NEOV:IndependentDirectorsMember 2023-10-01 2024-03-31 0001748137 NEOV:AmortizedValueOfRSUsGrantedMember 2022-07-01 2023-03-31 0001748137 NEOV:IndependentDirectorsMember 2022-07-01 2023-03-31 0001748137 NEOV:AmortizedValueOfSharesGrantedToVariousAdvisorsMember 2022-07-01 2023-03-31 0001748137 NEOV:FairValueOfIncentiveSharesTwoWholesaleDealerMember 2022-07-01 2023-03-31 0001748137 NEOV:StockOptionPlan2019Member 2019-02-28 0001748137 NEOV:StockOptionPlan2019Member NEOV:TwoExecutivesMember 2022-07-01 2023-06-30 0001748137 NEOV:StockOptionPlan2019Member NEOV:ThreeIndependentDirectorsMember 2022-07-01 2023-06-30 0001748137 2023-07-01 2023-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended March 31, 2024

 

or

 

Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ________________ to ______________

 

Commission File Number: 001-41447

 

NeoVolta, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   82-5299263

(State or other jurisdiction

of incorporation)

 

(I.R.S. Employer

Identification No.)

 

13651 Danielson Street, Suite A

Poway, CA

  92064

(Address of principal

executive offices)

  (zip code)

 

Registrant’s telephone number, including area code: (800) 364-5464

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol (s) Name of each exchange on which registered
Common Stock, par value $0.001 per share NEOV The NASDAQ Stock Market LLC
Warrants, each warrant exercisable for one share of common stock NEOVW The NASDAQ Stock Market LLC

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes: ☒      No: ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes: ☒      No: ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer ☐
Non-accelerated filer   Smaller reporting company
   

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No

 

The number of shares outstanding of Common Stock, par value $0.001 per share, as of May 10, 2024, was 33,236,091 shares.

 

   

 

 

NEOVOLTA, INC.

FORM 10-Q

MARCH 31, 2024

 

INDEX

 

  Page
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 3
   
PART I. FINANCIAL INFORMATION 4
   

Item 1. Financial Statements

4
Balance Sheets as of March 31, 2024 and June 30, 2023 (Unaudited) 4

Statements of Operations for the three months ended March 31, 2024 and 2023 (Unaudited)

5

Statements of Operations for the nine months ended March 31, 2024 and 2023 (Unaudited)

6

Statements of Stockholders’ Equity for the nine months ended March 31, 2024 and 2023 (Unaudited)

7

Statements of Cash Flows for the nine months ended March 31, 2024 and 2023 (Unaudited)

8
Notes to Financial Statements (Unaudited) 9
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 15
Item 3. Quantitative and Qualitative Disclosures About Market Risk 19
Item 4. Controls and Procedures 19
   

PART II. OTHER INFORMATION

20
   
Item 1. Legal Proceedings 20
Item 1A. Risk Factors 20
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 20
Item 3. Defaults Upon Senior Securities 20
Item 4. Mine Safety Disclosures 20
Item 5. Other Information 20
Item 6. Exhibits 21
Signatures 22

 

 

 

 

 

 2 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We make forward-looking statements under the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in other sections of this Report. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this Report. 

 

You should read the matters described in, and incorporated by reference in, “Risk Factors” and the other cautionary statements made in this Report, as being applicable to all related forward-looking statements wherever they appear in this Report. We cannot assure you that the forward-looking statements in this Report will prove to be accurate and therefore prospective investors are encouraged not to place undue reliance on forward-looking statements.

 

All forward-looking statements speak only at the date of the filing of this Quarterly Report. You should not rely upon forward-looking statements as predictions of future events. The reader should not place undue reliance on these forward-looking statements. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements we make in this Quarterly Report are reasonable, we provide no assurance that these plans, intentions or expectations will be achieved. We disclose important factors that could cause our actual results to differ materially from our expectations under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Quarterly Report and our Annual Report on Form 10-K for the year ended June 30, 2023, as filed with the SEC on September 22, 2023. These cautionary statements qualify all forward-looking statements attributable to us or persons acting on our behalf. We do not undertake any obligation to update or revise publicly any forward-looking statements except as required by law, including the securities laws of the United States and the rules and regulations of the SEC.

 

 

 

 

 

 3 

 

 

PART 1: FINANCIAL INFORMATION

 

ITEM 1 Financial Statements

 

NEOVOLTA, INC.

Balance Sheets

(Unaudited)
 

 

   March 31,   June 30, 
   2024   2023 
Assets          
Current assets:          
Cash and cash equivalents  $1,013,962   $2,002,789 
Accounts receivable, net   1,886,555    1,826,385 
Inventory   2,136,947    2,580,571 
Prepaid insurance and other current assets   115,224    96,119 
Total current assets   5,152,688    6,505,864 
           
Total assets  $5,152,688   $6,505,864 
           
Liabilities and Stockholders' Equity          
Current liabilities:          
Accounts payable  $3,167   $ 
Accrued liabilities   11,884    39,491 
Total current liabilities   15,051    39,491 
           
Commitments and contingencies (Note 3)        
           
Stockholders' equity:          
Common stock, $0.001 par value, 100,000,000 shares authorized, 33,236,091 shares and 33,155,127 shares issued and outstanding, respectively   33,236    33,155 
Additional paid-in capital   25,117,861    24,872,446 
Accumulated deficit   (20,013,460)   (18,439,228)
Total stockholders' equity   5,137,637    6,466,373 
           
Total liabilities and stockholders' equity  $5,152,688   $6,505,864 

 

See accompanying notes to unaudited financial statements.

 

 

 

 

 

 

 

 

 4 

 

 

NEOVOLTA, INC.

Statements of Operations

(Unaudited)

 

 

           
   Three Months Ended 
   March 31, 
   2024   2023 
         
Revenues from contracts with customers  $283,900   $629,010 
Cost of goods sold   117,755    537,261 
Gross profit   166,145    91,749 
           
Operating expenses:          
General and administrative   756,118    723,271 
Research and development   10,392    1,290 
Total operating expenses   766,510    724,561 
           
Loss from operations   (600,365)   (632,812)
           
Other income:          
Interest income   10,892     
Total other income   10,892     
           
Net loss  $(589,473)  $(632,812)
           
Weighted average shares outstanding - basic and diluted   33,236,091    33,151,685 
           
Net loss per share - basic and diluted  $(0.02)  $(0.02)

 

See accompanying notes to unaudited financial statements.

 

 

 

 

 

 

 

 5 

 

 

NEOVOLTA, INC.

Statements of Operations

(Unaudited)

 

 

           
   Nine Months Ended 
   March 31, 
   2024   2023 
         
Revenues from contracts with customers  $2,065,858   $2,733,951 
Cost of goods sold   1,572,668    2,302,380 
Gross profit   493,190    431,571 
           
Operating expenses:          
General and administrative   2,085,976    2,716,428 
Research and development   10,392    29,936 
Total operating expenses   2,096,368    2,746,364 
           
Loss from operations   (1,603,178)   (2,314,793)
           
Other income (expense):          
Interest income   28,946     
Interest expense       (4,134)
Total other income (expense)   28,946    (4,134)
           
Net loss  $(1,574,232)  $(2,318,927)
           
Weighted average shares outstanding - basic and diluted   33,205,766    31,650,491 
           
Net loss per share - basic and diluted  $(0.05)  $(0.07)

 

See accompanying notes to unaudited financial statements.

 

 

 

 

 

 

 

 

 

 

 6 

 

 

NEOVOLTA, INC.

Statements of Stockholders' Equity

Nine Months Ended March 31, 2024 and 2023

(Unaudited)

 

                     
           Additional       Total 
   Common Stock   Paid-in   Accumulated   Stockholders' 
   Shares   Amount   Capital   Deficit   Equity 
                     
Balance at June 30, 2023   33,155,127   $33,155   $24,872,446   $(18,439,228)  $6,466,373 
                          
Stock compensation expense           84,717        84,717 
Net loss               (428,715)   (428,715)
                          
Balance at September 30, 2023   33,155,127    33,155    24,957,163    (18,867,943)   6,122,375 
                          
Stock compensation expense   80,964    81    97,060        97,141 
Net loss               (556,044)   (556,044)
                          
Balance at December 31, 2023   33,236,091    33,236    25,054,223    (19,423,987)   5,663,472 
                          
Stock compensation expense           63,638        63,638 
Net loss               (589,473)   (589,473)
                          
Balance at March 31, 2024   33,236,091   $33,236   $25,117,861   $(20,013,460)  $5,137,637 

 

 

 

           Additional       Total 
   Common Stock   Paid-in   Accumulated   Stockholders' 
   Shares   Amount   Capital   Deficit   Equity 
                     
Balance at June 30, 2022   21,977,251   $21,978   $18,394,641   $(15,799,395)  $2,617,224 
                          
Issuance of common stock in underwritten public offering   1,121,250    1,121    3,779,284        3,780,405 
Issuance of common stock for conversion of debt and accrued interest   9,671,867    9,672    1,169,614        1,179,286 
Stock compensation expense           591,816        591,816 
Net loss               (698,586)   (698,586)
                          
Balance at September 30, 2022   32,770,368    32,771    23,935,355    (16,497,981)   7,470,145 
                          
Stock compensation expense   75,000    75    719,220        719,295 
Net loss               (987,529)   (987,529)
                          
Balance at December 31, 2022   32,845,368    32,846    24,654,575    (17,485,510)   7,201,911 
                          
Stock compensation expense   309,759    309    108,781        109,090 
Net loss               (632,812)   (632,812)
                          
Balance at March 31, 2023   33,155,127   $33,155   $24,763,356   $(18,118,322)  $6,678,189 

 

See accompanying notes to unaudited financial statements.

 

 

 7 

 

 

NEOVOLTA, INC.

Statements of Cash Flows

(Unaudited)

 

           
   Nine Months Ended 
   March 31, 
   2024   2023 
Cash flows from operating activities:          
Net loss  $(1,574,232)  $(2,318,927)
Adjustments to reconcile net loss to net cash used in operations:          
Stock compensation expense   245,496    1,420,201 
Provision for expected credit losses/bad debt expense   670,000    380,000 
Changes in current assets and liabilities          
Accounts receivable   (730,170)   (799,913)
Inventory   443,624    875,919 
Prepaid insurance and other current assets   (19,105)   33,291 
Accounts payable   3,167    (205,600)
Accrued expenses   (27,607)   (35,571)
Net cash flows used in operating activities   (988,827)   (650,600)
           
Cash flows from financing activities:          
Underwritten public offering of common stock       3,780,405 
Net cash flows provided by financing activities       3,780,405 
           
Net increase (decrease) in cash and cash equivalents   (988,827)   3,129,805 
           
Cash and cash equivalents at beginning of period   2,002,789    330,385 
           
Cash and cash equivalents at end of period  $1,013,962   $3,460,190 
           
Supplemental disclosures of cash flow information          
Cash paid for interest  $   $ 
Cash paid for income taxes        
           
Supplemental non-cash financing activities          
Conversion of convertible debt and accrued interest into common stock  $   $1,179,286 

 

See accompanying notes to unaudited financial statements.

 

 

 

 8 

 

 

NEOVOLTA, INC.

Notes to Financial Statements

(Unaudited)

 

 

(1)       Business and Summary of Significant Accounting Policies

 

Description of Business – NeoVolta Inc. (“we”, “our” or the “Company”) is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 2).

 

Interim Financial Information – The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of March 31, 2024, the results of its operations for the three and nine month periods ended March 31, 2024 and 2023, the changes in its stockholders’ equity for the nine month periods ended March 31, 2024 and 2023, and cash flows for the nine month periods ended March 31, 2024 and 2023. The balance sheet as of June 30, 2023 has been derived from the Company’s June 30, 2023 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2023, as filed with the SEC on September 22, 2023.

 

Cash and Cash Equivalents – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents. Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000, per bank. At March 31, 2024, the Company maintained accounts at two different banks, of which the combined balances of the accounts at the two banks were in excess of the combined FDIC insurance limits by $513,962.

 

Inventory – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Additionally, we made a bulk purchase of raw materials consisting of assembly parts from our former contract manufacturer in April 2023, for a gross amount of $1.4 million. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. No inventory reserve was required as of March 31, 2024 and June 30, 2023. The following table presents the components of inventory as of March 31, 2024 and June 30, 2023:

 

 Schedule of inventory  March 31, 2024   June 30, 2023 
         
Raw materials, consisting of assembly parts, batteries and inverters  $1,502,119   $2,353,055 
Finished goods   634,828    227,516 
Total  $2,136,947   $2,580,571 

 

 

 

 9 

 

 

Revenue Recognition – The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

 

·Identification of the contract with a customer
·Identification of the performance obligations in the contract
·Determination of the transaction price
·Allocation of the transaction price to the performance obligations in the contract
·Recognition of revenue when, or as, the Company satisfies a performance obligation

 

The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three dealers represented approximately 25%, 17% and 11% of the Company’s revenues in the nine months ended March 31, 2024, however, no other dealers accounted for more than 10% of the revenues in such period. Four dealers represented approximately 22%, 20%, 17% and 13% of the Company’s gross accounts receivable as of March 31, 2024. Three such dealers represented approximately 21%, 18% and 16% of the Company’s revenues in the nine months ended March 31, 2023. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the nine months ended March 31, 2024 and 2023 is provided.

 

Allowance for Expected Credit Losses – The Company recognizes an allowance for expected credit losses whenever a loss is expected to be incurred in the realization of a customer’s account. As of March 31, 2024 and June 30, 2023, our allowance for expected credit losses was $1,160,000 and $490,000, respectively.

 

Income Taxes – The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of reported assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.

 

The Company accounts for uncertain tax positions in accordance with the provisions of Accounting Standards Codification (“ASC”) 740-10 which prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken, or expected to be taken, on its tax return. The Company evaluates and records any uncertain tax positions based on the amount that management deems is more likely than not to be sustained upon examination and ultimate settlement with the tax authorities in the tax jurisdictions in which it operates.

 

Stock Compensation Expense – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.

 

Loss Per Common Share – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of March 31, 2024, the Company had total outstanding common stock equivalents of 1,229,750 shares as follows: (i) 1,121,250 shares related to warrants issued to investors in the public offering completed in August 2022; (ii) 58,500 shares related to warrants issued to the underwriters in that same offering, and (iii) 50,000 shares related to restricted stock units granted to two officers in March 2022 (see Note 2).

 

 

 

 10 

 

 

Research and Development Costs – Research and development costs are expensed as incurred.

 

Use of Estimates – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates. As a result of the continued spread of the COVID-19 coronavirus since early 2020, economic uncertainties have arisen which could impact business operations, supply chains, energy demand, and commodity prices that are beyond our control. Overall, we have not experienced a material adverse impact to our economic performance or ability to continue our business operations as a result of COVID-19. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time.

 

Related Parties – The Company accounts for related party transactions in accordance with ASC 850. A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that it might be prevented from fully pursuing its own separate interests is also a related party.

 

Fair Value Measurements and Financial Instruments – ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: 

 

Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

 

Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

Level 3 - Inputs that are both significant to the fair value measurement and unobservable.  The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, and accounts payable.

 

At March 31, 2024 and June 30, 2023, the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis.

 

Recent Accounting Pronouncements – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements. Effective July 1, 2023, the Company adopted the provisions of ASC 326 (Financial Instruments – Credit Losses) pertaining to “current expected credit losses,” which had no material impact on the Company’s financial statements.

 

 

 

 11 

 

 

Liquidity – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary equity financing to continue operations and the attainment of profitable operations. As disclosed in Note 2, we completed a public offering of our equity securities in August 2022 that raised total net proceeds of approximately $3,780,000. As of March 31, 2024, we had a cash balance of $1,013,962 and net working capital of $5,137,637. We anticipate that we will have sufficient cash resources in order to operate our business for at least the next 12 months from the date these financial statements are issued, without new sources of capital.

 

(2)       Equity

 

Common Stock – In August 2022, the Company completed an underwritten public offering of its equity securities in the form of Units with each Unit consisting of one share of common stock and one warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of common stock at an exercise price of $4.00 per share. The shares of common stock and the Warrants comprising the Units were immediately separated at closing of the offering and each is now independently listed on the NASDAQ Capital Market. Each Warrant became exercisable on the date of issuance and will expire five years from the date of issuance.

 

In the underwritten public offering, a total of 1,121,250 Units, including exercise of the underwriter’s overallotment option, were sold at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs were approximately $3,780,000. The Company also granted the underwriter non-tradeable warrants to purchase a total of 58,500 shares of common stock at an exercise price of $4.40 per share for a period of five years.

 

In conjunction with the public offering, all holders of the Company’s 2018 convertible notes in the total amount of $59,251, including accrued interest, converted their debt into a total of 9,404,867 shares of common stock at the stated conversion rate, and all holders of the Company’s 2021 convertible notes in the total amount of $1,120,035, including accrued interest, automatically converted their debt into a total of 267,000 shares of common stock at the stated conversion rate.

 

Warrants – The Warrants for a total of 1,179,750 shares of common stock issued to investors and the underwriters are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance, or August 1, 2027. The Warrants may be exercised upon payment of the exercise price in cash on or prior to the expiration date. Under the terms of the Warrant Agreement, we must use our best efforts to maintain the effectiveness of the registration statement and current prospectus relating to common stock issuable upon exercise of the Warrants until the expiration of the Warrants. If we fail to maintain the effectiveness of the registration statement and current prospectus relating to the common stock issuable upon exercise of the Warrants, the holders of the Warrants shall have the right to exercise the Warrants solely via a cashless exercise feature provided for in the Warrants, until such time as there is an effective registration statement and current prospectus. As of the date of this report, the Company has not maintained the effectiveness of the registration statement and the Warrants may be exercised on a cashless basis.

 

The following table presents activity with respect to the Company’s warrants for the nine months ended March 31, 2024:

Schedule of warrant activity                
   Number   Wtd. Avg.   Wtd. Avg.   Aggregate 
   of   Exercise   Remaining   Intrinsic 
   Shares   Price   Term (Yrs.)   Value 
Outstanding at June 30, 2023   1,179,750   $4.02           
Warrants issued                  
Warrants exercised/forfeited                  
Outstanding at March 31, 2024   1,179,750   $4.02    3.3   $ 
                     
Exercisable at March 31, 2024   1,179,750   $4.02    3.3   $ 

 

 

 

 12 

 

 

These warrants were issued in conjunction with an underwritten public equity offering, therefore, there was no employee or non-employee compensation expense recognized.

 

Stock Compensation Expense – In February 2022, we entered into a new employment agreement with our Chief Executive Officer (“CEO”), effective April 1, 2022. The initial term of the employment agreement was one year and is automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. The agreement provides for an initial annual salary of $165,000. Pursuant to the agreement, we issued our CEO a restricted stock unit (“RSU”) award for up to 150,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 50,000 shares; and (ii) Milestone 2 - Produce 2,000 ESSs in 2022 and continue his employment with our company until January 1, 2023: 100,000 shares. As of December 31, 2023, Milestone 1 was achieved, however, Milestone 2 was not achieved. The underlying 50,000 shares of common stock earned under Milestone 1 were issued to our CEO as of January 1, 2023.

 

In February 2022, we entered into a new employment agreement with our Chief Financial Officer (“CFO”), effective March 1, 2022. The initial term of the employment agreement is one year and is automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. The agreement provides for an initial annual salary of $125,000. Pursuant to the agreement, we issued our CFO an RSU award for up to 300,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 250,000 shares; and (ii) Milestone 2 - successfully complete and file the Company’s Form 10-K for the year ended June 30, 2023 no later than September 29, 2023 and continue his employment with our company until January 1, 2024: 50,000 shares. Milestone 1 was achieved as of January 1, 2023, and the underlying 250,000 shares of common stock earned under Milestone 1 were issued to our CFO as of that date. Milestone 2 was achieved as of January 1, 2024, and the underlying 50,000 shares of common stock earned under Milestone 2 are expected to be issued to our CFO in May 2024.

 

Based upon management’s assessment of the probability of our CEO and CFO ultimately achieving each milestone specified under the RSU awards indicated above, we calculated the grant date value of such awards and are amortizing it as stock compensation expense over the underlying performance periods. We have recognized stock compensation expense applicable to such RSU awards in the nine months ended March 31, 2024 and 2023 in the amounts of $81,683 and $1,200,723, respectively.

 

In conjunction with our public offering in August 2022, we appointed two new independent directors and adopted a new compensation plan for all independent directors based on an annual compensation amount of $65,000 with not less than 70% of such amount paid in shares of our common stock, calculated based on the share price at the end of such prior fiscal quarter, and up to 30% paid in cash, with such final amounts to be determined by each director. As of March 31, 2024, we booked an accrual of $146,250 of compensation expense (of which $131,625 will be settled through the issuance of shares) for our three independent directors under this plan.

 

In the nine months ended March 31, 2024, we recognized total non-cash stock compensation expense of $245,496 as follows: (i) $81,683 for the amortized value of the RSUs granted to our two executive officers, as previously described; (ii) $131,625 for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock; (iii) $19,763 for the amortized value of the shares granted to various advisors under their annual service contracts; and (iv) $12,425 for the fair value of incentive shares earned by a wholesale dealer as of December 31, 2023 (see Note 3). There was a total of 80,964 shares of common stock that were issued to our independent directors in the nine months ended March 31, 2024, which were previously expensed in the year ended June 30, 2023.

 

In the nine months ended March 31, 2023, we recognized total non-cash stock compensation expense of $1,420,201 as follows: (i) $1,200,723 for the amortized value of the RSUs granted to our two executive officers, as previously described; (ii) $131,625 for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock; (iii) $60,625 for the net amortized value of the shares granted to various advisors under their annual service contracts; and (iv) $27,228 for the fair value of incentive shares earned by two wholesale dealers as of December 31, 2022 (see Note 3). There was a total of 384,759 shares of common stock that were issued to various grantees, including our two executive officers, in the nine months ended March 31, 2023, of which 75,000 shares were previously expensed in the year ended June 30, 2022.

 

 

 

 13 

 

 

Other Matters – In February 2019, the Company’s Board of Directors approved the establishment of a new 2019 Stock Plan (“Plan”) with an authorization for the issuance of up to 2,500,000 shares of common stock. The Plan is designed to provide for future discretionary grants of stock options, stock awards and stock unit awards to key employees, consultants, advisors, and non-employee directors. As of March 31, 2024, the Company has made awards under the Plan as follows: (i) 450,000 shares for the RSUs granted to our two executive officers, as noted above; (ii) 54,964 shares for the initial services of our three independent directors in the year ended June 30, 2023, pursuant to the new compensation plan adopted in August 2022 for independent directors; and (iii) 32,858 shares granted to several wholesale dealers under an incentive sales program.

 

(3)       Commitments and Contingencies

 

Effective January 1, 2021, we secured new corporate and manufacturing office space under a sublease agreement with a company that served as our contract manufacturer at that time. Under the terms of the sublease agreement, we were required to make rental payments of $10,350 per month during the initial one-year term of the agreement. Further, under the terms of the sublease agreement, we were granted the right to renew the sublease for additional terms of 12 months each upon mutual agreement of both parties, provided thirty days’ notice is given for each subsequent term, at a modest increase in the monthly rent, through February 28, 2025. However, we were under no obligation to renew it. At inception of the sublease, management determined that exercise of the renewal option was not reasonably certain and, notwithstanding that the Company elected to renew the agreement for additional one year periods as of January 1, 2022, 2023 and 2024, continues to believe that is the case. Accordingly, we have accounted for it as a short-term lease under ASC 842, Leases. Under an amendment to our supply agreement with our former contract manufacturer in April 2023, we took over direct responsibility for the manufacturing process surrounding our ESS units on June 1, 2023, however, that amendment had no effect on the sublease agreement with our former contract manufacturer.

 

As indicated in Note 1, we sell our proprietary ESS units through wholesale dealers, primarily in California. In that regard, we have entered into agreements with several wholesale dealers operating in California and other states under which we have incentivized the dealers to achieve quarterly sales above targeted levels by agreeing to grant them shares of our common stock for exceeding such quarterly sales targets, determined as of the calendar year end, subject to defined maximums.

 

From time to time in the ordinary course of our business, the Company may be involved in legal proceedings, the outcomes of which may not be determinable. The Company is not involved in any legal proceedings at this time. The results of litigation are inherently unpredictable. Any claims against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable.

 

(4)        Subsequent Events

 

Effective April 29, 2024, the Company engaged a new Chief Executive Officer (“CEO”), replacing the Company’s former chief executive officer and founder who remains as Chairman of the Board and chief technology officer. The Company has entered into an employment agreement with the new CEO providing for an initial term extending through June 30, 2027, which will be automatically renewed for additional one-year terms unless either party chooses not to renew it. Pursuant to the agreement, the new CEO received an initial equity grant equal to 1,280,000 RSUs, which will vest over a four-year period, subject to his continued employment with the Company, and will be entitled to earn additional RSU’s in the form of three annual performance-based equity grants, beginning in the year ending June 30, 2025, with a target value of up to $660,000 each.

 

 

 

 

 

 

 

 14 

 

 

ITEM 2.MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Introduction

 

This information should be read in conjunction with the interim unaudited financial statements and the notes thereto included in this Quarterly Report on Form 10-Q, and the audited financial statements and notes thereto and “Part II. Other Information - Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations”, contained in our Annual Report on Form 10-K for the year ended June 30, 2023, filed with the Securities and Exchange Commission on September 22, 2023 (the “Annual Report”).

 

Certain capitalized terms used below and otherwise defined below, have the meanings given to such terms in the footnotes to our unaudited financial statements included above under “Part I - Financial Information” - “Item 1. Financial Statements”.

 

Unless the context requires otherwise, references to the “Company,” “we,” “us,” “our,” “NEOV”, refer specifically to NeoVolta, Inc.

 

In addition, unless the context otherwise requires and for the purposes of this Report only:

 

·“Exchange Act” refers to the Securities Exchange Act of 1934, as amended; 
   
·“SEC” or the “Commission” refers to the United States Securities and Exchange Commission; and 
   
·“Securities Act” refers to the Securities Act of 1933, as amended. 

 

Overview

 

We are a designer, manufacturer, and seller of high-end Energy Storage Systems (or ESS), primarily our NeoVolta NV14, NV14-K, and NV-24, which can store and use energy via batteries and an inverter at residential or commercial sites. We were founded to identify new ways to leverage emerging technologies with the dynamic changes that are taking place in the energy delivery space. We primarily market and sell our products directly to our certified solar installers and solar equipment distributors. We are also pursuing agreements with residential developers, commercial developers, and other commercial opportunities. Because we are purely dedicated to energy solar systems, virtually all our current resources and efforts go into further developing our flagship NV14, NV14-K, and NV-24 products, while focusing on specific industry needs for our next generation of products. We believe we are unique in the marketplace due to our low cost, our innovative battery chemistry, our product versatility and our commitment to installer service. Because of these factors, we believe NeoVolta is uniquely equipped to establish itself as a major player in the energy storage market.

 

In May 2019, we completed a public offering of 3,500,000 shares of our common stock at an offering price of $1.00 per share for gross proceeds of $3.5 million pursuant to Regulation A of the Securities Act. We used the proceeds of the offering to ramp up production, marketing, and sales of our NV14 product line. In that regard, we used the proceeds from the offering to fund the marketing, production and distribution of our products, which commenced in July 2019 through a group of wholesale customers in California, as well as to provide additional working capital for other corporate purposes. We have expanded to include one wholesale distribution customer in Nevada. As of the current date, we have had successful installations of our products in the additional States of Arizona, Utah, Colorado, Wyoming, Texas, Oklahoma, Missouri, Tennessee, Alabama, Georgia, Florida, and Puerto Rico.

 

As further discussed below under “Liquidity and Capital Resources,” we completed an underwritten public offering of our equity securities in the form of Units in August 2022. We sold a total of 1,121,250 Units in the offering at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs, were approximately $3,780,000. We are using the proceeds of this public offering to increase our current production capacity, expand our product portfolio, enlarge our product marketing and sales efforts, and for other general corporate purposes.

 

 

 

 15 

 

 

On April 14, 2023, California implemented Net Energy Metering 3 (NEM3) for subsequent new solar installations. NEM3 reduces the amount of NEM credit for each kilowatt (KW) of solar power sent to the utility from a rate of approximately $0.20 per KW to $0.09 per KW (each Utility varies). NEM3 effectively increases the average solar Return of Investment (ROI) from 5-6 years to 10-12 years (each Utility varies). Effectively, the Company believes that solar installation in California currently makes little financial sense without also including a battery system. Installing NeoVolta nets a ROI of 4-6 years. We estimate that NEM3 reduced our sales from the enactment date in December 2022 continuing through the recently competed quarter ended March 31, 2024, as solar installers worked off their permitted NEM2 installs. We expect our sales to gradually increase going forward.

 

Results of Operations

 

The following discussion reflects the Company’s revenues and expenses for the three and nine month periods ended March 31, 2024 and 2023, as reported in our financial statements included in Item 1.

 

Three months ended March 31, 2024 versus three months ended March 31, 2023

 

Revenues - Revenues from contracts with customers for the three months ended March 31, 2024 were $283,900 compared to $629,010 for the three months ended March 31, 2023. Such decrease was primarily due to various macroeconomic and regulatory factors including the negative impact of new utility regulations in the State of California that we believe has caused a temporary economic disincentive for residential utility customers to acquire our energy storage systems since the December 2022 enactment date and continuing through the three months ended March 31, 2024.

 

Cost of Goods Sold - Cost of goods sold for the three months ended March 31, 2024 were $117,755 compared to $537,261 for the three months ended March 31, 2023. The cost of goods sold in both periods reflected the cost of procuring and assembling the component parts of the energy storage systems that were sold in each fiscal period. The resulting improvement in our reported gross profit in the three months ended March 31, 2024 compared to the three months ended March 31, 2023, however, was largely due to the reversal in the three months ended March 31, 2024 of an inadvertent overcharge of $93,000 that was made to Cost of goods sold in the three months ended December 31, 2023.

 

General and Administrative Expense - General and administrative expenses for the three months ended March 31, 2024 were $756,118 compared to $723,271 for the three months ended March 31, 2023. Such increase was primarily due to a higher allowance for expected credit losses in the three months ended March 31, 2024 of $340,000, compared to $300,000 in the three months ended March 31, 2023, partially offset by a decrease in stock compensation expense related to the Company’s equity incentive programs.

 

Research and Development Expense - Research and development expenses for the three months ended March 31, 2024 were $10,392 compared to $1,290 for the three months ended March 31, 2023. Such fluctuation was largely due to timing differences in the level of the Company’s recent product development efforts.

 

Other Income and Expense - Interest income for the three months ended March 31, 2024 was $10,892 compared to zero for the three months ended March 31, 2023. This increase was due to rising money market rates which have enabled the Company to earn interest on its investable cash in the three months ended March 31, 2024.

 

Net Loss - Net loss for the three months ended March 31, 2024 was $589,473 compared to $632,812 for the three months ended March 31, 2023, representing the aggregate of the various revenue and expense categories indicated above. The Company has not recognized any income tax benefit for these net losses due to the uncertainty of its ultimate realization.

 

 

 

 16 

 

 

Nine months ended March 31, 2024 versus nine months ended March 31, 2023

 

Revenues - Revenues from contracts with customers for the nine months ended March 31, 2024 were $2,065,858 compared to $2,733,951 for the nine months ended March 31, 2023. Such decrease was primarily due to various macroeconomic and regulatory factors including the negative impact of new utility regulations in the State of California that we believe has caused a temporary economic disincentive for residential utility customers to acquire our energy storage systems since the December 2022 enactment date and continuing through the nine months ended March 31, 2024.

 

Cost of Goods Sold - Cost of goods sold for the nine months ended March 31, 2024 were $1,572,668 compared to $2,302,380 for the nine months ended March 31, 2023. The cost of goods sold in both periods reflected the cost of procuring and assembling the component parts of the energy storage systems that were sold in each fiscal period. Due to efficiencies that we have realized from taking over responsibility for manufacturing of our products from a contract operator since last year, we have improved gross profit to $493,190 in the nine months ended March 31, 2024 compared to $431,571 in the nine months ended March 31, 2023.

 

General and Administrative Expense - General and administrative expenses for the nine months ended March 31, 2024 were $2,085,976 compared to $2,716,428 for the nine months ended March 31, 2023. Such decrease was due to a reduction in stock compensation expense related to the Company’s equity incentive programs, partially offset by a higher allowance for expected credit losses in the nine months ended March 31, 2024 of $670,000, compared to $380,000 in the nine months ended March 31, 2023.

 

Research and Development Expense - Research and development expenses for the nine months ended March 31, 2024 were $10,392 compared to $29,936 for the nine months ended March 31, 2023. Such fluctuation was largely due to timing differences in the level of the Company’s recent product development efforts.

 

Other Income and Expense - Interest income for the nine months ended March 31, 2024 was $28,946 compared to zero for the nine months ended March 31, 2023. This increase was due to rising money market rates which have enabled the Company to earn interest on its investable cash in the nine months ended March 31, 2024. Interest expense for the nine months ended March 31, 2024 was zero compared to $4,134 for the nine months ended March 31, 2023. This decrease resulted from the conversion of our 2018 and 2021 convertible notes in conjunction with the closing of our public equity offering in August 2022.

 

Net Loss - Net loss for the nine months ended March 31, 2024 was $1,574,232 compared to $2,318,927 for the nine months ended March 31, 2023, representing the aggregate of the various revenue and expense categories indicated above. The Company has not recognized any income tax benefit for these net losses due to the uncertainty of its ultimate realization.

 

Liquidity and Capital Resources

 

Operating activities. Net cash used in operating activities in the nine months ended March 31, 2024 was $988,827 compared to $650,600 in the nine months ended, March 31, 2023, reflecting a modest decrease in the impact of changes in working capital on net operating cash flow in the current fiscal year period.

 

Financing activities. Net cash provided by financing activities in the nine months ended March 31, 2024 was zero, compared to $3,780,405 in the nine months ended March 31, 2023. As further discussed below, our net cash provided by financing activities in the nine months ended March 31, 2023 was entirely attributable to the successful completion of an underwritten public offering of our equity securities in early August 2022.

 

We completed an underwritten public offering of our equity securities in the form of Units in early August 2022. Each Unit consisted of one share of common stock and one warrant to purchase one share of common stock at an exercise price of $4.00 per share. We sold a total of 1,121,250 Units in the offering at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering, including the underwriters’ exercise of the overallotment option, were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs, were approximately $3,780,000.

 

 

 

 17 

 

 

In conjunction with the public offering, all holders of our 2018 convertible notes in the total amount of $59,251, including accrued interest, converted their debt into a total of 9,404,867 shares of common stock at the stated conversion rate, and all holders of our 2021 convertible notes in the total amount of $1,120,035, including accrued interest, automatically converted their debt into a total of 267,000 shares of common stock at the stated conversion rate. As a result of the simultaneous conversion of both sets of convertible notes, the Company fully eliminated its convertible debt.

 

As of March 31, 2024, we had a cash balance of approximately $1.0 million and net working capital of approximately $5.1 million. Currently, we are not generating a break-even level of net operating cash flow from our net sales. However, we anticipate that demand for our products will ultimately increase over time and that we will have sufficient cash to operate for at least the next 12 months.

 

Assembly Inventory Purchase

 

In April 2023, we made a bulk purchase of raw materials inventory from our contract manufacturer by making a cash payment to that company in the net amount of approximately $1.3 million. This transaction was completed pursuant to an amendment of our Master Supply Agreement with our contract manufacturer. In addition to the purchase of the raw materials inventory from our contract manufacturer, this amendment provided for the eventual assumption by us of full responsibility from our contract manufacturer for the manufacturing of our proprietary Energy Storage Systems (“ESS”) units. Pursuant to the amendment, we assumed such responsibility for the manufacturing process surrounding our ESS units from our contract manufacturer on June 1, 2023. In conjunction with assuming this responsibility, we hired the two employees of our contract manufacturer who previously performed contract manufacturing services for us. We are expecting to hire additional “assemblers” in the fairly near future.

 

Other Developments

 

In calendar year 2022, we experienced some negative impact of the COVID-19 pandemic on the sales of our assembled energy storage systems, primarily through a group of wholesale dealers and installers located in California. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time.

 

Additionally, we continue to monitor current international developments occurring in Ukraine and Israel. However, we do not believe that they will have a significant impact on either the domestic markets for our products or the international supply chains for our product components, which are largely sourced from Asia.

 

Off-Balance Sheet Arrangements

 

We have no obligations, assets or liabilities which would be considered off-balance sheet arrangements as defined in Item 303 of Regulation S-K.

 

Critical Accounting Policies and Estimates

 

Our discussion and analysis of our financial condition and results of operations are based on financial statements which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We believe that certain accounting policies affect our more significant judgments and estimates used in the preparation of our financial statements. See “Note 1. Business and Summary of Significant Accounting Policies” of the Notes to Financial Statements set forth above and under “Item 8. Financial Statements and Supplementary Data” of our Annual Report on Form 10-K for the year ended June 30, 2023, as filed with the SEC on September 22, 2023, for a further description of our critical accounting policies and estimates.

 

 

 

 18 

 

 

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Information for this Item is not required as the Registrant is a “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act.

 

ITEM 4.CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

We have established and maintain a system of disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our reports filed with the Securities and Exchange Commission pursuant to the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Commission and that such information is accumulated and communicated to our management, including our Chief Executive Officer, who is our principal executive officer, and Chief Financial Officer, who is our principal financial and accounting officer, to allow timely decisions regarding required disclosures.

 

As of March 31, 2024, our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as a result of the material weakness relating to the lack of segregation of duties, our disclosure controls and procedures as of the end of the period covered by this Quarterly Report were not effective. Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. We will be required to hire additional personnel in order to remediate our material weakness.

 

Limitations on Effectiveness of Controls and Procedures

 

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

 

Changes in Internal Controls over Financial Reporting

 

There was no change in our internal controls over financial reporting that occurred during the quarter ended March 31, 2024, that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

 

 

 

 

 

 19 

 

 

PART II. OTHER INFORMATION

 

 

ITEM 1.LEGAL PROCEEDINGS

 

Although we may, from time to time, be involved in litigation and claims arising out of our operations in the normal course of business, we are not currently a party to any material legal proceeding. In addition, we are not aware of any material legal or governmental proceedings against us, or contemplated to be brought against us.

 

ITEM 1A.RISK FACTORS

 

There have been no material changes from the risk factors previously disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended June 30, 2023, as filed with the SEC on September 22, 2023 (the “Form 10-K”), under the heading “Risk Factors”, and investors should review the risks provided in the Form 10-K prior to making an investment in the Company. The business, financial condition and operating results of the Company can be affected by a number of factors, whether currently known or unknown, including but not limited to those described in the Form 10-K for the year ended June 30, 2023, under “Risk Factors”, any one or more of which could, directly or indirectly, cause the Company’s actual financial condition and operating results to vary materially from past, or from anticipated future, financial condition and operating results. Any of these factors, in whole or in part, could materially and adversely affect the Company’s business, financial condition, operating results and stock price.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

There were no sales of unregistered securities during the three months ended March 31, 2024.

 

ITEM 3.DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4.MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5.OTHER INFORMATION

 

During the period covered by this Quarterly Report, none of the Company’s directors or executive officers has adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (each as defined in Item 408 of Regulation S-K under the Securities Exchange Act of 1934, as amended).

 

 

 

 

 20 

 

 

ITEM 6.EXHIBITS

 

Exhibit No.   Exhibit Description
10.1   Employment Agreement between NeoVolta, Inc. and Ardes Johnson dated April 19, 2024 (incorporated by reference to exhibit 10.1 of the Form 8-K filed April 24, 2024)
10.2   Amendment to Employment Agreement between NeoVolta, Inc. and Brent Willson dated April 22, 2022 (incorporated by reference to exhibit 10.2 of the Form 8-K filed April 24, 2024)
31.1*   Certification of Principal Executive Officer Pursuant to Section 302 of Sarbanes- Oxley Act of 2002
31.2*   Certification of Principal Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002
32.1*   Certification of Principal Executive Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Principal Financial Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS *   Inline XBRL Instance Document
101.SCH *   Inline XBRL Taxonomy Extension Schema Document
101.CAL *   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF *   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB *   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE *   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

______________________

* Filed herewith.

 

 

 

 

 

 

 

 

 21 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  NEOVOLTA, INC.  
     
     
May 10, 2024 /s/ Ardes Johnson  
  Ardes Johnson  
  Chief Executive Officer  
  (Principal Executive Officer)  

 

May 10, 2024 /s/ Steve Bond  
  Steve Bond  
  Chief Financial Officer  
  (Principal Financial/Accounting Officer)  

 

 

 

 

 

 

 22 

EX-31.1 2 neovolta_ex3101.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION

 

I, H. Ardes Johnson, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of NeoVolta, Inc. (the “registrant”);
   
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
   
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
   
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):
   
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 10, 2024

 

 

/s/ H. Ardes Johnson

H. Ardes Johnson

Chief Executive Officer

(Principal Executive Officer)

 

EX-31.2 3 neovolta_ex3102.htm CERTIFICATION

Exhibit 31.2

 

CERTIFICATION

 

I, Steve Bond, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of NeoVolta, Inc. (the “registrant”);
   
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
   
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
   
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):
   
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 10, 2024

 

/s/ Steve Bond

Steve Bond

Chief Financial Officer

(Principal Financial/Accounting Officer)

 

EX-32.1 4 neovolta_ex3201.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of NeoVolta, Inc. (the “registrant”) on Form 10-Q for the quarter ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, H. Ardes Johnson, Chief Executive Officer of the registrant, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of this Sarbanes Oxley Act of 2002, that, to my knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the registrant at the dates and for the periods indicated.

 

 

/s/ H. Ardes Johnson                                           

H. Ardes Johnson

Chief Executive Officer

(Principal Executive Officer)

May 10, 2024

 

 

EX-32.2 5 neovolta_ex3202.htm CERTIFICATION

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of NeoVolta, Inc. (the “registrant”) on Form 10-Q for the quarter ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Steven Bond, Chief Financial Officer of the registrant, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of this Sarbanes Oxley Act of 2002, that, to my knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the registrant at the dates and for the periods indicated.

 

 

/s/ Steve Bond                                          

Steve Bond

Chief Financial Officer

(Principal Financial/Accounting Officer)

May 10, 2024

 

GRAPHIC 6 image_001.jpg GRAPHIC begin 644 image_001.jpg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end EX-101.SCH 7 neov-20240331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements of Operations (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Statements of Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 995513 - Disclosure - Business and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995514 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995516 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995517 - Disclosure - Business and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995518 - Disclosure - Business and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995519 - Disclosure - Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 995520 - Disclosure - Schedule of inventory (Details) link:presentationLink link:calculationLink link:definitionLink 995521 - Disclosure - Business and Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995522 - Disclosure - Equity (Details - Warrant activity) link:presentationLink link:calculationLink link:definitionLink 995523 - Disclosure - Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 neov-20240331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 neov-20240331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 neov-20240331_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, par value $0.001 per share Warrants, each warrant exercisable for one share of common stock Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] One Dealer [Member] Second Dealer [Member] Third Dealer [Member] Accounts Receivable [Member] Fourth Dealer [Member] Antidilutive Securities [Axis] Investor Warrants [Member] Underwriter Warrants [Member] Restricted Stock Units [Member] Sale of Stock [Axis] Underwritten Public Offering [Member] Units [Member] Counterparty Name [Axis] Underwriter [Member] Derivative Instrument [Axis] Non Tradeable Warrants [Member] August Public Offering [Member] Securities Financing Transaction [Axis] May 2018 Notes Payable [Member] October 2021 Notes Payable [Member] Title and Position [Axis] Chief Executive Officer [Member] Transaction Type [Axis] Milestone 1 [Member] Chief Financial Officer [Member] Award Type [Axis] Restricted Stock Units (RSUs) [Member] Three Independent Directors [Member] Amortized value of RSUs granted [Member] Independent Directors [Member] Amortized Value Of Shares Granted To Various Advisors [Member] Fair Value Of Incentive Shares Wholesale Dealer [Member] Fair Value Of Incentive Shares Two Wholesale Dealer [Member] Plan Name [Axis] 2019 Stock Option Plan [Member] Two Executives [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] Assets Current assets: Cash and cash equivalents Accounts receivable, net Inventory Prepaid insurance and other current assets Total current assets Total assets Liabilities and Stockholders' Equity Current liabilities: Accounts payable Accrued liabilities Total current liabilities Commitments and contingencies (Note 3) Stockholders' equity: Common stock, $0.001 par value, 100,000,000 shares authorized, 33,236,091 shares and 33,155,127 shares issued and outstanding, respectively Additional paid-in capital Accumulated deficit Total stockholders' equity Total liabilities and stockholders' equity Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Income Statement [Abstract] Revenues from contracts with customers Cost of goods sold Gross profit Operating expenses: General and administrative Research and development Total operating expenses Loss from operations Other income (expense): Interest income Interest expense Total other income (expense) Net loss Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted Earnings Per Share, Basic Earnings Per Share, Diluted Beginning balance, value Shares, Outstanding, Beginning Balance Stock compensation expense Net loss Stock compensation expense, shares Issuance of common stock in underwritten public offering Issuance of common stock in underwritten public offering, shares Issuance of common stock for conversion of debt and accrued interest Issuance of common stock for conversion of debt and accrued interest, shares Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture Shares, Outstanding, Beginning Balance Ending balance, value Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operations: Stock compensation expense Provision for expected credit losses/bad debt expense Changes in current assets and liabilities Accounts receivable Inventory Prepaid insurance and other current assets Accounts payable Accrued expenses Net cash flows used in operating activities Cash flows from financing activities: Underwritten public offering of common stock Net cash flows provided by financing activities Net increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Supplemental disclosures of cash flow information Cash paid for interest Cash paid for income taxes Supplemental non-cash financing activities Conversion of convertible debt and accrued interest into common stock Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Trading Arrangements, by Individual [Table] Trading Arrangement [Axis] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Organization, Consolidation and Presentation of Financial Statements [Abstract] Business and Summary of Significant Accounting Policies Equity [Abstract] Equity Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Description of Business Interim Financial Information Cash and Cash Equivalents Inventory Revenue Recognition Allowance for Expected Credit Losses Income Taxes Stock Compensation Expense Loss Per Common Share Research and Development Costs Use of Estimates Related Parties Fair Value Measurements and Financial Instruments Recent Accounting Pronouncements Liquidity Schedule of inventory Schedule of warrant activity Raw materials, consisting of assembly parts, batteries and inverters Finished goods Total Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Cash, Uninsured Amount Inventory, Gross Concentration Risk, Percentage Accounts Receivable, Allowance for Credit Loss Antidilutive shares Cash and Cash Equivalents, at Carrying Value Working Capital Warrants outstanding, beginning Weighted Average Exercise Price, Beginning Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Warrants outstanding, beginning Weighted Average Exercise Price, Beginning Warrants and Rights Outstanding, Term Aggregate Intrinsic Value, Ending Warrants exercisable, weighted average exercise price Warrants term, exercisable Aggregate Intrinsic Value, Exercisable Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary, Sale of Stock [Line Items] Unit description Shares issued new, units issued Gross proceeds from sale of equity Net proceeds from sale of equity Warrants granted Debt converted, amount converted Debt converted, shares issued Class of Warrant or Right, Outstanding Restricted stock granted, shares Share-Based Payment Arrangement, Noncash Expense Accrued compensation expenses Stock issued for compensation, shares Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Working Capital Amortized value of RSUs granted [Member] Assets, Current Assets [Default Label] Liabilities, Current Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Expense, Operating and Nonoperating Nonoperating Income (Expense) Shares, Outstanding Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name Inventory, Policy [Policy Text Block] Class of Warrant or Right, Exercise Price of Warrants or Rights EX-101.PRE 11 neov-20240331_pre.xml XBRL PRESENTATION FILE XML 13 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover - shares
9 Months Ended
Mar. 31, 2024
May 10, 2024
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --06-30  
Entity File Number 001-41447  
Entity Registrant Name NeoVolta, Inc.  
Entity Central Index Key 0001748137  
Entity Tax Identification Number 82-5299263  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 13651 Danielson Street  
Entity Address, Address Line Two Suite A  
Entity Address, City or Town Poway  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92064  
City Area Code (800)  
Local Phone Number 364-5464  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   33,236,091
Common Stock, par value $0.001 per share    
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol NEOV  
Security Exchange Name NASDAQ  
Warrants, each warrant exercisable for one share of common stock    
Title of 12(b) Security Warrants, each warrant exercisable for one share of common stock  
Trading Symbol NEOVW  
Security Exchange Name NASDAQ  
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2024
Jun. 30, 2023
Current assets:    
Cash and cash equivalents $ 1,013,962 $ 2,002,789
Accounts receivable, net 1,886,555 1,826,385
Inventory 2,136,947 2,580,571
Prepaid insurance and other current assets 115,224 96,119
Total current assets 5,152,688 6,505,864
Total assets 5,152,688 6,505,864
Current liabilities:    
Accounts payable 3,167 0
Accrued liabilities 11,884 39,491
Total current liabilities 15,051 39,491
Commitments and contingencies (Note 3)
Stockholders' equity:    
Common stock, $0.001 par value, 100,000,000 shares authorized, 33,236,091 shares and 33,155,127 shares issued and outstanding, respectively 33,236 33,155
Additional paid-in capital 25,117,861 24,872,446
Accumulated deficit (20,013,460) (18,439,228)
Total stockholders' equity 5,137,637 6,466,373
Total liabilities and stockholders' equity $ 5,152,688 $ 6,505,864
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Balance Sheets (Unaudited) (Parenthetical) - $ / shares
Mar. 31, 2024
Jun. 30, 2023
Statement of Financial Position [Abstract]    
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Common Stock, Shares Authorized 100,000,000 100,000,000
Common Stock, Shares, Issued 33,236,091 33,155,127
Common Stock, Shares, Outstanding 33,236,091 33,155,127
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]        
Revenues from contracts with customers $ 283,900 $ 629,010 $ 2,065,858 $ 2,733,951
Cost of goods sold 117,755 537,261 1,572,668 2,302,380
Gross profit 166,145 91,749 493,190 431,571
Operating expenses:        
General and administrative 756,118 723,271 2,085,976 2,716,428
Research and development 10,392 1,290 10,392 29,936
Total operating expenses 766,510 724,561 2,096,368 2,746,364
Loss from operations (600,365) (632,812) (1,603,178) (2,314,793)
Other income (expense):        
Interest income 10,892 0 28,946 0
Interest expense 0 0 0 (4,134)
Total other income (expense) 10,892 0 28,946 (4,134)
Net loss $ (589,473) $ (632,812) $ (1,574,232) $ (2,318,927)
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Statements of Operations (Unaudited) (Parenthetical) - $ / shares
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]        
Weighted Average Number of Shares Outstanding, Basic 33,236,091 33,151,685 33,205,766 31,650,491
Weighted Average Number of Shares Outstanding, Diluted 33,236,091 33,151,685 33,205,766 31,650,491
Earnings Per Share, Basic $ (0.02) $ (0.02) $ (0.05) $ (0.07)
Earnings Per Share, Diluted $ (0.02) $ (0.02) $ (0.05) $ (0.07)
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Jun. 30, 2022 $ 21,978 $ 18,394,641 $ (15,799,395) $ 2,617,224
Shares, Outstanding, Beginning Balance at Jun. 30, 2022 21,977,251      
Stock compensation expense 591,816 591,816
Net loss (698,586) (698,586)
Issuance of common stock in underwritten public offering $ 1,121 3,779,284 3,780,405
Issuance of common stock in underwritten public offering, shares 1,121,250      
Issuance of common stock for conversion of debt and accrued interest $ 9,672 1,169,614 1,179,286
Issuance of common stock for conversion of debt and accrued interest, shares 9,671,867      
Shares, Outstanding, Beginning Balance at Sep. 30, 2022 32,770,368      
Ending balance, value at Sep. 30, 2022 $ 32,771 23,935,355 (16,497,981) 7,470,145
Beginning balance, value at Jun. 30, 2022 $ 21,978 18,394,641 (15,799,395) 2,617,224
Shares, Outstanding, Beginning Balance at Jun. 30, 2022 21,977,251      
Net loss       (2,318,927)
Shares, Outstanding, Beginning Balance at Mar. 31, 2023 33,155,127      
Ending balance, value at Mar. 31, 2023 $ 33,155 24,763,356 (18,118,322) 6,678,189
Beginning balance, value at Sep. 30, 2022 $ 32,771 23,935,355 (16,497,981) 7,470,145
Shares, Outstanding, Beginning Balance at Sep. 30, 2022 32,770,368      
Stock compensation expense $ 75 719,220 719,295
Net loss (987,529) (987,529)
Stock compensation expense, shares 75,000      
Shares, Outstanding, Beginning Balance at Dec. 31, 2022 32,845,368      
Ending balance, value at Dec. 31, 2022 $ 32,846 24,654,575 (17,485,510) 7,201,911
Stock compensation expense 309 108,781 109,090
Net loss (632,812) (632,812)
Stock compensation expense, shares 309,759      
Shares, Outstanding, Beginning Balance at Mar. 31, 2023 33,155,127      
Ending balance, value at Mar. 31, 2023 $ 33,155 24,763,356 (18,118,322) 6,678,189
Beginning balance, value at Jun. 30, 2023 $ 33,155 24,872,446 (18,439,228) 6,466,373
Shares, Outstanding, Beginning Balance at Jun. 30, 2023 33,155,127      
Stock compensation expense 84,717 84,717
Net loss (428,715) (428,715)
Shares, Outstanding, Beginning Balance at Sep. 30, 2023 33,155,127      
Ending balance, value at Sep. 30, 2023 $ 33,155 24,957,163 (18,867,943) 6,122,375
Beginning balance, value at Jun. 30, 2023 $ 33,155 24,872,446 (18,439,228) 6,466,373
Shares, Outstanding, Beginning Balance at Jun. 30, 2023 33,155,127      
Net loss       (1,574,232)
Shares, Outstanding, Beginning Balance at Mar. 31, 2024 33,236,091      
Ending balance, value at Mar. 31, 2024 $ 33,236 25,117,861 (20,013,460) 5,137,637
Beginning balance, value at Sep. 30, 2023 $ 33,155 24,957,163 (18,867,943) 6,122,375
Shares, Outstanding, Beginning Balance at Sep. 30, 2023 33,155,127      
Stock compensation expense $ 81 97,060 97,141
Net loss (556,044) (556,044)
Stock compensation expense, shares 80,964      
Shares, Outstanding, Beginning Balance at Dec. 31, 2023 33,236,091      
Ending balance, value at Dec. 31, 2023 $ 33,236 25,054,223 (19,423,987) 5,663,472
Beginning balance, value at Sep. 30, 2023 $ 33,155 24,957,163 (18,867,943) 6,122,375
Shares, Outstanding, Beginning Balance at Sep. 30, 2023 33,155,127      
Shares, Outstanding, Beginning Balance at Mar. 31, 2024 33,236,091      
Ending balance, value at Mar. 31, 2024 $ 33,236 25,117,861 (20,013,460) 5,137,637
Beginning balance, value at Dec. 31, 2023 $ 33,236 25,054,223 (19,423,987) 5,663,472
Shares, Outstanding, Beginning Balance at Dec. 31, 2023 33,236,091      
Stock compensation expense 63,638 63,638
Net loss (589,473) (589,473)
Shares, Outstanding, Beginning Balance at Mar. 31, 2024 33,236,091      
Ending balance, value at Mar. 31, 2024 $ 33,236 $ 25,117,861 $ (20,013,460) $ 5,137,637
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (1,574,232) $ (2,318,927)
Adjustments to reconcile net loss to net cash used in operations:    
Stock compensation expense 245,496 1,420,201
Provision for expected credit losses/bad debt expense 670,000 380,000
Changes in current assets and liabilities    
Accounts receivable (730,170) (799,913)
Inventory 443,624 875,919
Prepaid insurance and other current assets (19,105) 33,291
Accounts payable 3,167 (205,600)
Accrued expenses (27,607) (35,571)
Net cash flows used in operating activities (988,827) (650,600)
Cash flows from financing activities:    
Underwritten public offering of common stock 0 3,780,405
Net cash flows provided by financing activities 0 3,780,405
Net increase (decrease) in cash and cash equivalents (988,827) 3,129,805
Cash and cash equivalents at beginning of period 2,002,789 330,385
Cash and cash equivalents at end of period 1,013,962 3,460,190
Supplemental disclosures of cash flow information    
Cash paid for interest 0 0
Cash paid for income taxes 0 0
Supplemental non-cash financing activities    
Conversion of convertible debt and accrued interest into common stock $ 0 $ 1,179,286
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Pay vs Performance Disclosure - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure [Table]                
Net Income (Loss) $ (589,473) $ (556,044) $ (428,715) $ (632,812) $ (987,529) $ (698,586) $ (1,574,232) $ (2,318,927)
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual [Table]  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Business and Summary of Significant Accounting Policies
9 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Business and Summary of Significant Accounting Policies

(1)       Business and Summary of Significant Accounting Policies

 

Description of Business – NeoVolta Inc. (“we”, “our” or the “Company”) is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 2).

 

Interim Financial Information – The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of March 31, 2024, the results of its operations for the three and nine month periods ended March 31, 2024 and 2023, the changes in its stockholders’ equity for the nine month periods ended March 31, 2024 and 2023, and cash flows for the nine month periods ended March 31, 2024 and 2023. The balance sheet as of June 30, 2023 has been derived from the Company’s June 30, 2023 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2023, as filed with the SEC on September 22, 2023.

 

Cash and Cash Equivalents – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents. Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000, per bank. At March 31, 2024, the Company maintained accounts at two different banks, of which the combined balances of the accounts at the two banks were in excess of the combined FDIC insurance limits by $513,962.

 

Inventory – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Additionally, we made a bulk purchase of raw materials consisting of assembly parts from our former contract manufacturer in April 2023, for a gross amount of $1.4 million. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. No inventory reserve was required as of March 31, 2024 and June 30, 2023. The following table presents the components of inventory as of March 31, 2024 and June 30, 2023:

 

 Schedule of inventory  March 31, 2024   June 30, 2023 
         
Raw materials, consisting of assembly parts, batteries and inverters  $1,502,119   $2,353,055 
Finished goods   634,828    227,516 
Total  $2,136,947   $2,580,571 

 

Revenue Recognition – The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

 

·Identification of the contract with a customer
·Identification of the performance obligations in the contract
·Determination of the transaction price
·Allocation of the transaction price to the performance obligations in the contract
·Recognition of revenue when, or as, the Company satisfies a performance obligation

 

The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three dealers represented approximately 25%, 17% and 11% of the Company’s revenues in the nine months ended March 31, 2024, however, no other dealers accounted for more than 10% of the revenues in such period. Four dealers represented approximately 22%, 20%, 17% and 13% of the Company’s gross accounts receivable as of March 31, 2024. Three such dealers represented approximately 21%, 18% and 16% of the Company’s revenues in the nine months ended March 31, 2023. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the nine months ended March 31, 2024 and 2023 is provided.

 

Allowance for Expected Credit Losses – The Company recognizes an allowance for expected credit losses whenever a loss is expected to be incurred in the realization of a customer’s account. As of March 31, 2024 and June 30, 2023, our allowance for expected credit losses was $1,160,000 and $490,000, respectively.

 

Income Taxes – The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of reported assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.

 

The Company accounts for uncertain tax positions in accordance with the provisions of Accounting Standards Codification (“ASC”) 740-10 which prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken, or expected to be taken, on its tax return. The Company evaluates and records any uncertain tax positions based on the amount that management deems is more likely than not to be sustained upon examination and ultimate settlement with the tax authorities in the tax jurisdictions in which it operates.

 

Stock Compensation Expense – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.

 

Loss Per Common Share – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of March 31, 2024, the Company had total outstanding common stock equivalents of 1,229,750 shares as follows: (i) 1,121,250 shares related to warrants issued to investors in the public offering completed in August 2022; (ii) 58,500 shares related to warrants issued to the underwriters in that same offering, and (iii) 50,000 shares related to restricted stock units granted to two officers in March 2022 (see Note 2).

 

Research and Development Costs – Research and development costs are expensed as incurred.

 

Use of Estimates – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates. As a result of the continued spread of the COVID-19 coronavirus since early 2020, economic uncertainties have arisen which could impact business operations, supply chains, energy demand, and commodity prices that are beyond our control. Overall, we have not experienced a material adverse impact to our economic performance or ability to continue our business operations as a result of COVID-19. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time.

 

Related Parties – The Company accounts for related party transactions in accordance with ASC 850. A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that it might be prevented from fully pursuing its own separate interests is also a related party.

 

Fair Value Measurements and Financial Instruments – ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: 

 

Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

 

Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

Level 3 - Inputs that are both significant to the fair value measurement and unobservable.  The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, and accounts payable.

 

At March 31, 2024 and June 30, 2023, the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis.

 

Recent Accounting Pronouncements – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements. Effective July 1, 2023, the Company adopted the provisions of ASC 326 (Financial Instruments – Credit Losses) pertaining to “current expected credit losses,” which had no material impact on the Company’s financial statements.

 

Liquidity – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary equity financing to continue operations and the attainment of profitable operations. As disclosed in Note 2, we completed a public offering of our equity securities in August 2022 that raised total net proceeds of approximately $3,780,000. As of March 31, 2024, we had a cash balance of $1,013,962 and net working capital of $5,137,637. We anticipate that we will have sufficient cash resources in order to operate our business for at least the next 12 months from the date these financial statements are issued, without new sources of capital.

 

XML 23 R11.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Equity
9 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Equity

(2)       Equity

 

Common Stock – In August 2022, the Company completed an underwritten public offering of its equity securities in the form of Units with each Unit consisting of one share of common stock and one warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of common stock at an exercise price of $4.00 per share. The shares of common stock and the Warrants comprising the Units were immediately separated at closing of the offering and each is now independently listed on the NASDAQ Capital Market. Each Warrant became exercisable on the date of issuance and will expire five years from the date of issuance.

 

In the underwritten public offering, a total of 1,121,250 Units, including exercise of the underwriter’s overallotment option, were sold at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs were approximately $3,780,000. The Company also granted the underwriter non-tradeable warrants to purchase a total of 58,500 shares of common stock at an exercise price of $4.40 per share for a period of five years.

 

In conjunction with the public offering, all holders of the Company’s 2018 convertible notes in the total amount of $59,251, including accrued interest, converted their debt into a total of 9,404,867 shares of common stock at the stated conversion rate, and all holders of the Company’s 2021 convertible notes in the total amount of $1,120,035, including accrued interest, automatically converted their debt into a total of 267,000 shares of common stock at the stated conversion rate.

 

Warrants – The Warrants for a total of 1,179,750 shares of common stock issued to investors and the underwriters are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance, or August 1, 2027. The Warrants may be exercised upon payment of the exercise price in cash on or prior to the expiration date. Under the terms of the Warrant Agreement, we must use our best efforts to maintain the effectiveness of the registration statement and current prospectus relating to common stock issuable upon exercise of the Warrants until the expiration of the Warrants. If we fail to maintain the effectiveness of the registration statement and current prospectus relating to the common stock issuable upon exercise of the Warrants, the holders of the Warrants shall have the right to exercise the Warrants solely via a cashless exercise feature provided for in the Warrants, until such time as there is an effective registration statement and current prospectus. As of the date of this report, the Company has not maintained the effectiveness of the registration statement and the Warrants may be exercised on a cashless basis.

 

The following table presents activity with respect to the Company’s warrants for the nine months ended March 31, 2024:

Schedule of warrant activity                
   Number   Wtd. Avg.   Wtd. Avg.   Aggregate 
   of   Exercise   Remaining   Intrinsic 
   Shares   Price   Term (Yrs.)   Value 
Outstanding at June 30, 2023   1,179,750   $4.02           
Warrants issued                  
Warrants exercised/forfeited                  
Outstanding at March 31, 2024   1,179,750   $4.02    3.3   $ 
                     
Exercisable at March 31, 2024   1,179,750   $4.02    3.3   $ 

 

These warrants were issued in conjunction with an underwritten public equity offering, therefore, there was no employee or non-employee compensation expense recognized.

 

Stock Compensation Expense – In February 2022, we entered into a new employment agreement with our Chief Executive Officer (“CEO”), effective April 1, 2022. The initial term of the employment agreement was one year and is automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. The agreement provides for an initial annual salary of $165,000. Pursuant to the agreement, we issued our CEO a restricted stock unit (“RSU”) award for up to 150,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 50,000 shares; and (ii) Milestone 2 - Produce 2,000 ESSs in 2022 and continue his employment with our company until January 1, 2023: 100,000 shares. As of December 31, 2023, Milestone 1 was achieved, however, Milestone 2 was not achieved. The underlying 50,000 shares of common stock earned under Milestone 1 were issued to our CEO as of January 1, 2023.

 

In February 2022, we entered into a new employment agreement with our Chief Financial Officer (“CFO”), effective March 1, 2022. The initial term of the employment agreement is one year and is automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. The agreement provides for an initial annual salary of $125,000. Pursuant to the agreement, we issued our CFO an RSU award for up to 300,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 250,000 shares; and (ii) Milestone 2 - successfully complete and file the Company’s Form 10-K for the year ended June 30, 2023 no later than September 29, 2023 and continue his employment with our company until January 1, 2024: 50,000 shares. Milestone 1 was achieved as of January 1, 2023, and the underlying 250,000 shares of common stock earned under Milestone 1 were issued to our CFO as of that date. Milestone 2 was achieved as of January 1, 2024, and the underlying 50,000 shares of common stock earned under Milestone 2 are expected to be issued to our CFO in May 2024.

 

Based upon management’s assessment of the probability of our CEO and CFO ultimately achieving each milestone specified under the RSU awards indicated above, we calculated the grant date value of such awards and are amortizing it as stock compensation expense over the underlying performance periods. We have recognized stock compensation expense applicable to such RSU awards in the nine months ended March 31, 2024 and 2023 in the amounts of $81,683 and $1,200,723, respectively.

 

In conjunction with our public offering in August 2022, we appointed two new independent directors and adopted a new compensation plan for all independent directors based on an annual compensation amount of $65,000 with not less than 70% of such amount paid in shares of our common stock, calculated based on the share price at the end of such prior fiscal quarter, and up to 30% paid in cash, with such final amounts to be determined by each director. As of March 31, 2024, we booked an accrual of $146,250 of compensation expense (of which $131,625 will be settled through the issuance of shares) for our three independent directors under this plan.

 

In the nine months ended March 31, 2024, we recognized total non-cash stock compensation expense of $245,496 as follows: (i) $81,683 for the amortized value of the RSUs granted to our two executive officers, as previously described; (ii) $131,625 for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock; (iii) $19,763 for the amortized value of the shares granted to various advisors under their annual service contracts; and (iv) $12,425 for the fair value of incentive shares earned by a wholesale dealer as of December 31, 2023 (see Note 3). There was a total of 80,964 shares of common stock that were issued to our independent directors in the nine months ended March 31, 2024, which were previously expensed in the year ended June 30, 2023.

 

In the nine months ended March 31, 2023, we recognized total non-cash stock compensation expense of $1,420,201 as follows: (i) $1,200,723 for the amortized value of the RSUs granted to our two executive officers, as previously described; (ii) $131,625 for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock; (iii) $60,625 for the net amortized value of the shares granted to various advisors under their annual service contracts; and (iv) $27,228 for the fair value of incentive shares earned by two wholesale dealers as of December 31, 2022 (see Note 3). There was a total of 384,759 shares of common stock that were issued to various grantees, including our two executive officers, in the nine months ended March 31, 2023, of which 75,000 shares were previously expensed in the year ended June 30, 2022.

 

Other Matters – In February 2019, the Company’s Board of Directors approved the establishment of a new 2019 Stock Plan (“Plan”) with an authorization for the issuance of up to 2,500,000 shares of common stock. The Plan is designed to provide for future discretionary grants of stock options, stock awards and stock unit awards to key employees, consultants, advisors, and non-employee directors. As of March 31, 2024, the Company has made awards under the Plan as follows: (i) 450,000 shares for the RSUs granted to our two executive officers, as noted above; (ii) 54,964 shares for the initial services of our three independent directors in the year ended June 30, 2023, pursuant to the new compensation plan adopted in August 2022 for independent directors; and (iii) 32,858 shares granted to several wholesale dealers under an incentive sales program.

 

XML 24 R12.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies
9 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

(3)       Commitments and Contingencies

 

Effective January 1, 2021, we secured new corporate and manufacturing office space under a sublease agreement with a company that served as our contract manufacturer at that time. Under the terms of the sublease agreement, we were required to make rental payments of $10,350 per month during the initial one-year term of the agreement. Further, under the terms of the sublease agreement, we were granted the right to renew the sublease for additional terms of 12 months each upon mutual agreement of both parties, provided thirty days’ notice is given for each subsequent term, at a modest increase in the monthly rent, through February 28, 2025. However, we were under no obligation to renew it. At inception of the sublease, management determined that exercise of the renewal option was not reasonably certain and, notwithstanding that the Company elected to renew the agreement for additional one year periods as of January 1, 2022, 2023 and 2024, continues to believe that is the case. Accordingly, we have accounted for it as a short-term lease under ASC 842, Leases. Under an amendment to our supply agreement with our former contract manufacturer in April 2023, we took over direct responsibility for the manufacturing process surrounding our ESS units on June 1, 2023, however, that amendment had no effect on the sublease agreement with our former contract manufacturer.

 

As indicated in Note 1, we sell our proprietary ESS units through wholesale dealers, primarily in California. In that regard, we have entered into agreements with several wholesale dealers operating in California and other states under which we have incentivized the dealers to achieve quarterly sales above targeted levels by agreeing to grant them shares of our common stock for exceeding such quarterly sales targets, determined as of the calendar year end, subject to defined maximums.

 

From time to time in the ordinary course of our business, the Company may be involved in legal proceedings, the outcomes of which may not be determinable. The Company is not involved in any legal proceedings at this time. The results of litigation are inherently unpredictable. Any claims against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable.

 

XML 25 R13.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Subsequent Events
9 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
Subsequent Events

(4)        Subsequent Events

 

Effective April 29, 2024, the Company engaged a new Chief Executive Officer (“CEO”), replacing the Company’s former chief executive officer and founder who remains as Chairman of the Board and chief technology officer. The Company has entered into an employment agreement with the new CEO providing for an initial term extending through June 30, 2027, which will be automatically renewed for additional one-year terms unless either party chooses not to renew it. Pursuant to the agreement, the new CEO received an initial equity grant equal to 1,280,000 RSUs, which will vest over a four-year period, subject to his continued employment with the Company, and will be entitled to earn additional RSU’s in the form of three annual performance-based equity grants, beginning in the year ending June 30, 2025, with a target value of up to $660,000 each.

XML 26 R14.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Business and Summary of Significant Accounting Policies (Policies)
9 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business

Description of Business – NeoVolta Inc. (“we”, “our” or the “Company”) is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 2).

 

Interim Financial Information

Interim Financial Information – The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of March 31, 2024, the results of its operations for the three and nine month periods ended March 31, 2024 and 2023, the changes in its stockholders’ equity for the nine month periods ended March 31, 2024 and 2023, and cash flows for the nine month periods ended March 31, 2024 and 2023. The balance sheet as of June 30, 2023 has been derived from the Company’s June 30, 2023 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2023, as filed with the SEC on September 22, 2023.

 

Cash and Cash Equivalents

Cash and Cash Equivalents – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents. Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000, per bank. At March 31, 2024, the Company maintained accounts at two different banks, of which the combined balances of the accounts at the two banks were in excess of the combined FDIC insurance limits by $513,962.

 

Inventory

Inventory – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Additionally, we made a bulk purchase of raw materials consisting of assembly parts from our former contract manufacturer in April 2023, for a gross amount of $1.4 million. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. No inventory reserve was required as of March 31, 2024 and June 30, 2023. The following table presents the components of inventory as of March 31, 2024 and June 30, 2023:

 

 Schedule of inventory  March 31, 2024   June 30, 2023 
         
Raw materials, consisting of assembly parts, batteries and inverters  $1,502,119   $2,353,055 
Finished goods   634,828    227,516 
Total  $2,136,947   $2,580,571 

 

Revenue Recognition

Revenue Recognition – The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

 

·Identification of the contract with a customer
·Identification of the performance obligations in the contract
·Determination of the transaction price
·Allocation of the transaction price to the performance obligations in the contract
·Recognition of revenue when, or as, the Company satisfies a performance obligation

 

The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three dealers represented approximately 25%, 17% and 11% of the Company’s revenues in the nine months ended March 31, 2024, however, no other dealers accounted for more than 10% of the revenues in such period. Four dealers represented approximately 22%, 20%, 17% and 13% of the Company’s gross accounts receivable as of March 31, 2024. Three such dealers represented approximately 21%, 18% and 16% of the Company’s revenues in the nine months ended March 31, 2023. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the nine months ended March 31, 2024 and 2023 is provided.

 

Allowance for Expected Credit Losses

Allowance for Expected Credit Losses – The Company recognizes an allowance for expected credit losses whenever a loss is expected to be incurred in the realization of a customer’s account. As of March 31, 2024 and June 30, 2023, our allowance for expected credit losses was $1,160,000 and $490,000, respectively.

 

Income Taxes

Income Taxes – The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of reported assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.

 

The Company accounts for uncertain tax positions in accordance with the provisions of Accounting Standards Codification (“ASC”) 740-10 which prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken, or expected to be taken, on its tax return. The Company evaluates and records any uncertain tax positions based on the amount that management deems is more likely than not to be sustained upon examination and ultimate settlement with the tax authorities in the tax jurisdictions in which it operates.

 

Stock Compensation Expense

Stock Compensation Expense – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.

 

Loss Per Common Share

Loss Per Common Share – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of March 31, 2024, the Company had total outstanding common stock equivalents of 1,229,750 shares as follows: (i) 1,121,250 shares related to warrants issued to investors in the public offering completed in August 2022; (ii) 58,500 shares related to warrants issued to the underwriters in that same offering, and (iii) 50,000 shares related to restricted stock units granted to two officers in March 2022 (see Note 2).

 

Research and Development Costs

Research and Development Costs – Research and development costs are expensed as incurred.

 

Use of Estimates

Use of Estimates – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates. As a result of the continued spread of the COVID-19 coronavirus since early 2020, economic uncertainties have arisen which could impact business operations, supply chains, energy demand, and commodity prices that are beyond our control. Overall, we have not experienced a material adverse impact to our economic performance or ability to continue our business operations as a result of COVID-19. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time.

 

Related Parties

Related Parties – The Company accounts for related party transactions in accordance with ASC 850. A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that it might be prevented from fully pursuing its own separate interests is also a related party.

 

Fair Value Measurements and Financial Instruments

Fair Value Measurements and Financial Instruments – ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: 

 

Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

 

Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

Level 3 - Inputs that are both significant to the fair value measurement and unobservable.  The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, and accounts payable.

 

At March 31, 2024 and June 30, 2023, the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis.

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements. Effective July 1, 2023, the Company adopted the provisions of ASC 326 (Financial Instruments – Credit Losses) pertaining to “current expected credit losses,” which had no material impact on the Company’s financial statements.

 

Liquidity

Liquidity – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary equity financing to continue operations and the attainment of profitable operations. As disclosed in Note 2, we completed a public offering of our equity securities in August 2022 that raised total net proceeds of approximately $3,780,000. As of March 31, 2024, we had a cash balance of $1,013,962 and net working capital of $5,137,637. We anticipate that we will have sufficient cash resources in order to operate our business for at least the next 12 months from the date these financial statements are issued, without new sources of capital.

 

XML 27 R15.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Business and Summary of Significant Accounting Policies (Tables)
9 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of inventory

 

 Schedule of inventory  March 31, 2024   June 30, 2023 
         
Raw materials, consisting of assembly parts, batteries and inverters  $1,502,119   $2,353,055 
Finished goods   634,828    227,516 
Total  $2,136,947   $2,580,571 
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Equity (Tables)
9 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of warrant activity
Schedule of warrant activity                
   Number   Wtd. Avg.   Wtd. Avg.   Aggregate 
   of   Exercise   Remaining   Intrinsic 
   Shares   Price   Term (Yrs.)   Value 
Outstanding at June 30, 2023   1,179,750   $4.02           
Warrants issued                  
Warrants exercised/forfeited                  
Outstanding at March 31, 2024   1,179,750   $4.02    3.3   $ 
                     
Exercisable at March 31, 2024   1,179,750   $4.02    3.3   $ 
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of inventory (Details) - USD ($)
Mar. 31, 2024
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Raw materials, consisting of assembly parts, batteries and inverters $ 1,502,119 $ 2,353,055
Finished goods 634,828 227,516
Total $ 2,136,947 $ 2,580,571
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Business and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Jun. 30, 2023
Product Information [Line Items]      
Cash, Uninsured Amount $ 513,962    
Inventory, Gross     $ 1,400,000
Accounts Receivable, Allowance for Credit Loss 1,160,000   490,000
Cash and Cash Equivalents, at Carrying Value 1,013,962   $ 2,002,789
Working Capital $ 5,137,637    
Common Stock [Member]      
Product Information [Line Items]      
Antidilutive shares 1,229,750    
Investor Warrants [Member]      
Product Information [Line Items]      
Antidilutive shares 1,121,250    
Underwriter Warrants [Member]      
Product Information [Line Items]      
Antidilutive shares 58,500    
Restricted Stock Units [Member]      
Product Information [Line Items]      
Antidilutive shares 50,000    
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Dealer [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 25.00% 21.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Second Dealer [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 17.00% 18.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Third Dealer [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 11.00% 16.00%  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Dealer [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 22.00%    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Second Dealer [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 20.00%    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Third Dealer [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 17.00%    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Fourth Dealer [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 13.00%    
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Equity (Details - Warrant activity) - USD ($)
6 Months Ended 9 Months Ended
Dec. 31, 2023
Mar. 31, 2024
Equity [Abstract]    
Warrants outstanding, beginning 1,179,750 1,179,750
Weighted Average Exercise Price, Beginning $ 4.02 $ 4.02
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period  
Warrants outstanding, beginning   1,179,750
Weighted Average Exercise Price, Beginning   $ 4.02
Warrants and Rights Outstanding, Term   3 years 3 months 18 days
Aggregate Intrinsic Value, Ending   $ 0
Warrants exercisable, weighted average exercise price   $ 4.02
Warrants term, exercisable   3 years 3 months 18 days
Aggregate Intrinsic Value, Exercisable   $ 0
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Equity (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Aug. 31, 2022
Mar. 31, 2024
Dec. 31, 2022
Mar. 31, 2024
Mar. 31, 2023
Jun. 30, 2023
Feb. 28, 2019
Subsidiary, Sale of Stock [Line Items]              
Class of Warrant or Right, Outstanding   1,179,750   1,179,750   1,179,750  
Share-Based Payment Arrangement, Noncash Expense       $ 245,496 $ 1,420,201    
2019 Stock Option Plan [Member]              
Subsidiary, Sale of Stock [Line Items]              
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized             2,500,000
Restricted Stock Units (RSUs) [Member]              
Subsidiary, Sale of Stock [Line Items]              
Share-Based Payment Arrangement, Noncash Expense       81,683 1,200,723    
Amortized value of RSUs granted [Member]              
Subsidiary, Sale of Stock [Line Items]              
Share-Based Payment Arrangement, Noncash Expense       81,683 1,200,723    
Independent Directors [Member]              
Subsidiary, Sale of Stock [Line Items]              
Share-Based Payment Arrangement, Noncash Expense       131,625 131,625    
Amortized Value Of Shares Granted To Various Advisors [Member]              
Subsidiary, Sale of Stock [Line Items]              
Share-Based Payment Arrangement, Noncash Expense       19,763 60,625    
Fair Value Of Incentive Shares Wholesale Dealer [Member]              
Subsidiary, Sale of Stock [Line Items]              
Share-Based Payment Arrangement, Noncash Expense       12,425      
Fair Value Of Incentive Shares Two Wholesale Dealer [Member]              
Subsidiary, Sale of Stock [Line Items]              
Share-Based Payment Arrangement, Noncash Expense         $ 27,228    
Chief Executive Officer [Member] | Milestone 1 [Member]              
Subsidiary, Sale of Stock [Line Items]              
Restricted stock granted, shares     50,000        
Chief Financial Officer [Member] | Milestone 1 [Member]              
Subsidiary, Sale of Stock [Line Items]              
Restricted stock granted, shares     250,000        
Three Independent Directors [Member]              
Subsidiary, Sale of Stock [Line Items]              
Accrued compensation expenses   $ 146,250   $ 146,250      
Three Independent Directors [Member] | 2019 Stock Option Plan [Member]              
Subsidiary, Sale of Stock [Line Items]              
Restricted stock granted, shares           54,964  
Independent Directors [Member]              
Subsidiary, Sale of Stock [Line Items]              
Stock issued for compensation, shares   80,964          
Two Executives [Member] | 2019 Stock Option Plan [Member]              
Subsidiary, Sale of Stock [Line Items]              
Restricted stock granted, shares           450,000  
Underwritten Public Offering [Member] | Underwriter [Member] | Non Tradeable Warrants [Member]              
Subsidiary, Sale of Stock [Line Items]              
Warrants granted 58,500            
Underwritten Public Offering [Member] | Units [Member]              
Subsidiary, Sale of Stock [Line Items]              
Unit description each Unit consisting of one share of common stock and one warrant (each, a “Warrant” and collectively, the “Warrants”)            
Shares issued new, units issued 1,121,250            
Gross proceeds from sale of equity $ 4,485,000            
Net proceeds from sale of equity 3,780,000            
August Public Offering [Member] | May 2018 Notes Payable [Member]              
Subsidiary, Sale of Stock [Line Items]              
Debt converted, amount converted $ 59,251            
Debt converted, shares issued 9,404,867            
August Public Offering [Member] | October 2021 Notes Payable [Member]              
Subsidiary, Sale of Stock [Line Items]              
Debt converted, amount converted $ 1,120,035            
Debt converted, shares issued 267,000            
EXCEL 33 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( ,V#JE@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #-@ZI8/DA^'NX K @ $0 &1O8U!R;W!S+V-O&ULS9)1 M2\,P$,>_BN2]O;15P=#E9<,G!<&!XEM(;EM8DX;DI-VW-ZU;A^@'\#%W__SN M=W"M#D+W$5]B'S"2Q70SNLXGH<.*'8B" $CZ@$ZE,B=\;N[ZZ!3E9]Q#4/JH M]@@UY_?@D)11I& "%F$A,MD:+71$17T\XXU>\.$S=C/,:, .'7I*4)45,#E- M#*>Q:^$*F&"$T:7O IJ%.%?_Q,X=8.?DF.R2&H:A')HYEW>HX/WYZ75>M[ ^ MD?(:\Z]D!9T"KMAE\ENSWFP?F:QY?5OPNZ+BVYJ+A@O^\#&Y_O"["KO>V)W] MQ\870=G"K[N07U!+ P04 " #-@ZI8F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M ,V#JEC%4]@X8P8 +DD 8 >&PO=V]R:W-H965T&UL MM9I=;]LV%(;_"N$-0P?$L40Y3M(Y!APUV8*UKANG+;H[1J)MH9+HD52<_/L= M2K*4!M2QJT4WB;[.*[[D(?V0XG@KY'>UYER3QR1.U45OK?7F[6"@@C5/F#H6 M&Y["G:60"=-P*E<#M9&?-7,+9H%()HX2G*A(ID7QYT9NZ M;WWOS 3D3WR)^%8].R;&RKT0W\W)37C1,P#;208_'O@/H]CHP3E^+<4 M[57O-('/CW?JU[EY,'//%/=%_#4*]?JB=]8C(5^R+-:W8OL7+PV=&+U Q"K_ M2[;%LZ.3'@DRI452!D,)DB@M_K/'LB(.":!E 'T1X'H- 5X9X.5&BY+EMMXQ MS29C*;9$FJ=!S1SD=9-'@YLH-=_B>;!S3*]-RW:L," M?M&#KJFX?."]R6^_N"/G#\32L+(T1,LT!3]A[NDZ9BN;)SQ^R6)EJPH?#6MI MZJ0R=7)8.WW*F-1&M72WJBR-SHP#26#$30? )O] MX5J-[8>&M31X6AD\/6;LM@R^N]LFS^4-C6OH[K_R=_Y2_;YS)9G>X5E/[H5$M_;E._7OI MH*7R,RE?&L2R=8]G].1=:C%@]OZK:''Q5&E] M9 M)R3 0&[UB"PT#$5$2.*+#!HWB.?$SM/G%)UQN=N#!^IQ&/%>0*W(/9E-5[%XCDUHSDXFB#>K_;"JMW M7'*119 K4ZO9+CC)K4')Q=GFI5G?G$%2WXEM:C6*R\W%EMG&.Q^/:VNSYB47 MAYR7-JO..Y?B(4H#>T+CFKZ]/;O@)EIS$\5!YZ71N5 :?HO^B3:-X],>Q7/J MC.PK!%V $ZW!B>+,DV?J5'+6; P7>'/F.+];C74!3+0&)HISSGN13UG6(L6( M<(^(-QKV3X8-#=<%)M$:D^AAF%02?C'!CM)5WBGM,Y@]BM^L2VH^'M769XU) M]"!,NDDUE\4RJIF]L)UQJT]DV4QHH!WR67&B MUYQ M#4'>01 $QI)\HB&"[X!\^:<7\C'30$1I"*EM_=#P2E!3?H HU(:YFOG4]S#Q M/.J-G'-W/'BP>:SQQ]N#/S^8VS!)'EB<C4L>3CIWD8X!Y9?$I6_N?R<+'F026M_J&U?Z'U7JX])M*^'9]S.<@&"P M"G.$>DKN16SUC@O,KCY:UR'PL+:^:H;R<.+9M28,R\&:I2O>N'BX1V@V7;R; MVC\2=D%/7DU/'DX]7YDTBZ(P5>,L6)-M<4KX(Y=!I-@]Y/82YJEF,I GG\GT MH$A491+56A>O!$AE!76!6UZ-6QZ.23_3OW&E#JK:QU_9MG)J6/-PMCJ@W^," MIM]_M1KK@LZ\FLX\G)Q^HN/C0DC'?U4&&SS;'&+0.=\SHR!_LE07^T2JJ]6^ MG&F^&V50/UYLZOG #'DK$O,EA#K'I] !9;%/ICC18I-O-;D76HLD/UQS%G)I M'H#[2R'T[L2\H-JM-/D/4$L#!!0 ( ,V#JE@;" #@B 0 /80 8 M>&PO=V]R:W-H965T&ULK9C;;N,V$(9?A5 7[2[@1*2H8VH; M2+PHN@5:!)NFO68D)B(BB5Z2LC=]^@YE1SZ(5EPT%[8I:6;TC<3A/_1T+=6S M+CDWZ'M=-7KFE<8LKWQ?YR6OF;Z42][ E4>I:F;@4#WY>JDX*SJGNO(#C&._ M9J+QYM/NW*V:3V5K*M'P6X5T6]=,O=SP2JYG'O%>3WP53Z6Q)_SY=,F>^!TW M]\M;!4=^'Z40-6^TD U2_''F79.K!&QN"P<^*+WA5V4C \6T;U.OO:1WWQZ_1?^F2AV0>F.8+6?TM"E/.O-1# M!7]D;66^RO6O?)M09./ELM+=-UIO;;&'\E8;66^=@: 6S>:7?=\^B#T'$IYP M"+8.P;D.=.M NT0W9%U:GYEA\ZF2:Z2L-42S@^[9=-Z0C6CL:[PS"JX*\#/S M&U:Q)N?HSD;0Z.-]P]I"&%Y\0A?H_NXS^OCAT]0W<"=K[^?;J#>;J,&)J+\S M=8DHF: !Z'#?3'N_EO;@#ONW.FANP_Y]4D&?9)!%R\Z$6_1*L4;@YC6D.25 M*Y]- .H.8&OI2B]9SF<>%(OF:L6]^8\_D!C_[,KNG8(=Y$K[7.E8]/F"Z1*Q MID"Y'?!OK5BQ"I+7KJPWH>(NE"WXU9Q@0K,XF/JK_82&=K!,!$F:]78'K&'/ M&HZR7N>Y; $-UH.< ^=#Q2>HX<:%NHD4[J.F:1Q%T1&JRRZ(:1JY4:,>-1I% M_=*LX"%*]>)BBP;W# B-LS Y8G/812F.$N)FBWNV>)3M5O$E$P42C6Y55\WV M_4M3<@5+R/[4=\''PP=&HL"6[0'[T"R+"3DQ 9*>/!DE_U,:5IW!F QN'@%C MG*9'D$.[.,)1&H=NS+3'3,_ /(V7GHDWM!O%RWJ\[*SEK1+L053"".Y>X[+W M7./>*=A!P@3O5 N?MW(LV8M=-IP2A0>/FY+XN"8=5MC].LB>II*WZ%3+B_T7 MX@0DCM)+T^/*.BN\MUF#("G.7'+,.S<98=Z)&WE U M6=?"U%;'-N(F&R.:)][DP(L^_B$-1]3=J(P&=D]4Y&Q9_G^@P^1W*DG"T?J^ M,S)_+F55<*5_ZB3=O#@+G(S*[7^M\/>*=ICU3G#)N.+:5PY]OK;)3] '?(DQ M@7)7"/J9%OH$@O$$;SY(EPP0$&M-*97XAQ<31.DDH/$$9Z2_"O,&SI(HFI @ M>3TKM+:EVBEF:[2! 4RL";0D>LF[/4;EU'PR%'-*X8['!>$R(]&);H3L))^, M:_YU 5TZ[(.@@JWV7X@&&KZE@(IVP@[5.X@(2=)X4, .RS!-@C",3R#OM)Z, MBSVLBFW=5@PV%W:C)7+A;/3(4,0OH-LD-(SQ,:S#E*0AS8(@/4&[DWQRCN9K M1^DYH5TM $UB.I ;1P\0QF!'3P#OF@ R*KE;X+UEO)O39R>0#5I\=P_C,'0W M,?[>IM3^(P![PB?H4%'%'\$37R90&6JSR=X<&+GL]JD/TL"NMQN6G &X-8#K MCQ)6^>V!W?KV?W7,_P502P,$% @ S8.J6*F4O#^? @ 0@< !@ !X M;"]W;W)KI65P!( M[FHN],2K$-09<;B=>Z-T/7+%5A7; S[,U7<$<\'H]4Z;G]RPE MJT%H)@51L)QXI^')-+7Q+N"&P5;OM(EULI#RUG8NRXD76$' H4#+0,UG U/@ MW!(9&3\Z3J]?T@)WV_?LY\Z[\;*@&J:2?V4E5A/OG4=*6-*&XY7<7D#G)[%\ MA>3:O(G=%6F;/U MD2+-,R6W1-EHPV8;+C<.;=PP87=QCLK,,H/#_(QR*@H@<\N@R<&UH$W)$,I# MVF( M^S3$3['G4UG7QNT<97%[1,R&$ZF(RTU);BAO@,S #-@]'\I#2W[LR&V]V.3! M* C"S-_L&OQ;U)[R<:]\_ +E3J$FIPU64K%?4 ZI;0G'.SK"H'L>*'Y.Y)[J MI%>=O%CU$;G4NAF6G/PA)(ZC. W>/\SQ4&"8)&%T/"PX[06G_R#X2X,:J2B9 M6 VI3I^K>BAP4+6_4^'L[6*JR8H)33@L#308'1O_JJW8;0?EVA6]A4130EVS M,I<<*!M@YI=2XGW'UM'^VLQ_ U!+ P04 " #-@ZI8'L?Q +L$ !P% M& 'AL+W=OTVO(EX<>YQSZ^]N': MHYV07]2:B[Q48V>M]>;&==5BS8M$78L-+\V;I9!%HLVM7+EJ(WF25D%% M[A+/8VZ19*4S&57/[N5D)+8ZSTI^+Y':%D4B_[GCN=B-'>R\/7C(5FMM'[B3 MT299\4>NGS;WTMRY+4N:%;Q4F2B1Y,NQ/9'O&<+[2E2,S?"Y_R/+=,IA]?&U*G;=,&'EZ_L?]8B3=BGA/%IR+_ M,TOU>NQ$#DKY,MGF^D'L?N:-H,#R+42NJE^TJ[%^Z*#%5FE1-,&F!T56UO_) M:S,0!P&&!PX@30#I!O@G F@30#_:@M\$^!]M(6@"*NENK;T:N%FBD\E(BAV2 M%FW8[$4U^E6T&:^LM!/E44OS-C-Q>O*H$\U-XK5"8HE^VW"9V 0J=/%4)MLT MTSR]1%?HZ7&&+KZ]'+G:M&DCW47#?U?SDQ/\%'T6I5XK-"]3G@+QL^'X>"#> M-5I;P>1-\!T9)/R(>,0'^C/]>#B%Y/R_UN?_N?6CP:!M]FG%%YS@ M^U0N1,%1.PG07[?/2DNS>O^&4EV349C,6MJ-VB0+/G:,9RDN7[@S^>X;S+P? MH'$^)]GLG&3S,Y$=9<1O,^(/L4\>^ LOMURAI10%6IBY;[.AC"OH=>,'7"HH M.34OJWCMY^%E0B(:>][(?3D<]CZ,D=C#'=@,8/-8$ 71,6X.X$)*XP"WN*-A M"-IA" :'82J4MH:T$B)52(D9-;];>D&)23JS88P8!AWUL<4@!%*PNYRZ\.( M%P5QR#IS$,"%F/DD@B=AW$J/WS%:Q1.Y6%?:4^.ZN=C83R D/.XO/8_&I*,; M0)'NBII]B&K>1Y$XI@Q6C+U]K><-:OY=:)-LT5M^8%GG]=/(6-#]4$PA'/&# MGKL"..+%C/;L%0*&O@'Z)^0?E+IX4/XOUF"K[ZIHZUQ0.N[UX(IY'F5=KP6! ME$28=,4#0+.$*0Y[Z@$DH=@/8WI"/MG+)\.VJ]=W#AH3O*U<\7+K^RC7*C;F"(EEOAW 5F+Z%M"L3 ,)F M"@!-4>J;(J.K%T :,S5#''8DNP7Z';Z88>#ZSQVG5BOCZ+,WOZ558JE/.E:&PO=V]R:W-H965T&ULK59=;]HP%/TK5C9- MK=22[] RB,37M#YT145='Z8]F.1"HB8QLQWH_OUL)V2 3,:V\D!LYYQS?8\_ M1I43WQ:^W#'D'HZ E. M37"."=X)@EL3W',C>#7!.S>"7Q-4ZF:5NS)N@CD.^Y1L$95HH28;RGW%%GZE MA=PG#CGF(-8=\X06:*'-5 L%Y"ABZ<"EW'*(;Y$%S-,!20!GD8X MNT37Z#TR$4O$*.N;7$Q#BIE1'7)4A71.A'31/1%B#$V+&&(-?]+.OVWAFR+] MQ@-GY\'(:16\Q[2#7/L*.9;C:>8S/I_NZM+YO^C3?XY^8(;;; A7Z?DG].Z* MB.2 FGV!O@T7C%-QH+_KEKH2<_5B\I+KL36.8&"(6XP!W8 1?GAG!]9'G<]O M*39Y2['I&XD=K(C7K(C7IAX^J\L.8C3*:2'29F@F'%%VM&R.2NIF;Q+75L=RCI(_"S71HX[\F>I17>O@=\*";F-! M]Z\M:-D$W;-,. LUT:..3="C_F""N?>YSX&N5)W%4$3*@E<7?3/:E')#5<$< MC8_LWMC6C$]$Z5=5:K_EJ[I1?&U6J:@.,EB*4%:G*S8OK6JQJL/)6A4;"\)% MZ:*:B2A?@4J >+\DA.\Z,D!3$(>_ %!+ P04 " #-@ZI8>3J_8]<) 8 M3 & 'AL+W=O]^^E.PU+7(XMERF6&#C MA^&0^@_)X4^D?/U:U5^;)Z7:Z-MZM6EN)D]M^_Q^-FL63VI=-.^J9[71WSQ6 M];IH]=OZRZQYKE6Q[ NM5S,:Q\EL792;R>UU_]G'^O:ZVK:KSV^KGXHNY5^_GY8ZW?S0Y>EN5:;9JRVD2U M>KR9_$3>YR+I"O06_RS5:W/T.NHNY:&JOG9O?E[>3.*N16JE%FWGHM!_7M2= M6JTZ3[H=O^Z=3@YU=@6/7W_W_N?^XO7%/!2-NJM6_RJ7[=/-))U$2_58;%?M MI^KU+VI_0:+SMZA63?]_]+JSE7(2+;9-6ZWWA74+UN5F][?XMA?BJ "EG@)T M7X!:!5CB*<#V!9A=@Z])?%^ 6P4(\Q00^P+]I<]VU]X+-R_:XO:ZKEZCNK/6 MWKH7O?I]::U7N>DZRGU;ZV]+7:Z]O6^+5NG MTU4/4;W;;7X^E2MEJIN_ACE MOV[+]K?HA\^;8KLL6[7\,9I&G^_GT0^___%ZUNK:.Q^SQ;ZF#[N:J*>FNVJ] MUCVCKR+Z]R]J_:#J_P!N[G W/RUU4W07*U;1QZ)<3LM-=%<\EZU^CSB=XTX_ MJ5:/*;6,\J+>E)LO#>8KQWW]H])M&1:;Z: <(D,/D:&]'^;Q\T%]*3==8_1 M6!6;A;J*7HK55D5%&_UUNWD7L?@JHC&E4"AVKI/>=3=7O-Q2DLGT>O9RK+1K M15*6\823H>'<-9P2(;.,96)HF0,5)T12R@]V S'800R&BG'_5-2JN8K^OFV; MMM@LM2Q7D5'HPTZALZ395<0M:205UD7?H2WJ)O#WS7.Q4#<3/4,WJGY1D]L_ M_(XD\9^@_A?261[(V2 2_! )CD>B'[^+:JU355/TD[WZUKU6D-BH+[BE$30G M<"=H(B,I2:Q^&JBZ_&1U ^G$03J!2O:G63 MJ/YZJ1[:2"U%N]&BDWK=(M:J&HI$ZOSA))K9"D0.B2+"%VKT8O842O MANKK1I%G-L@.&F9OKB'6PS.GV5I+DB;2DA-MY=@>'M)9'LC9(#HD-@P1!UJ= MW:MG?'6VKVDP,5(I8Y;8BU>\36.C$=1;'LK;,!Y'3$?0>.1]" !N."T_<::5 M3GX[6^[-!HMHEC'!A,4#<\!R2A*>R2RUG.: J>0R)MR3$XDA*?*&*$7.8ZF] MV6#N@V$*L/31%&"*XA0Q/$7^;T!%SB8JO$VCAVQ0I@KE;1@/0U4$QRJ,#?"B M(R_T+JBW>5!O.7'!:TH923,J/1W>L!?!X>O\#O]+4>L.3_H.S\!XN-##&!&" M4'O!@+=IM-8AO>6AO WC80"/X(3GS5&GY7>!KI??UMY%+,IEPIBP[QH EE-- M^WKZIM2>D%W3))&I[J&>_FG C>#DAN6HTVE;GI>V793SI6W7TINV75,\;1MR M(C@ZA5Q6NF3B6U9>P$+(D WI+0_E;1@/0V$$Q[!QM_[VSH[[I'3&J$M>DF24 MQG9WO(!O0$#U5)AY^BHU"$1Q!,+R-UYTQ,V]4([FU*6L:99*03-K<)]A.!3, M, K%&<7?F3!2IP CB#BV;T7A=8\=Q$&]Y:&\#74_VE7"6>C\276N%H=$#&\R MN73":,J%.ZGB;1H=CY#>\E#>AO$P($9Q$/.N@T[+SX"DG_+$UA[ ,YX(+NS9 M> Y83HGDJ5[9QO:\X)I*&I.,$,^\8$"(AMQ?HBXPL#BS%7"-2)Q*>R4SQULV M(LN %6;ZGT<< S'T\ATDO.B8+!-J#XE"FT.ZBQ)[57V&X5 P0QD4IXP+LPRP M.Q-G4C@=ZX+=(&1:"^DM#^5M*+S!&8KC3$#' ;;]/H> 3=@PKE;1@/ MPU(49ZG+<9NZ.TT0;E.7L#RX#5CZTL8EL1%&U 2%S8H M3R7E=HZ> Y9:$LXT"J6V)*YIPI.$2>8Y86,0AH7:Q3DI$ -V<> AB[=I]"F; MH+LXH;P-XV$(B5U*2*#D%V %F/Z9BU@IE\0*W#Q4??G)^H;R&=!A..A@:R6\ MZ!BQ CF:,V!3B--4$GM+Z S#H6!'1^Q";0D=WVZ#Q[^+![[Q'_:47=AC=F^Q M)<0,"3& MRMLP'H9Z&$X]:,X)B1-W0;W-@WK+&;1Y)"2GS,/SS& ,"[4E=,PU'(P'L"7$ M*$OBS#D('G1+**BW/)2W83P,1C$&+?O01,!6$:5CV+3FX8BN,,=>XN+C@%[WV?RE'6AO WC8;B(G]@ &O< AWOZS;YO?L== M),ED;(^Z.=ZN,4]G0/41[MEZX : . Y 6/;&BXYYDB60HSD'=FN$2&+.[:%] MVG HV-&C0)?NU6!WU[E+"&F<)=SN54'/J07UEH?R-M3=D! /=9;M>!,1GE*A MLVS@*@AOT^AX!#W+%LK;,!X&P_B%9]E.RP^=97-701PXRR9BP2EU4CYTEBW3 M2^\LE?:\X)H*3:5<>E;IW& 0#W.6#98$.,L&K8* LVR>51"$(YY5D&N*KX(, MN/"W.,L&"P2!"[P*"@HN0;WEH;P-XV' A9\XRQ8.)+E+$[XI-.@#1$&]Y:&\ M#9^,-> D<'"Z'"0%1$WN%"H :H)!$K#T@21@BH*D,-0D<&K"IM"3644 3_% MD@!/\(N3:[! P,DU>,CB;1H[9(-ZRT-Y&\;#X)(X ML5\T"B1Q9V.><'=Q)F$)2^TN&ZB^_&1]0_D,/(G+G_C!BXX1*Y"CN0!V@$2: M<6DOHO$VCQW]0Z@GE;1@/0STBP!,\L/SG40]@ MYDO9KJ4W9;NF<,J>'?VH4O>;6?JJ=%=KHI5ZU"7C=U*K7^]^AFKWIJV>^]]9 M>JC:MEKW+Y]4L51U9Z"_?ZRJ]ON;[J>;#C\&=OM?4$L#!!0 ( ,V#JEC. M#4LAD 4 % 6 8 >&PO=V]R:W-H965T&ULK5AM;]LV M$/XKA#<,+;#4(B7K)7,,).Z*]4.'H$&VS[1$VUPET25I._GW.U*V94DTFP+N MAX:2[X[/O?">$Z=[(;^I-6,:O51EK>Y&:ZTWM^.QRM>LHNJ#V+ :?ED*65$- MCW(U5AO):&&5JG),@B >5Y37H]G4OGN4LZG8ZI+7[%$BM:TJ*E\?6"GV=R,\ M.K[XRE=K;5Z,9],-7;$GII\WCQ*>QB22,- MULS"QL9J@S>\-FE\TA)^Y:"G9T^::@9IT0J))9I3M4:?(+4*O7NNZ;;@FA7O MT0UZ?OJ(WOWZ?CK6L*?1'.<'^P^-?7+!?H:^B%JO%?JS+EC1U1\#UA-@<@3\ M0+P&OU#Y 87X=T0"$CGPS-^N'GK@A*?XA=;>Y((]&[&EC=A2B@K!^9)4\WK5 M%"C7G*E;5]@:LZ';K#F\MVI#RW7W <_.'R^4K&.A&(3A&( M?-9G?T.O*852+B<;S=AJFH:RF]W@21*1D$S'NW,''((DQ&E&DI-@!]SD!&[B M3<]]\1^6O6NY9NJN9*P3 MG?@4G=B;NBA'+)H$G95#(U7M ">OA"^]Q(!OCB)(!_/3>& M8F':$>MXD9Z\2/WM8DWK%5.FR/*ME%"7B )RJ$Y:%ZCD=,%+VS-9_G8FN.))Q'QG=T43HSE0U2<).$ 4[ZJ7+)95F&0W>N<-!R M8^#%^;G>08:$?'7R7C#8-HK"V)!2!YU#+DTF&<3GAXV'4<(:#21_^4"X,27;A-&/2HB=OJX$-?;U4 <3G;UQ MG/01#J5N2#")+YU5W'([]A*GP2BWT&0.W<0=Q]"Q>Q(' Y0.N7 R22X%LJ5? M_&/^S=LII,=AG4'$B3\:XLK2-"4#!QR"\22X'.:6H[&?I/LSU)+74,YOF*'P M59GX6M:Z46BY&/O)^!D&9+F77&M6H\UV4?(<1O(EDR80,)L#35? ?LIPMC,8 M0^+M-TJ'2)BD071VZ+O@6W+&?G;N%>'&D#7,^VCQZLRF$_^0<0?X':3LQ=_2 M,O;RG<7/:Q@FX(L0O2M8LWIO>=JX93JK7;#O6R"LT@R43B?2MYZFH6"(299> M=*7E5NPGU_DEO(AJM& K7M>'BH(.P47A=&-(J20(2))F?3>&@F$8A.D%+TA+ MO<1/O5XOF.$Y'WXRY%P)KACM9F%^"&5'O:-?:D=BF"<9"2->PD>G]W-54RN[)6E0G;X;6Z]3F]/ MUZ+W]C*P]_X!W\Z;R\W63'/7^H5*Z.H*E6P))H,/"6"3S?5E\Z#%QMX +H36 MHK++-:,P;A@!^'TIA#X^F U.E\BS_P%02P,$% @ S8.J6#&XT&SP @ M5@L !@ !X;"]W;W)KVK-E!(\;A_<1V7L(I8%9G!'TA_)DF]Z6J"A M):SP-N4/9#^!.AY7^L4D9>4OVE=:Q]!0O&6<9#4L5I E>?6/G^KW< 0('S5@ MU8#U$G!> >P:L-L"3@TX;0&W!MRV@%<#7EO KP&_[5L*:B!H.T-8 V&9#M7^ ME9L_P!Q'74KVB$JU<).-,H-*6NQYDLM3QX & M"8M3PK84T#5ZG _0U?N/79V+R22BQ[5QOS*V7C&VT3W)^8:A8;Z$I8*?G.?# M,[PN@FPBM0Z1]JVSAO>8WB#;_(0LPW(4Z[D[CP\@;G!;@0_.XW,H!&Z\B@_; M+UZ%C]HOWE+@X_:+5^&3_WOSTS?'?I((=I/R=NGGOBGE?W[#BQ1^J1*^LK75 MMO)2ZK "Q]#3Q*W#@.Y BSZ\,SWCLRK;+FDVN*39\))FHTN:C2]I-KFDV?1" M9B?Y[#3Y[)QSC[Z*BFB:QR0#=/6%,*8\K"L+K[20]<\NNG:#T/'%![4[3DN5 MSO4,QSG5#10ZQPI\TSW5#14ZS[8"TSK5C12Z,/!=*SS5C55^8> &WJENHM"9 MKN]8]HN)IPJA99M!:/F-L-H5_>B2S8"NRPJ-H9ALEK7/B_&^ MV1F;BO&)*!JK&N^??55QBA-PG>0,I; 24QDWOCC::%7%51U.BO**7Q N"H:R MN1&%+U I$,]7A/!#1T[0E-+17U!+ P04 " #-@ZI8)4 E+4P" "2!@ M& 'AL+W=OV_GVT(RZ:$2GD)MCGG\W<<^1"V7#S) M$D"AEXHR&3FE4O7*=65:0H7EA-? ])N-T!Y&SF^N8. ME(Q4P"3A# G((V?MKS9+$V\#OA-HY$@$*J# 'KQS/< M :4&I#5^]TQGV-(DGHZ/]"^V=EU+@B7<G<;6I>*N/-P.!#@)GA!5H+01F!>AC5S)T ME=[!Q+EI3]MTM. ";8KN.5.E1)]9!MF_^:XV&_2"H]XF& 7>8S%!4_\&!5XP M&^%-AW*GEC>_P#M7Y@U*7M&69>299 VFZ.XZM0.(/1MPA?>](D*1&&[H40I;YCJ6L:P.C3<===G_H9WW5I?S((PB2CD.M6;+/7?*;H. MV$T4KVW72;C2/O./ L!BV@V)8R++8GDN7SG.Q?IY,'8.[>1TM-C76EW.MIXW[R;3%RQD;5P8]-( MC965L;7PN+7KB6NL%&4X5%>3?#H]F-1"Z='927AV;<].3.LKI>6U)=?6M;!/ M%[(R#Z>C;+1]<*/6&\\/)F2JEJJ9TRFJQC*1LD*UEXEB#P=R\O956Q()CQK9,YZE7R MP>'U5OK'X#M\60HG+TWU=U7ZS>GH<$2E7(FV\C?FX3?9^3-G>86I7/BEAV[O M=$1%Z[RIN\.PH%8Z_HO'#H?_YD#>'SHO"M-JK_2:KDVE M"B7=R<1#.8N8%)VBBZ@H_XFB(_ILM-\X^J!+63X_/X'1O>7YUO*+_%6!GX4= MTRQ+*9_F^Z_(F_5(S(*\^4_D_UCP^ MT$>EA2Z4J.@6#R6(ZAW]XWSIO 75_OD20M& VO^+>?N_>_FO2_Y^!?E71RVZ\H>PM;4U(_IP)]%ZZPJIF"WSOR97V MTJIZ$(DK'$Z3V?S63J=SQ-XIY#?):V- M*1T=S/;3P_R0\GR1SK.#Y(OQ<)P/9+.#]&A_$:[GA]-TOLCH1L*!5B8WLC MF8%)0*G#V3%=E7 MP+X%UF\DVQ[XBS+D 5]7@J1]_50C;0!>%X!M6:EU6'7 M[YG0K9#W$AZCF#V3@1W:B5BK&ZL*N=U]7E6F>'TK>?._V#% A47;"!8];"0J M@+$(71K.79JZ$?J)',2Y50C=3U31E\'VM=32@A9N*]DE*VOJW@P70=Y"_"-S M<*X2W+7 'E>+JB+=UDMI>?%A8RKIP&CT(/S:F-A*.]"A"L* ##),X:SB;*@4 M[-5*C&&CE3+9'K.RB94-%!--8\VC8B[C6#ZG;$%9!JZ!Y^%Z1GE&V2%E!R$L M#\%]R*4/CPWZK"R32RM+Y>F3 >T=*(WRE4ZG4]H_BO]7NH"S]$4\8GF(EHB9 M[X*X%G*MQTR1>/%(C7&J#R3OLV50'. +<;?F7KFP ] ,:@A*LRZ%1=Y__G*8Y]/C\]O+<)4=OZ7%_G0OFP)7A41G2%!SEB'4=I \'M@Y0%\&N&LI M7&M#[2>D-0ZT/N*QZFN2VW8'*I4K*L,' I&?.>;%747 MQ@'^KRZ$[H.+3CGL1X+"]VO4=O;@HU V^1VQD/1YQXT8E6&;PI#0QA5$,9 * M^+(ZMZUQ*TBB^R!IH^ QC$*.6$[WR,P2Z",#W]$G/I=DM$=?M2C_0#RP]JTU M_!>J8Y=33ELNM)-RQL@V4;N?&]:4;68" ,K8&I\2DFJH*%4(+\'3=EFO;U+DZB&2\)S]2S2*?1^85_VY4?L MCE\0T<-#_TD>+/DQ")Q.4'B>Q6P15 MO<02<\E]U 2B-F@D3Q0Z%B2BHEBS-#;0??DTU![=8:X(7N&=H6]Q5[6=(R"5 M[GDQV_&BU[W$/B"WFP2[EC[(@V?5EFN+WADQ#KVD$-8^<9#C :32MO@9O;<4 M%7>-O?"RE.P*M!IDXZ !EJP>NG<&."K;?M1 $[!^C^<80KG;UO0-ZL=08# + MCU[6UG$_*;:C:KB0NU$UW75%$%FJX&H:MO8+C7B* )S[[Z=4WL>3:K*=5)^/ M,Z4J _,V N3F!SLK7TZ%+@#EH,GPC1\&J>LHG0[NKMGBV"4=^!3 =[PK]-76 M6@X7FI$"5IC'Y'?O -9HPRTL O9R"0U*LF-Z/GI\4L"QY!3(TFDW\<\Q)"_2 M@]F"7GJCF@Q>HS&/K&ULI5A;;]M&%G[GKQBH:6$#C$12%\N.;4N>DOOZ[/!P.5+ MM9*N;VI5XVMO<^*@72T\W!I?GM5RH1^4_U0\6IT$GI= K53EM*F'5 M_*)WE9Y=CXB>"7[7:NVVK@59,C/F"QW>%Q>]A "I4N6>)$C\/:D;598D"#"^ MMC)[G4IBW+[>2+]CVV'+3#IU8\K/NO#+B]ZT)PHUETWI/YKUWU1KSYCDY:9T M_"O6@38%<=XX;U8M,Q"L=!7^Y;?6#UL,T^0[#%G+D#'NH(A1_BR]O#RW9BTL M44,:7;"IS UPNJ*@/'J+IQI\_O+V:Z/]\_G 0Q;=&>0MWW7@R[[#=RH^F,HO MG;BM"E7L\@^ H0.2;8!<9P<%?I"V+X9I++(D&QV0-^P,&[*\\4'#Q#^O9LY; MQ/Y?^VP,(H;[15 ]G+E:YNJBAX1WRCZIWN5//Z23Y-T!@*,.X.B0] .>/\BW M']51=BQ:BV_,:H5T?_0F_R*4S)?B4Z6]R T*R7E=+2(S%Z92PBVE50*'/' X MYI!5P4_7TEI9>7%$(F(AQ4\_3+,L>?E8J41FOG- !=\ E5Z:!8R#AC1B? ETJ3N-1,HJGDQ-&#'3# ML<@F)XQRXP1Z='(:G\"8WR!K#J>9-7 )+TD1QQ)D$?_&N M-\+1GIF@0K:(52A-1:49H;"0 YO*BA[1UHNFY,!O8KQ1&?W:K&;*BL^^Z(NK MIT5_Z^IJL;!J(;VB]+G]IFRNG1(?%35^LN)]Y>%E!X<_4EXY\6!UKL1ORJ[$ MT3^LZQ^+WV79J.B^\O%+ \##A-$-MWST1HSZ219UWM/.-:K@S$J1 M=^W_RW/50BH&<,5<:;^'^)7J7<_\1;<8]H>XW#"W-G.P_EMFBKA3+]%:*U1> ML"C2>])75OMJ1*A0X2\9C8ACB!FKVDMH<$A9H59U:9X5@FQQK-YV9Y0ZQKF3 MK$I]HVN%',O-HM)_*,0ZM(V;;;+;0!:-0]6AW.[4S#88X61Z%L,:I)J'>C(& MB2I%A6D<=&)^([^0.HJOV#K36'&SU&HN[G0EJURCJ.[GW5KQXWM64G+;0MGV6"^PLH$9 M?@!NCB]5DRP*3?93)ZK46V8C'0ZA*95#QFGRN:BE14SRI3%.D?.Y5EE41 79 MZ0]H7^#4UCSI0H721< W=LBJ:O#G9$D>IBZ39MSY^N*AL:ZA@FV[02>,8]!6 M"'OW[IY$?GS\)"22KHA(1U,3WS )872A2FD6@&%G!#0UKTN(T!/WIYUNM=(P MWL,C3ARMEQK1")2,PY%8=-F9PF9$SD(W*L3LF65<&R Y/HN.]+'XL)$B4O%6 M/#9Y#H_.&XH"I6@)9BZ"N@PS:R].5 ZE03N#*M U2BP1UJWP=PF7A\Z)X'E= MBE]D10D.] [2#$C==Y 68@ZZO2V:ED>1)F__WO5H3B5N MSEWWB[C[H7)+=%BB@O&/JO:*^W%VVK;'_]W2MF9&9V+'T/Y.)- ]HC::A9"< M'+OLPY@A=#.\?*;8;'QWC>VX"-FSDA56>L*U\4,D'>K#,=1V^*("9G*FR]#3 M0N+>WK,&2F#LU1K%B:5B*QEYH>ER4-!PU'--:@D/B^VRGN9V@=JF42!GYDE1 MF42H];PI^291+W@"%CB+)YI/A 117FY$$!K:DS#UL1+\01BP3<$Y(0?W-E2H MLJ^=5"O+KU 5AB*NM2E M&QX)"(>J"11Y7,-H;VSKX<+4'":FV[&^+E$+W"/16/9*B&:<>-2TJDW[W!&Q MM;%-PA+)=E"OYD[.Y7:2_/@2^\!02UV09=_OE;%X2:<7&.36L%W7O 1A7:!; MBE;K5@,>P*2Y=N 77U%B*/M07)LV_6.G/I<.&SA#9MZYKKHUU!'Q3KN-T&ZY M2C;^P>[&V'?S@$-$;\OD=6KWN6W"TOU&I*,)+]WO#Z94M"-J*X7#FDQ[!R$_ M6"BD+1N-X]'II,L]B)UD8Y%BG9K@F,4CG+#RGTY&_R&BX?^)*(7*!"60;A7" M!M8DX;_L),ZRJ;CG%>"#Q):&3,[H?83S:]2VQ/&(8>][71QLO;2OE%WPIPD' M5(AJ>'_O[G9?/Z["2_\+>?AT N,7V+V1S'.P)OT3O!3;\#DB'+RI^1/ S'@L M/'RY5!*]B0CP?&[PFM,>2$'W3>CR3U!+ P04 " #-@ZI8 F7$52@& "2 M#0 &0 'AL+W=O^O()0B M: '%^K"=N(EMP'82)$53!''2'(H>J-W1+FLNN2&YEM5?WS?#E:S$CH'T(FFY MPYDW,^\-J>.5#U>Q(4KJIK4NGHR:E+KGDTDL&VIUW/,=.;Q9^M#JA,=03V(7 M2%>RJ;63^73Z=-)JXT:GQ[+V/IP>^SY9X^A]4+%O6QW6YV3]ZF0T&VT6/IBZ M2;PP.3WN=$V7E#YU[P.>)ELOE6G)1>.="K0\&9W-GI\?L+T8_&EH%7=^*\YD MX?T5/[RM3D93!D26RL0>-+ZNZ8*L94> \67P.=J&Y(V[OS?>7TONR&6A(UUX M^]E4J3D9'8U414O=V_3!K][0D,\A^RN]C?*I5MGV<#Y291^3;X?-0- :E[_U MS5"'G0U'T^]LF \;YH([!Q*4+W72I\?!KU1@:WCC'Y*J[ 8XX[@IERG@K<&^ M='KAV]8D5#E%I5VE+KQ+QM7D2D/Q>)(0@@TGY>#N/+N;?\?=K^H='#11O7(5 M55_OGP#:%M]\@^]\_J##=SKLJ?W96,VG\X,'_.UO\]T7?X?_)U_UTL32^M@' M4G^=+6(*(,W?]U4A!]F_/P@+Z7GL=$DG(R@E4KBFT>GC1[.GTQ'@ M(>\_WK('W=T/]N?]7]1.G.)NJ5XMER2*4K]IUT//*C=I-BY6I"*5*&*E'&19 M^M#YH!,)VA;62Y2U#_"E_')I2IAS?-6#,T%I#(B%)2A-Z3H0,0"((C5X4_JV MTVZM4J.3$JB5TE'Y/N"5DW;M!*!0P$QL$P;)GOHD 5)#*E%HL6\I#W?CC15R M6!%H$.A+;SB3Y.'YBA=IT[ !\_S:;C_<.IZN"\9?JK*F?'SHTSR6A; M>$=/UJ2#A-Y$W@;<4Z_[@)4P'JKP0R#KH%UBC+ +/(88+8"B^%]MQ0PO=%49 MGH?(8>M_-L^XHR)=-JKO,"[;/O6PN6T![!8>N74Z)!!@K+K@KTTE84U(:U7I M=7S\Z&@^>_9".9^XKR:J&A1Q'#G[!I:(DL)AP>''"LW1B%Y13*A5&02H<0)< M0-FUU'R,E>#[NE&O:1&$>47UM1:#H!M30S* M?2;1J.,WQ3!M%[B0.RT$JY2P"MPS MOHJBAN4WDIS+Y[[(C\?H6,1B7 \9(\R"K$'U,A1T# &+$F5 D4IHEV':M92V MT3#36.R%;HS%) X)S38^I"?"[$M16T)G\!F$B 87"H-2P^.% MM@; G-%[ZJW+206J=:AN4T A*0@ I+^M;90I QQ@$DI[)Q!:C!<\ K^.(W7U M+%Z%MB9DF7-?-0:$W\1DMJ'HU^;?0:@;KPRA;*0#7] T($,B'!=3=^&Y+SK4 MQ/6RL+%1+=89L]#'9_&SQQ9-T)C@3( \$5L(")A\>94%>%,2">MB#V3?1!OB MH)X[E!>]+,4%;3."'D'KCSL!3"S89C< +]\)HD2FK XY23Z*\B.N?A+00H_#E$$' MX 1D0+=1VM[A4 7A4PY]!M^EU09S5]<8"AAZ/1)8-<3\*5JH.'DHN8=;GE^) MM=K;BI.0(D*YN#\#T7B(SXA+'SG6+8KQYMQ2T=3.X(QECNB6A2N =P:/4^,N8X1#B'+.([N:5<SVT=##?!T:.% . 4,@*I]'T7 MK;NZ_<-QEN_9M^;YWPKNI37:!Y1+;)WN/<.%,^1_ M /DA^4YNW3@S<8>7GPW^-%%@ [Q?>HR^X8$#;/^&G?X'4$L#!!0 ( ,V# MJEC C6.5H0, *T' 9 >&PO=V]R:W-H965T32. MC@./LJP\#\2+62-*?$+_N7FPU(M[2BYKU$X:#1:+>70WOEE.>7U8\*?$G3MI M SO9&/.%.[_E\RAA0:@P\TP0]+?%%2K%()+Q]<",^BTY\+1]I/\2O).7C7"X M,NHOF?MJ'EU%D&,A6N4?S>Y7//CYR+S,*!=^8=>M3:\CR%KG37T()@6UU-V_ M>#[DX23@*OE.0'H(2(/N;J.@\F?AQ6)FS0XLKR8:-X+5$$WBI.:/\N0MS4J* M\XNG=N/P:XO:PWI+OVX6>\+R9)P=$,L.D7X'<0V?C/:5@[7.,7\9'Y.<7E-Z MU+1,SP(_"3N"R7@(:9).S_ FO<=)X'W\48_P]]W&>4LGXI_7[':TR>LTOB4W MKA$9SB.Z!@[M%J/%VS?CB^3VC-9IKW5ZCOYCW^,\XMWT/?S?\KHH,-P N&NL M5)!>=_D=#GR%L#)U(_0>4)=T%7,0H.E"K2J)!:R?,6M#Y'U1R PMO'O[YBI- MD]O5^CZTQK?OAW1#&R4RJ4LX ?+T^/+6 9%:>D 6=A5 MAF!<4!P(1R*$I.NG:6T@+XVP.0<<8!ZS2AMEROV1-H(_3BQ5Q* ,H"5;4GM# MH8!UH\R^YO2(TB*&UD[ZBG<8!.OK>VBLVBD4;6EK,N%1YYU? M:]JR@M];C3!)0EXOA^1#9A51E8(-@FCI*@LO,Z'4GOS1)B0H@/-<>J-#4/W M:,IBAI3Y_-0/G11)Z-)R.'78HH'Q,+U*ADF2#!Z?/KL7?K;H/)@M?SBRT-I. M=(-6FGQ(!7[S+YTU9E3204;50>J6MOR6]L$QV! @!>VI*=L*U3+IPO:AF7\='$1G "*K!J]=DWC MDQ)*![4,#P5K;[7OJFD_VK]%=UT)_K:\>\BH?)5\=A46%)J,+JDNV>YQZ#K> M-*$@;XRG,Q&:%;VG:'D!S1?&^&.'-^A?Z,5_4$L#!!0 ( ,V#JE@\38H2 MF0@ $\: 9 >&PO=V]R:W-H965TQTUR )&VQ6;38(&EG'Q;[0$NTS8E$JB25R_[Z_0XERTXJ M,SM]L77A^;Z_QL,":)1"$R1Q 1UX6[UX]]%J]"4\#)=6/_+'MNUXP'+:NMT MV1)#@E*JYI\_M8;X?PC2EB#U,O)0?N>/GIT8_,D.K@4877E5/#>&DHEVY MC<^65M\<1:QE7.[IJM87K)[N1*R:7,N'+L(LMTK9Q4*W:C"YE)8=F[ MS=7[TY&#'(0VREJ>EPW/= _/8_95*[>V[)/*1?Z2?@3Y.R72C1*7:1#P*S=# M-DEBEH[3PP#>I#/*Q.--]^#]TZRXDO_EY#]Y\^"S4"3/H%H%#\8"N>B;-!1;S,@QB< M__Y;W:>Y&_^/2CE@^\((_I4R ( MU:_ 7GPV32;Q\5$:4F+6*3%[8R<> *G-+KBCE<)GOX@X&-Q;]C>6Q--Q&B?),:[3>#*=Q./I-()/2*3:G*VT MSBT[FAS&\W3.TG063Y.CZ)MVW6@@SKDQO*E8.[ MM:5*F#!5)8R/)95A3Q>%7/FW%IO[ G0#\E%@.U#T7F!@A;*\J>F5D9G8K+XH M"IV%ES*G?T6.':L0M&FWX7$M4!ZT@5_%GNY*EQ57S\P"SBZ]7^UAQ;[M+%\) M)0Q\UFZ0;;0TNNS$L(V1-R;^V:U!5W#J;N#:MN1%P51=+H2AEX]K70B+#(!> M!;^FJ?126?AJX<%@&51]"5JH?\4+"7F5Y$/(:(2(-F1&5$W9@__SJC+Z25*@ M@2R=LF3&D@2!@"#TUQ.6)BR9L^0HY/?'G=\?!_V>=O;16Q"BL4]/%5HZ2'%E M1"X=^Z(1UKW9,XC:'PC]K*(7K) =4(GC\7C,#H^;_X"2R7C;BHW?2*H9]I=] MXT_]ZH3)]R76+>8+I^--4V>]GC44-@X]?.3X$ZNTE5T\T#J3>XMX+_3A8_2# MM'X%/&RG/43[HW)ND!NO=+Z-_G>__S9/T_')Q=V5OTI.WK/9X?@@&<,])9(Y MR8NF8>$CQNSD( <7M/#@W'MM*;BMC>^O&%(W"&K7;-2RJ]9VTX&Q7-JLT$3@ M\\$+Q1R_;V-7;+P)J6$ANA>*26<]D1&N-FH8[1I/H*36/F))+!*8=*8WG25? M,:3)(2=8LA\OR6"XY [%2F'Z:006HH3-+2LU9"[D/047%BFFM&ODBRR2 -"! M55= $T^\RX\D"F81'Y7,"N>*!K;;-I*(UVZM#8027;:CQW_61MI<9MVV-_L" ME\?\YW/3,.CC.^-&$O3Q.Z>S>V]'3':-W!1DRHI>CP^"]7O\?@Y!#=*M!FE0 M \H![ ;)%2Q*@-^MN>D7/HC3+WPO./)-FA['L^F8,D^*.UQ-YVA1\/=V_ME. M/4EPZD 38(7OK7)#R] M?.;2L#^0_03[NLW&31[<'9DP^M;EOJDFS*-?&V(<_17&5.U\_4 J)2^SFZYP M22H\>*2U1'*#+Z(<&FJ0FB*4(]&B"_C OA!=E+ #]EWQ_$^D7KS[46OZ\_UD M6R&I]4(B-_>":@9E=8)#Y<3<*Q=HO;CSG'?K5\[;TB5]IYSQ(D;Q@+HH:[X> MT; ".*PH)%_(PN?L82M3"IFN5573 B";IDR\%BTKZASW5 @IZ=DR59 O2#; M0RY1YQPJ$LFL-G=QU+"AZO^2/4%:B5&.FWY=?K;= M20]$9Q[V%AXD^7D3J'(V3$[ +VRPOV88]DX,5\,8J!A2L&W,E\GW)U'37WM6 M'6*.,?.AX01'K=!Z/S/?XP,1S8/1"VU\L"Z>=[DWZI"O<'I#*WVG3W.(:16! M4ZG.+R9;O^AX+[ .EMN>Y[5#T$X+#SJY];Z?I1M#D/\A=@>AL3;!AB.+*17-?9+NQ<5?VX,<.%>'SK0.CIX MB#8'#R\'P%SFWO/6',Y-#[92]H="NP'Y3C])-VYWD]KFL>5!C70R.[%1:WSF MC6]IE6^A:V-HN]!WRC=ZM^V93Q(^],$8+%X=!QNM-+6\^U/]+QP&O<5G3[[W M%DE.7HZ%0"(X?1 KQ?:J3-]H88=-^0SO\'4$L#!!0 ( ,V# MJEAN@ Y"PP( -0% 9 >&PO=V]R:W-H965TKHF;G$CNPMUEW?CK\5W: M,*2NXB4Y^^S/GWVV9SNI?NH*T0,-I.- ME#^M\+&8>Z$EA#7FQB(P^MWC%=:U!2(:O_:8WA#2.CX]']"O7>Z4RX9IO)+U M-UZ8:NY-/2APR[K:W,K=!]SGDUJ\7-;:?6&WMPT]R#MM9+-W)@8-%_V?/>SK M\#\.\=XA=KS[0([E.V98-E-R!\I:$YH]N%2=-Y'CPC[*VBBZY>1GLF6G2:,U M,%' NG\9D%M8\U+P+<^9,+#(<]D)PT4)*UGSG*.&UW=L4Z-^,PL,L;!80;Z/ MN.PCQL]$O( ;*4REX;THL/C7/R#V0PKQ(85E?!+PAJES2"(?XC >GHTPF-;8;.I':)DR=+MAQEJB:]3 M"([5.G@R:0VJTNT3#6X^^J$;M,/*6O23^M>\WW=4E9(+#35NR34\GU _JGZ' M](*1K9O;C32T!=RQHK6+RAK0_59*&PO=V]R:W-H965TD\,)%V'=4"WH.E:#,,>%)NQA=I2*M%)^_>3;,?-MC3 M7BQ*XCD\M$EZL)+J2>>(!"]E(?30R8D6%YZGDQQ+IEVY0&%NYE*5C,Q699Y> M*&1I#2H++_3]$Z]D7#CQH#Z;J'@@*RJXP(D"794E4Z]C+.1JZ 3.^N".9SG9 M R\>+%B&4Z3OBXDR.Z]C27F)0G,I0.%\Z(R"BW'?^M<.#QQ7>L,&F\E,RB>[ MN4F'CF\%88$)609FEB5>85%8(B/CN>5TNI 6N&FOV3_5N9M<9DSCE2P>>4KY MT#ES(,4YJPJZDZO/V.9S;/D26>CZ":O&-SQW(*DTR;(%&P4E%\W*7MKWL $X M\]\!A"T@K'4W@6J5'QFQ>*#D"I3U-FS6J%.MT48<%_:C3$F96VYP%%\_5YQ> MX>">S0K4AP./#*F]\I*68-P0A.\0G,.M%)1KN!8IIG_B/2.F4Q2N%8W#G82W M3+D0!4<0^F%_!U_491C5?,>[,_PYFFE2I@A^;POXL]GII&2ZL"0"%#<-FO2F.3/1 M8*)X@G"/JH2#'TJ[A_# B@I[WRK2Q$1J08S@2R40(K_^QA$$1\'I^='IL0\? MH._Z8>^QD:B!:UUA"OM[9V$07*[7MWML):6>&4]SY+3%^:_0IKR2O*NO?V)# MY$;&7(/;G&US_#<8MM6&M]&J):JL'D@:$ED):KJV.^UFWJAI]3?W9F :,9EY M^5#@W$!]]]1T@&J&4+,AN:@;?R;)C)':S,W<1F4=S/U<2EIO;(#N3Q#_!E!+ M P04 " #-@ZI8YC3V]JP" "0!@ &0 'AL+W=O$ ]N>$G\<<_Q.3?7-UDCU9W> !AR7W&AI][&F/K<]W6Q@8KJ M4UF#P)V55!4U.%5K7]<*:.E %?>C(!CY%67"RS.W-E=Y)K>&,P%S1?2VJJAZ MN 0NFZD7>H\+-VR],7;!S[.:KF$!YK:>*YSY/4O)*A":24$4K*;>17@^2VV\ M"_C.H-%[8V*=+*6\LY-/Y=0+K"#@4!C+0/&U@QEP;HE0QN^.T^N/M,#]\2/[ MM?..7I94PTSR'ZPTFZDW\4@)*[KEYD8V'Z'SXP06DFOW)$T7&WBDV&HCJPZ, M"BHFVC>][_*P!PB35P!1!XC^%1!W@-@9;94Y6U?4T#Q3LB'*1B.;';C<.#2Z M8<)^Q851N,L09_(%ED6YY4#DBC"Q V&D>B!'5V HX_J8O">WBRMR]/8X\PT> M9T%^T5%?MM31*]1?J#HE<7A"HB!*!N"SP_#/6X'PP,'CIW ?3?9.H]YIY/C2 M5_B^JC45[ ^UU7-"9E)HR5E)VV(2)9DKT&B_7K4]2^W R]^]"4?!AZ'L_">R)[F*^US% MA]CS&]I@D1E0:%^?D *3Q;1A8FT30[6&:LD?2$V5P=TE-382M$NC+2*%'26C)_) M&HA+)T$Z#I_I\O?ZA>W5>%/73&C"887(X'2,1*KM?^W$R-JUD*4TV)#<<(._ M#% V /=74IK'B>U*_4\H_PM02P,$% @ S8.J6,@'G/F7!@ ?34 !D M !X;"]W;W)K&ULM5M;;]LV&/TKA#<,+9#%%B7? M,L= 8K5;AF8+XJ5]*/; R+0M5")=DK(;8#]^U"6F:2N,%7SN0R/)Y"%YR$-^ M1Q1'&RZ^R26E"OU($R8O6TNE5A?MMHR6-"7RG*\HT[_,N4B)TK=BT98K0W8GQB&']S'BZ7* M'[3'HQ59T"E5#ZL[H>_:6Y19G%(F8\Z0H//+UI5W$09%AB+%YYANY,XURIOR MR/FW_.9F=MGJY#6B"8U4#D'TGS6=T"3)D70]OE>@K6V9><;=ZV?TCT7C=6,> MB:03GGR)9VIYV1JTT(S.29:H>[[Y@U8-ZN9X$4]D\3_:5&D[+11E4O&TRJQK MD,:L_$M^5$3L9- X]1EPE0'O9PA>R.!7&?QC,P15AJ!@IFQ*P4-(%!F/!-\@ MD:?6:/E%06:16S<_9GF_3Y70O\8ZGQI?9U(_D1(1-D/3LO,1GZ-IO&#Q/(X( M4^@JBGC&5,P6Z(XG<113B=Z%5)$XD>@O(@3)^^X]^A4]3$/T[N?WH[;25V<(=W!0 M4Y_)\=G]FNRA._N?&=/9.W79K=;XVU[R"[SN"WAW@L^R2*$;5BH]5\S73SH1 MNE$TE?_6$5XB^O6(^71R(5ZW'7\X<]/&JO=YEQ%M>4 M&2 PBYGNEIFNDYD;MJ9,@M+^CD_[;=99'2 MVY+2C42DC%;5+DQ.F MZ30""18"@5GT>1T3BW7 E_D*$HA,4+00"LVFT]=R3MXY99W&2Y=$IDDNB MRZAET#N]KO[4[2[N,;D *'9Y&!##GYUN=?N0J O>0"?+W$NQ;K!&H\R M2+00"LTFTH3F'GQL[H$&YZ!H(12:3:>)SSUW@'ZL:(.:N I[^%"TH $Z%)I- MC@G1/7>,_J#=L=B(6-%C=0L:L8.BA5!H-I:$4<*3JK8N,'%K^F6TA3 M, %%"Z'0;#:-R?"&\+H%=1R@:"$4FOV:U'@.[ S"C]5MA6+IMN8MAKNPIM1 MH=G4&/^ W?[AGJXIRRBZIBQ:ID084XO^0Y/BW;Q>AR><190I48[$^UA:R?[6 MXS*D)-$)77IWUZ3I 5%"Z'0[%XP1@5C<+UC4+L"BA9"H=ET&KN"G?'[^'"X MGJ$[*O)G9%'[VJX"'.Y(OW..N_O*KTWEV:E"=^7>VGAC+K#;7$ H>DHCSF9' MB1K2>DQ T4(H-+LCC)'!77A1@WH94+00"LVFTW@9[-ZF>(.H>S5R]?9?3=>G M&NR+^A3. QOG@=W. T+4_RQC<9RF(8W)!!0MA$*S^\'8'#R US2HSP%%"Z'0 M;#J-S\&O[:8TUO2P3JW>OJ9K4_7V-7T*5^(;5^*_XDH.]UU/%WR[Z]+X4PE0 M"P2%9O>#L4"^!__A":B7 44+H=!L.HV7\=V;+LTU70'NA=7[.^;N8AN3= J' MXN]\Z^1V*##:/SY,=U>G\7B%_53J%'[)-W[)#^#E#^IZ0-%"*#2;3N-Z?/?V MS1ODWZV3_[[Z0:T,%)K-D;$R?N,OKDX9S[MKTWBT@N[H0*'9/6%\E=^'%S^H M/0)%"Z'0;#J-/?+=NT!O$/_@&(_N+K8Q2:

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end XML 34 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 35 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 37 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 97 139 1 false 36 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://neovolta.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Balance Sheets (Unaudited) Sheet http://neovolta.com/role/BalanceSheets Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical) Sheet http://neovolta.com/role/BalanceSheetsParenthetical Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Statements of Operations (Unaudited) Sheet http://neovolta.com/role/StatementsOfOperations Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Statements of Operations (Unaudited) (Parenthetical) Sheet http://neovolta.com/role/StatementsOfOperationsParenthetical Statements of Operations (Unaudited) (Parenthetical) Statements 5 false false R6.htm 00000006 - Statement - Statements of Stockholders' Equity (Unaudited) Sheet http://neovolta.com/role/StatementsOfStockholdersEquity Statements of Stockholders' Equity (Unaudited) Statements 6 false false R7.htm 00000007 - Statement - Statements of Cash Flows (Unaudited) Sheet http://neovolta.com/role/StatementsOfCashFlows Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 8 false false R9.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 9 false false R10.htm 995513 - Disclosure - Business and Summary of Significant Accounting Policies Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies Business and Summary of Significant Accounting Policies Notes 10 false false R11.htm 995514 - Disclosure - Equity Sheet http://neovolta.com/role/Equity Equity Notes 11 false false R12.htm 995515 - Disclosure - Commitments and Contingencies Sheet http://neovolta.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 995516 - Disclosure - Subsequent Events Sheet http://neovolta.com/role/SubsequentEvents Subsequent Events Notes 13 false false R14.htm 995517 - Disclosure - Business and Summary of Significant Accounting Policies (Policies) Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies Business and Summary of Significant Accounting Policies (Policies) Policies http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies 14 false false R15.htm 995518 - Disclosure - Business and Summary of Significant Accounting Policies (Tables) Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables Business and Summary of Significant Accounting Policies (Tables) Tables http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies 15 false false R16.htm 995519 - Disclosure - Equity (Tables) Sheet http://neovolta.com/role/EquityTables Equity (Tables) Tables http://neovolta.com/role/Equity 16 false false R17.htm 995520 - Disclosure - Schedule of inventory (Details) Sheet http://neovolta.com/role/ScheduleOfInventoryDetails Schedule of inventory (Details) Details 17 false false R18.htm 995521 - Disclosure - Business and Summary of Significant Accounting Policies (Details Narrative) Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative Business and Summary of Significant Accounting Policies (Details Narrative) Details http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables 18 false false R19.htm 995522 - Disclosure - Equity (Details - Warrant activity) Sheet http://neovolta.com/role/EquityDetails-WarrantActivity Equity (Details - Warrant activity) Details http://neovolta.com/role/EquityTables 19 false false R20.htm 995523 - Disclosure - Equity (Details Narrative) Sheet http://neovolta.com/role/EquityDetailsNarrative Equity (Details Narrative) Details http://neovolta.com/role/EquityTables 20 false false All Reports Book All Reports neov-20240331.xsd neov-20240331_cal.xml neov-20240331_def.xml neov-20240331_lab.xml neov-20240331_pre.xml neovolta_i10q-033124.htm image_001.jpg http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 true true JSON 39 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "neovolta_i10q-033124.htm": { "nsprefix": "NEOV", "nsuri": "http://neovolta.com/20240331", "dts": { "schema": { "local": [ "neov-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "neov-20240331_cal.xml" ] }, "definitionLink": { "local": [ "neov-20240331_def.xml" ] }, "labelLink": { "local": [ "neov-20240331_lab.xml" ] }, "presentationLink": { "local": [ "neov-20240331_pre.xml" ] }, "inline": { "local": [ "neovolta_i10q-033124.htm" ] } }, "keyStandard": 128, "keyCustom": 11, "axisStandard": 14, "axisCustom": 0, "memberStandard": 9, "memberCustom": 25, "hidden": { "total": 32, "http://fasb.org/us-gaap/2024": 27, "http://xbrl.sec.gov/dei/2024": 5 }, "contextCount": 97, "entityCount": 1, "segmentCount": 36, "elementCount": 339, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 309, "http://xbrl.sec.gov/dei/2024": 34, "http://xbrl.sec.gov/ecd/2024": 4 }, "report": { "R1": { "role": "http://neovolta.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true } }, "R2": { "role": "http://neovolta.com/role/BalanceSheets", "longName": "00000002 - Statement - Balance Sheets (Unaudited)", "shortName": "Balance Sheets (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "unique": true } }, "R3": { "role": "http://neovolta.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical)", "shortName": "Balance Sheets (Unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true } }, "R4": { "role": "http://neovolta.com/role/StatementsOfOperations", "longName": "00000004 - Statement - Statements of Operations (Unaudited)", "shortName": "Statements of Operations (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2024-01-012024-03-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true } }, "R5": { "role": "http://neovolta.com/role/StatementsOfOperationsParenthetical", "longName": "00000005 - Statement - Statements of Operations (Unaudited) (Parenthetical)", "shortName": "Statements of Operations (Unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "From2024-01-012024-03-31", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true } }, "R6": { "role": "http://neovolta.com/role/StatementsOfStockholdersEquity", "longName": "00000006 - Statement - Statements of Stockholders' Equity (Unaudited)", "shortName": "Statements of Stockholders' Equity (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "AsOf2022-06-30_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember", "name": "us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "unique": true } }, "R7": { "role": "http://neovolta.com/role/StatementsOfCashFlows", "longName": "00000007 - Statement - Statements of Cash Flows (Unaudited)", "shortName": "Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "us-gaap:ProvisionForDoubtfulAccounts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "unique": true } }, "R8": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2024-01-012024-03-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true }, "uniqueAnchor": null }, "R9": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2024-01-012024-03-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true } }, "R10": { "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies", "longName": "995513 - Disclosure - Business and Summary of Significant Accounting Policies", "shortName": "Business and Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true } }, "R11": { "role": "http://neovolta.com/role/Equity", "longName": "995514 - Disclosure - Equity", "shortName": "Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true } }, "R12": { "role": "http://neovolta.com/role/CommitmentsAndContingencies", "longName": "995515 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true } }, "R13": { "role": "http://neovolta.com/role/SubsequentEvents", "longName": "995516 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true } }, "R14": { "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies", "longName": "995517 - Disclosure - Business and Summary of Significant Accounting Policies (Policies)", "shortName": "Business and Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "14", "firstAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "NEOV:DescriptionOfBusinessPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "NEOV:DescriptionOfBusinessPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true } }, "R15": { "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables", "longName": "995518 - Disclosure - Business and Summary of Significant Accounting Policies (Tables)", "shortName": "Business and Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "15", "firstAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true } }, "R16": { "role": "http://neovolta.com/role/EquityTables", "longName": "995519 - Disclosure - Equity (Tables)", "shortName": "Equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "16", "firstAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-01to2024-03-31", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true } }, "R17": { "role": "http://neovolta.com/role/ScheduleOfInventoryDetails", "longName": "995520 - Disclosure - Schedule of inventory (Details)", "shortName": "Schedule of inventory (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "17", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:InventoryRawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:InventoryRawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true } }, "R18": { "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "995521 - Disclosure - Business and Summary of Significant Accounting Policies (Details Narrative)", "shortName": "Business and Summary of Significant Accounting Policies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "18", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:CashUninsuredAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:CashUninsuredAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true, "unique": true } }, "R19": { "role": "http://neovolta.com/role/EquityDetails-WarrantActivity", "longName": "995522 - Disclosure - Equity (Details - Warrant activity)", "shortName": "Equity (Details - Warrant activity)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "19", "firstAnchor": { "contextRef": "AsOf2023-06-30", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "unique": true } }, "R20": { "role": "http://neovolta.com/role/EquityDetailsNarrative", "longName": "995523 - Disclosure - Equity (Details Narrative)", "shortName": "Equity (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "20", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2019-02-28_custom_StockOptionPlan2019Member", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "neovolta_i10q-033124.htm", "unique": true } } }, "tag": { "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r30", "r387" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r370" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts receivable, net", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r509" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r448" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r36", "r387", "r589" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r296", "r498", "r499", "r500", "r501", "r542", "r590" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r454" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r454" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r454" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r454" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operations:" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r419", "r430", "r440", "r465" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r422", "r433", "r443", "r468" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r454" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r461" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r423", "r434", "r444", "r461", "r469", "r473", "r481" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "auth_ref": [ "r479" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r90", "r153", "r157", "r158", "r160", "r559" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "NEOV_AmortizedValueOfRSUsGrantedMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "AmortizedValueOfRSUsGrantedMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amortized value of RSUs granted [Member]", "documentation": "Amortized value of RSUs granted [Member]" } } }, "auth_ref": [] }, "NEOV_AmortizedValueOfSharesGrantedToVariousAdvisorsMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "AmortizedValueOfSharesGrantedToVariousAdvisorsMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amortized Value Of Shares Granted To Various Advisors [Member]" } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r426" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Antidilutive shares", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r134" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r11" ] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r11" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets [Default Label]", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r66", "r73", "r86", "r109", "r137", "r141", "r147", "r148", "r154", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r242", "r244", "r256", "r275", "r329", "r383", "r384", "r387", "r400", "r513", "r514", "r556" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r82", "r93", "r109", "r154", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r242", "r244", "r256", "r387", "r513", "r514", "r556" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r426" ] }, "NEOV_AugustPublicOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "AugustPublicOfferingMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "August Public Offering [Member]" } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Exercise Price" } } }, "auth_ref": [ "r476" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r477" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r472" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r472" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method" } } }, "auth_ref": [ "r472" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r472" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r472" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined" } } }, "auth_ref": [ "r472" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Securities" } } }, "auth_ref": [ "r475" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r474" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r473" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r473" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets", "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "verboseLabel": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r6", "r85", "r374" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r7" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents at beginning of period", "periodEndLabel": "Cash and cash equivalents at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r6", "r51", "r107" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r0", "r51" ] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental non-cash financing activities" } } }, "auth_ref": [] }, "us-gaap_CashUninsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashUninsuredAmount", "crdr": "debit", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash, Uninsured Amount", "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r452" ] }, "srt_ChiefExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ChiefExecutiveOfficerMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "auth_ref": [ "r508" ] }, "srt_ChiefFinancialOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ChiefFinancialOfficerMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Chief Financial Officer [Member]" } } }, "auth_ref": [ "r508" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://neovolta.com/role/Cover", "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r79", "r87", "r88", "r89", "r109", "r128", "r129", "r131", "r133", "r139", "r140", "r154", "r167", "r169", "r170", "r171", "r174", "r175", "r179", "r180", "r183", "r186", "r192", "r256", "r291", "r292", "r293", "r294", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r317", "r338", "r355", "r364", "r365", "r366", "r367", "r368", "r489", "r496", "r502" ] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Exercise Price, Beginning", "periodEndLabel": "Weighted Average Exercise Price, Beginning", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r193" ] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants granted", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r193" ] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity", "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants outstanding, beginning", "periodEndLabel": "Warrants outstanding, beginning", "label": "Class of Warrant or Right, Outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r453" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r453" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies (Note 3)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r33", "r67", "r276", "r316" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://neovolta.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r58", "r165", "r166", "r371", "r511", "r512" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r390", "r391", "r392", "r394", "r395", "r396", "r397", "r498", "r499", "r501", "r542", "r588", "r590" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://neovolta.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r35" ] }, "NEOV_CommonStockParValue0.001PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "CommonStockParValue0.001PerShareMember", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock, par value $0.001 per share" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://neovolta.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r35", "r317" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://neovolta.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r35" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://neovolta.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r4", "r35", "r317", "r335", "r590", "r591" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, $0.001 par value, 100,000,000 shares authorized, 33,236,091 shares and 33,155,127 shares issued and outstanding, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r35", "r277", "r387" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r458" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r457" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r459" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r456" ] }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CompensationRelatedCostsPolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Stock Compensation Expense", "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense." } } }, "auth_ref": [ "r61", "r62" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r13", "r14", "r26", "r27", "r151", "r370" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r13", "r14", "r26", "r27", "r151", "r288", "r370" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r13", "r14", "r26", "r27", "r151", "r370", "r491" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r13", "r14", "r26", "r27", "r151" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r13", "r14", "r26", "r27", "r151", "r370" ] }, "NEOV_ConversionOfConvertibleDebtAndAccruedInterestIntoCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://neovolta.com/20240331", "localname": "ConversionOfConvertibleDebtAndAccruedInterestIntoCommonStock", "crdr": "credit", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of convertible debt and accrued interest into common stock" } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of goods sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r45", "r46", "r272" ] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "CounterpartyNameAxis", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "auth_ref": [ "r110", "r111", "r176", "r181", "r267", "r270", "r274", "r376", "r378" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r56", "r151" ] }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtConversionConvertedInstrumentAmount1", "crdr": "credit", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt converted, amount converted", "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r9", "r10" ] }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtConversionConvertedInstrumentSharesIssued1", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt converted, shares issued", "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period." } } }, "auth_ref": [ "r9", "r10" ] }, "us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredCompensationLiabilityCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accrued compensation expenses", "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date." } } }, "auth_ref": [] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r308", "r309", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r330", "r331", "r332", "r333", "r343", "r344", "r345", "r346", "r349", "r350", "r351", "r352", "r360", "r361", "r362", "r363", "r390", "r392", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r23", "r24", "r25", "r64", "r308", "r309", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r330", "r331", "r332", "r333", "r343", "r344", "r345", "r346", "r349", "r350", "r351", "r352", "r360", "r361", "r362", "r363", "r378", "r390", "r392", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553" ] }, "NEOV_DescriptionOfBusinessPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://neovolta.com/20240331", "localname": "DescriptionOfBusinessPolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Description of Business" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r414" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r412", "r414", "r426" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r413" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r401" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r414" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r414" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r447" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r404" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://neovolta.com/role/StatementsOfOperationsParenthetical" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r100", "r117", "r118", "r119", "r120", "r121", "r122", "r126", "r128", "r131", "r132", "r133", "r136", "r238", "r241", "r254", "r255", "r273", "r282", "r381" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://neovolta.com/role/StatementsOfOperationsParenthetical" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r100", "r117", "r118", "r119", "r120", "r121", "r122", "r128", "r131", "r132", "r133", "r136", "r238", "r241", "r254", "r255", "r273", "r282", "r381" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Loss Per Common Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r11", "r12", "r135" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r407" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r403" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r403" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r488" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r403" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r485" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r426" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r403" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r403" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r403" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r403" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r486" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r4", "r80", "r97", "r98", "r99", "r112", "r113", "r114", "r116", "r121", "r123", "r125", "r138", "r155", "r156", "r164", "r194", "r233", "r234", "r235", "r236", "r237", "r239", "r240", "r241", "r246", "r247", "r248", "r249", "r250", "r251", "r253", "r257", "r258", "r259", "r260", "r261", "r262", "r264", "r265", "r266", "r281", "r283", "r284", "r285", "r296", "r355" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r455" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r419", "r430", "r440", "r465" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r416", "r427", "r437", "r462" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r461" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements and Financial Instruments", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r3" ] }, "NEOV_FairValueOfIncentiveSharesTwoWholesaleDealerMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "FairValueOfIncentiveSharesTwoWholesaleDealerMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair Value Of Incentive Shares Two Wholesale Dealer [Member]" } } }, "auth_ref": [] }, "NEOV_FairValueOfIncentiveSharesWholesaleDealerMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "FairValueOfIncentiveSharesWholesaleDealerMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair Value Of Incentive Shares Wholesale Dealer [Member]" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r423", "r434", "r444", "r469" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r423", "r434", "r444", "r469" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r423", "r434", "r444", "r469" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r423", "r434", "r444", "r469" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r423", "r434", "r444", "r469" ] }, "NEOV_FourthDealerMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "FourthDealerMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fourth Dealer [Member]" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "General and administrative", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r49", "r340" ] }, "NEOV_GrossProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://neovolta.com/20240331", "localname": "GrossProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gross proceeds from sale of equity" } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r44", "r47", "r72", "r109", "r154", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r256", "r382", "r383", "r503", "r504", "r505", "r506", "r507", "r513" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r96", "r225", "r226", "r227", "r228", "r229", "r232", "r290" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid for income taxes", "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax." } } }, "auth_ref": [ "r8", "r106", "r230", "r231" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccruedLiabilities", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accrued expenses", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in current assets and liabilities" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid insurance and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r2" ] }, "NEOV_IndependentDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "IndependentDirectorsMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Independent Directors [Member]" } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]" } } }, "auth_ref": [ "r423", "r434", "r444", "r461", "r469", "r473", "r481" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingArrLineItems", "auth_ref": [ "r479" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r415", "r484" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r415", "r484" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r415", "r484" ] }, "us-gaap_InterestAndOtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestAndOtherIncome", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest income", "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "label": "Interest Expense, Operating and Nonoperating", "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense." } } }, "auth_ref": [ "r137", "r141", "r144", "r145", "r148", "r263", "r383", "r384" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid for interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r102", "r104", "r105" ] }, "NEOV_InterimFinancialInformationPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://neovolta.com/20240331", "localname": "InterimFinancialInformationPolicyPolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Interim Financial Information" } } }, "auth_ref": [] }, "us-gaap_InventoryFinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryFinishedGoods", "crdr": "debit", "presentation": [ "http://neovolta.com/role/ScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "label": "Finished goods", "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer." } } }, "auth_ref": [ "r492" ] }, "us-gaap_InventoryGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryGross", "crdr": "debit", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Inventory, Gross", "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r494" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets", "http://neovolta.com/role/ScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "label": "Inventory", "verboseLabel": "Total", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r92", "r375", "r387" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventory", "label": "Inventory, Policy [Policy Text Block]", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r74", "r84", "r91", "r161", "r162", "r163", "r271", "r379" ] }, "us-gaap_InventoryRawMaterials": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryRawMaterials", "crdr": "debit", "presentation": [ "http://neovolta.com/role/ScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "label": "Raw materials, consisting of assembly parts, batteries and inverters", "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r493" ] }, "NEOV_InvestorWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "InvestorWarrantsMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investor Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders' equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r40", "r68", "r279", "r387", "r497", "r510", "r554" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders' Equity" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r32", "r83", "r109", "r154", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r243", "r244", "r245", "r256", "r387", "r513", "r556", "r557" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MajorCustomersAxis", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r151", "r385", "r388", "r389", "r515", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587" ] }, "NEOV_May2018NotesPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "May2018NotesPayableMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "May 2018 Notes Payable [Member]" } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]" } } }, "auth_ref": [ "r453" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Name" } } }, "auth_ref": [ "r453" ] }, "NEOV_Milestone1Member": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "Milestone1Member", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Milestone 1 [Member]" } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r472" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r480" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r151", "r385", "r388", "r389", "r515", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r454" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash flows provided by financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r103" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash flows used in operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r51", "r52", "r53" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://neovolta.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows", "http://neovolta.com/role/StatementsOfOperations", "http://neovolta.com/role/StatementsOfStockholdersEquity", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "Net loss", "verboseLabel": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r48", "r53", "r69", "r81", "r94", "r95", "r99", "r109", "r115", "r117", "r118", "r119", "r120", "r121", "r124", "r125", "r130", "r154", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r238", "r241", "r255", "r256", "r280", "r337", "r353", "r354", "r398", "r513" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recent Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r453" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r451" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r450" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r480" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r480" ] }, "NEOV_NonTradeableWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "NonTradeableWarrantsMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non Tradeable Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income (expense)", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r50" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "auth_ref": [] }, "NEOV_October2021NotesPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "October2021NotesPayableMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "October 2021 Notes Payable [Member]" } } }, "auth_ref": [] }, "NEOV_OneDealerMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "OneDealerMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "One Dealer [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpensesAbstract", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r72", "r382", "r503", "r504", "r505", "r506", "r507" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Business and Summary of Significant Accounting Policies", "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements." } } }, "auth_ref": [ "r28", "r54", "r55", "r63" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued liabilities", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r31" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r453" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r414" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r421", "r432", "r442", "r467" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Amount" } } }, "auth_ref": [ "r424", "r435", "r445", "r470" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r424", "r435", "r445", "r470" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PayVsPerformanceDisclosureLineItems", "auth_ref": [ "r449" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r452" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r452" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r451" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name" } } }, "auth_ref": [ "r454" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r450" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameAxis", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameDomain", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Benefits Adjustments, Footnote" } } }, "auth_ref": [ "r451" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r408" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r410" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid insurance and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r495" ] }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceInitialPublicOffering", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Underwritten public offering of common stock", "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public." } } }, "auth_ref": [ "r1" ] }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net proceeds from sale of equity", "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity." } } }, "auth_ref": [ "r1", "r291" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductInformationLineItems", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Provision for expected credit losses/bad debt expense", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r101", "r159" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r449" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r449" ] }, "NEOV_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy1": { "xbrltype": "textBlockItemType", "nsuri": "http://neovolta.com/20240331", "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy1", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Allowance for Expected Credit Losses" } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RecoveryOfErrCompDisclosureLineItems", "auth_ref": [ "r416", "r427", "r437", "r462" ] }, "NEOV_RelatedPartiesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://neovolta.com/20240331", "localname": "RelatedPartiesPolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Related Parties" } } }, "auth_ref": [] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "auth_ref": [ "r110", "r111", "r176", "r181", "r267", "r270", "r274", "r377", "r378" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Research and development", "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity." } } }, "auth_ref": [ "r224", "r372", "r383", "r558" ] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Research and Development Costs", "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process." } } }, "auth_ref": [ "r223" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r417", "r428", "r438", "r463" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date" } } }, "auth_ref": [ "r418", "r429", "r439", "r464" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement does not require Recovery" } } }, "auth_ref": [ "r425", "r436", "r446", "r471" ] }, "NEOV_RestrictedStockUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "RestrictedStockUnitsMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units [Member]" } } }, "auth_ref": [] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r37", "r60", "r278", "r286", "r287", "r295", "r318", "r387" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r80", "r112", "r113", "r114", "r116", "r121", "r123", "r125", "r155", "r156", "r164", "r233", "r234", "r235", "r236", "r237", "r239", "r240", "r241", "r246", "r248", "r249", "r251", "r253", "r264", "r265", "r283", "r285", "r296", "r590" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenues from contracts with customers", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r70", "r71", "r137", "r142", "r143", "r146", "r148", "r149", "r150", "r151", "r195", "r196", "r272" ] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r339", "r373", "r380" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r480" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r480" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares issued new, units issued", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalesRevenueNetMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r151", "r490" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of inventory", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r5", "r41", "r42", "r43" ] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Nature of Operation, Product Information, Concentration of Risk [Table]", "documentation": "Disclosure of information about concentration risk of product within nature of operation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://neovolta.com/role/EquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of warrant activity", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r20" ] }, "NEOV_SecondDealerMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "SecondDealerMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Second Dealer [Member]" } } }, "auth_ref": [] }, "us-gaap_SecuritiesFinancingTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SecuritiesFinancingTransactionAxis", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Securities Financing Transaction [Axis]", "documentation": "Information by type of securities financing transactions, including, but not limited to those measured at fair value or cost." } } }, "auth_ref": [ "r65" ] }, "us-gaap_SecuritiesFinancingTransactionTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SecuritiesFinancingTransactionTypeDomain", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Measurement of financing transaction securities held." } } }, "auth_ref": [ "r65" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r402" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r406" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r405" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r411" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r2" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r213" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r211" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r386" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222" ] }, "NEOV_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable": { "xbrltype": "monetaryItemType", "nsuri": "http://neovolta.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable", "crdr": "debit", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value, Exercisable" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "crdr": "debit", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value, Ending", "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesOutstanding", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Shares, Outstanding, Beginning Balance", "periodEndLabel": "Shares, Outstanding, Beginning Balance", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r409" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://neovolta.com/role/Cover", "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r79", "r87", "r88", "r89", "r109", "r128", "r129", "r131", "r133", "r139", "r140", "r154", "r167", "r169", "r170", "r171", "r174", "r175", "r179", "r180", "r183", "r186", "r192", "r256", "r291", "r292", "r293", "r294", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r317", "r338", "r355", "r364", "r365", "r366", "r367", "r368", "r489", "r496", "r502" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r4", "r35", "r38", "r39", "r80", "r97", "r98", "r99", "r112", "r113", "r114", "r116", "r121", "r123", "r125", "r138", "r155", "r156", "r164", "r194", "r233", "r234", "r235", "r236", "r237", "r239", "r240", "r241", "r246", "r247", "r248", "r249", "r250", "r251", "r253", "r257", "r258", "r259", "r260", "r261", "r262", "r264", "r265", "r266", "r281", "r283", "r284", "r285", "r296", "r355" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://neovolta.com/role/Cover", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r112", "r113", "r114", "r138", "r265", "r272", "r289", "r307", "r310", "r311", "r312", "r313", "r314", "r315", "r317", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r330", "r331", "r332", "r333", "r334", "r336", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r355", "r393" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://neovolta.com/role/Cover", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r112", "r113", "r114", "r138", "r152", "r265", "r272", "r289", "r307", "r310", "r311", "r312", "r313", "r314", "r315", "r317", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r330", "r331", "r332", "r333", "r334", "r336", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r355", "r393" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r420", "r431", "r441", "r466" ] }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockGrantedDuringPeriodValueSharebasedCompensation", "crdr": "credit", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r19", "r22" ] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of common stock for conversion of debt and accrued interest, shares", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r4", "r18", "r35", "r38", "r60", "r177" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of common stock in underwritten public offering, shares", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r4", "r34", "r35", "r60", "r291", "r355", "r365" ] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted stock granted, shares", "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards." } } }, "auth_ref": [ "r4", "r60" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock compensation expense, shares", "verboseLabel": "Stock issued for compensation, shares", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r4", "r34", "r35", "r60" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of common stock for conversion of debt and accrued interest", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r4", "r35", "r38", "r39", "r60" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of common stock in underwritten public offering", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r4", "r34", "r35", "r60", "r296", "r355", "r365", "r399" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock compensation expense", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r21", "r34", "r35", "r60" ] }, "NEOV_StockOptionPlan2019Member": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "StockOptionPlan2019Member", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2019 Stock Option Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://neovolta.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://neovolta.com/role/BalanceSheets", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders' equity", "periodStartLabel": "Beginning balance, value", "periodEndLabel": "Ending balance, value", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r35", "r38", "r39", "r57", "r319", "r335", "r356", "r357", "r387", "r400", "r497", "r510", "r554", "r590" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityAbstract", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' equity:" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://neovolta.com/role/Equity" ], "lang": { "en-us": { "role": { "label": "Equity", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r59", "r108", "r178", "r180", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r194", "r252", "r358", "r359", "r369" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://neovolta.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r268", "r269" ] }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]", "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity." } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsidiarySaleOfStockLineItems", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsidiary, Sale of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Liquidity", "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern." } } }, "auth_ref": [ "r29" ] }, "us-gaap_SupplementalCashFlowElementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalCashFlowElementsAbstract", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental disclosures of cash flow information" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List, Table" } } }, "auth_ref": [ "r460" ] }, "NEOV_ThirdDealerMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "ThirdDealerMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Third Dealer [Member]" } } }, "auth_ref": [] }, "NEOV_ThreeIndependentDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "ThreeIndependentDirectorsMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Three Independent Directors [Member]" } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "TitleOfIndividualAxis", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Title and Position [Axis]" } } }, "auth_ref": [ "r508", "r555" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r452" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r459" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r479" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r481" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TransactionDomain", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Agreement between buyer and seller for the exchange of financial instruments." } } }, "auth_ref": [ "r378" ] }, "us-gaap_TransactionTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TransactionTypeAxis", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Transaction Type [Axis]", "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments." } } }, "auth_ref": [ "r378" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Adoption Date" } } }, "auth_ref": [ "r482" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Arrangement Duration" } } }, "auth_ref": [ "r483" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Expiration Date" } } }, "auth_ref": [ "r483" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r481" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Title" } } }, "auth_ref": [ "r481" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Termination Date" } } }, "auth_ref": [ "r482" ] }, "NEOV_TwoExecutivesMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "TwoExecutivesMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Two Executives [Member]" } } }, "auth_ref": [] }, "NEOV_UnderwriterMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "UnderwriterMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Underwriter [Member]" } } }, "auth_ref": [] }, "NEOV_UnderwriterWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "UnderwriterWarrantsMember", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Underwriter Warrants [Member]" } } }, "auth_ref": [] }, "NEOV_UnderwrittenPublicOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "UnderwrittenPublicOfferingMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Underwritten Public Offering [Member]" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r478" ] }, "NEOV_UnitDescription": { "xbrltype": "stringItemType", "nsuri": "http://neovolta.com/20240331", "localname": "UnitDescription", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unit description" } } }, "auth_ref": [] }, "NEOV_UnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "UnitsMember", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Units [Member]" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UseOfEstimates", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r15", "r16", "r17", "r75", "r76", "r77", "r78" ] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Warrants and Rights Outstanding, Term", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r543", "r544", "r545" ] }, "NEOV_WarrantsAndRightsOutstandingTermExercisable": { "xbrltype": "durationItemType", "nsuri": "http://neovolta.com/20240331", "localname": "WarrantsAndRightsOutstandingTermExercisable", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Warrants term, exercisable" } } }, "auth_ref": [] }, "NEOV_WarrantsEachWarrantExercisableForOneShareOfCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://neovolta.com/20240331", "localname": "WarrantsEachWarrantExercisableForOneShareOfCommonStockMember", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Warrants, each warrant exercisable for one share of common stock" } } }, "auth_ref": [] }, "NEOV_WarrantsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://neovolta.com/20240331", "localname": "WarrantsExercisableWeightedAverageExercisePrice", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Warrants exercisable, weighted average exercise price" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://neovolta.com/role/StatementsOfOperationsParenthetical" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r127", "r133" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://neovolta.com/role/StatementsOfOperationsParenthetical" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r126", "r133" ] }, "NEOV_WorkingCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://neovolta.com/20240331", "localname": "WorkingCapital", "crdr": "debit", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Working Capital", "documentation": "Working Capital" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://neovolta.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r487" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "30", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480513/718-10-30-3" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "30", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480843/718-30-35-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205/tableOfContent" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "40", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205-40/tableOfContent" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/275/tableOfContent" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/810/tableOfContent" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/330/tableOfContent" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r373": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r374": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16" }, "r377": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21" }, "r378": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22" }, "r379": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r380": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r381": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r382": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r383": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r384": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r385": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r386": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r388": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r389": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r390": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r392": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r397": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r398": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r399": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r400": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r401": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r402": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r403": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r404": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r405": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r407": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r408": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r409": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r410": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r411": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r412": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r413": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r414": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r415": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r416": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r417": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r418": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r419": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r420": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r421": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r422": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r423": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r424": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r425": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r426": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r427": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r428": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r429": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r430": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r431": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r432": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r433": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r434": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r435": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r436": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r437": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r438": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r439": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r440": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r441": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r442": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r443": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r444": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r445": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r446": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r447": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r449": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r450": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r451": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r452": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r453": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r454": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r455": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r456": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r457": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r458": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r459": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r460": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r461": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r462": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r463": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r464": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r465": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r466": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r467": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r468": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r469": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r470": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r471": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r472": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r473": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r474": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r475": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r476": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r477": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r478": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r479": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r480": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r481": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r482": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r483": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r484": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r485": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r486": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r487": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r488": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r489": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r490": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r491": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r492": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r493": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r494": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r495": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r496": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r497": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r498": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r499": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r500": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r501": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r502": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r503": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r504": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r505": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r506": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r507": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r508": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r509": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r510": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r511": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r512": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r513": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r514": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r515": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r516": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r517": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r518": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r519": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r520": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r521": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r522": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r523": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r524": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r525": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r526": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r527": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r528": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r529": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r530": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r531": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r532": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r533": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r534": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r535": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r536": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r537": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r538": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r539": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r540": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r541": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r542": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r543": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r544": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r545": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r546": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r547": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r548": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r549": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r550": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r551": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r552": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r553": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r554": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r555": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r556": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r557": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r558": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1" }, "r559": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r560": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r561": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r562": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r563": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r564": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r565": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r566": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r567": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r568": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r569": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r570": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r571": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r572": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r573": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r574": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r575": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r576": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r577": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r578": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r579": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r580": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r581": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r582": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r583": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r584": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r585": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r586": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r587": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r588": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r589": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r590": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r591": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" } } } ZIP 40 0001683168-24-003236-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-24-003236-xbrl.zip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end XML 42 neovolta_i10q-033124_htm.xml IDEA: XBRL DOCUMENT 0001748137 2023-07-01 2024-03-31 0001748137 NEOV:CommonStockParValue0.001PerShareMember 2023-07-01 2024-03-31 0001748137 NEOV:WarrantsEachWarrantExercisableForOneShareOfCommonStockMember 2023-07-01 2024-03-31 0001748137 2024-05-10 0001748137 2024-03-31 0001748137 2023-06-30 0001748137 2024-01-01 2024-03-31 0001748137 2023-01-01 2023-03-31 0001748137 2022-07-01 2023-03-31 0001748137 us-gaap:CommonStockMember 2023-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001748137 us-gaap:RetainedEarningsMember 2023-06-30 0001748137 us-gaap:CommonStockMember 2023-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001748137 us-gaap:RetainedEarningsMember 2023-09-30 0001748137 2023-09-30 0001748137 us-gaap:CommonStockMember 2023-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001748137 us-gaap:RetainedEarningsMember 2023-12-31 0001748137 2023-12-31 0001748137 us-gaap:CommonStockMember 2022-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001748137 us-gaap:RetainedEarningsMember 2022-06-30 0001748137 2022-06-30 0001748137 us-gaap:CommonStockMember 2022-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001748137 us-gaap:RetainedEarningsMember 2022-09-30 0001748137 2022-09-30 0001748137 us-gaap:CommonStockMember 2022-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001748137 us-gaap:RetainedEarningsMember 2022-12-31 0001748137 2022-12-31 0001748137 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001748137 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001748137 2023-07-01 2023-09-30 0001748137 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0001748137 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0001748137 2023-10-01 2023-12-31 0001748137 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001748137 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001748137 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001748137 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001748137 2022-07-01 2022-09-30 0001748137 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001748137 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001748137 2022-10-01 2022-12-31 0001748137 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001748137 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001748137 us-gaap:CommonStockMember 2024-03-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001748137 us-gaap:RetainedEarningsMember 2024-03-31 0001748137 us-gaap:CommonStockMember 2023-03-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001748137 us-gaap:RetainedEarningsMember 2023-03-31 0001748137 2023-03-31 0001748137 NEOV:OneDealerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2024-03-31 0001748137 NEOV:SecondDealerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2024-03-31 0001748137 NEOV:ThirdDealerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2024-03-31 0001748137 NEOV:OneDealerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2024-03-31 0001748137 NEOV:SecondDealerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2024-03-31 0001748137 NEOV:ThirdDealerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2024-03-31 0001748137 NEOV:FourthDealerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2024-03-31 0001748137 NEOV:OneDealerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2023-03-31 0001748137 NEOV:SecondDealerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2023-03-31 0001748137 NEOV:ThirdDealerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2023-03-31 0001748137 us-gaap:CommonStockMember 2023-07-01 2024-03-31 0001748137 NEOV:InvestorWarrantsMember 2023-07-01 2024-03-31 0001748137 NEOV:UnderwriterWarrantsMember 2023-07-01 2024-03-31 0001748137 NEOV:RestrictedStockUnitsMember 2023-07-01 2024-03-31 0001748137 NEOV:UnitsMember NEOV:UnderwrittenPublicOfferingMember 2022-08-01 2022-08-31 0001748137 NEOV:UnderwriterMember NEOV:NonTradeableWarrantsMember NEOV:UnderwrittenPublicOfferingMember 2022-08-31 0001748137 NEOV:May2018NotesPayableMember NEOV:AugustPublicOfferingMember 2022-08-01 2022-08-31 0001748137 NEOV:October2021NotesPayableMember NEOV:AugustPublicOfferingMember 2022-08-01 2022-08-31 0001748137 srt:ChiefExecutiveOfficerMember NEOV:Milestone1Member 2022-07-01 2022-12-31 0001748137 srt:ChiefFinancialOfficerMember NEOV:Milestone1Member 2022-07-01 2022-12-31 0001748137 us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2024-03-31 0001748137 us-gaap:RestrictedStockUnitsRSUMember 2022-07-01 2023-03-31 0001748137 NEOV:ThreeIndependentDirectorsMember 2024-03-31 0001748137 NEOV:AmortizedValueOfRSUsGrantedMember 2023-07-01 2024-03-31 0001748137 NEOV:IndependentDirectorsMember 2023-07-01 2024-03-31 0001748137 NEOV:AmortizedValueOfSharesGrantedToVariousAdvisorsMember 2023-07-01 2024-03-31 0001748137 NEOV:FairValueOfIncentiveSharesWholesaleDealerMember 2023-07-01 2024-03-31 0001748137 NEOV:IndependentDirectorsMember 2023-10-01 2024-03-31 0001748137 NEOV:AmortizedValueOfRSUsGrantedMember 2022-07-01 2023-03-31 0001748137 NEOV:IndependentDirectorsMember 2022-07-01 2023-03-31 0001748137 NEOV:AmortizedValueOfSharesGrantedToVariousAdvisorsMember 2022-07-01 2023-03-31 0001748137 NEOV:FairValueOfIncentiveSharesTwoWholesaleDealerMember 2022-07-01 2023-03-31 0001748137 NEOV:StockOptionPlan2019Member 2019-02-28 0001748137 NEOV:TwoExecutivesMember NEOV:StockOptionPlan2019Member 2022-07-01 2023-06-30 0001748137 NEOV:ThreeIndependentDirectorsMember NEOV:StockOptionPlan2019Member 2022-07-01 2023-06-30 0001748137 2023-07-01 2023-12-31 iso4217:USD shares iso4217:USD shares pure false --06-30 2024 Q3 0001748137 10-Q true 2024-03-31 false 001-41447 NeoVolta, Inc. NV 82-5299263 13651 Danielson Street Suite A Poway CA 92064 (800) 364-5464 Common Stock, par value $0.001 per share NEOV NASDAQ Warrants, each warrant exercisable for one share of common stock NEOVW NASDAQ Yes Yes Non-accelerated Filer true true false false 33236091 1013962 2002789 1886555 1826385 2136947 2580571 115224 96119 5152688 6505864 5152688 6505864 3167 0 11884 39491 15051 39491 0.001 0.001 100000000 100000000 33236091 33236091 33155127 33155127 33236 33155 25117861 24872446 -20013460 -18439228 5137637 6466373 5152688 6505864 283900 629010 117755 537261 166145 91749 756118 723271 10392 1290 766510 724561 -600365 -632812 10892 0 -0 -0 10892 0 -589473 -632812 33236091 33236091 33151685 33151685 -0.02 -0.02 -0.02 -0.02 2065858 2733951 1572668 2302380 493190 431571 2085976 2716428 10392 29936 2096368 2746364 -1603178 -2314793 28946 0 -0 4134 28946 -4134 -1574232 -2318927 33205766 33205766 31650491 31650491 -0.05 -0.05 -0.07 -0.07 33155127 33155 24872446 -18439228 6466373 84717 84717 -428715 -428715 33155127 33155 24957163 -18867943 6122375 80964 81 97060 97141 -556044 -556044 33236091 33236 25054223 -19423987 5663472 63638 63638 -589473 -589473 33236091 33236 25117861 -20013460 5137637 21977251 21978 18394641 -15799395 2617224 1121250 1121 3779284 3780405 9671867 9672 1169614 1179286 591816 591816 -698586 -698586 32770368 32771 23935355 -16497981 7470145 75000 75 719220 719295 -987529 -987529 32845368 32846 24654575 -17485510 7201911 309759 309 108781 109090 -632812 -632812 33155127 33155 24763356 -18118322 6678189 -1574232 -2318927 245496 1420201 670000 380000 730170 799913 -443624 -875919 19105 -33291 3167 -205600 -27607 -35571 -988827 -650600 0 3780405 0 3780405 -988827 3129805 2002789 330385 1013962 3460190 0 0 0 0 0 1179286 <p id="xdx_807_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_zt87S3sQQ9Yb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(<span style="font-size: 10pt">1)       <span id="xdx_82E_zMhPwVEtoFr6">Business and Summary of Significant Accounting Policies</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84C_ecustom--DescriptionOfBusinessPolicyTextBlock_zLKRItJoJrh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_866_zk0vaxMRtknl">Description of Business</span></i> – NeoVolta Inc. (“we”, “our” or the “Company”) is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 2).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84D_ecustom--InterimFinancialInformationPolicyPolicyTextBlock_z9UKahfOq4nk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86E_zBeCrCZEahPk">Interim Financial Information</span> </i>– The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of March 31, 2024, the results of its operations for the three and nine month periods ended March 31, 2024 and 2023, the changes in its stockholders’ equity for the nine month periods ended March 31, 2024 and 2023, and cash flows for the nine month periods ended March 31, 2024 and 2023. The balance sheet as of June 30, 2023 has been derived from the Company’s June 30, 2023 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2023, as filed with the SEC on September 22, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zzhCG8QJX7k8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_860_zEQfYQAcriDb">Cash and Cash Equivalents</span></i> – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents. Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000, per bank. At March 31, 2024, the Company maintained accounts at two different banks, of which the combined balances of the accounts at the two banks were in excess of the combined FDIC insurance limits by $<span id="xdx_90D_eus-gaap--CashUninsuredAmount_iI_c20240331_z0UmnpB7BPCe">513,962</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_840_eus-gaap--InventoryPolicyTextBlock_zJ11QUNnouW4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_860_zN0JjXI1dhTk">Inventory</span></i> – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Additionally, we made a bulk purchase of raw materials consisting of assembly parts from our former contract manufacturer in April 2023, for a gross amount of $<span id="xdx_90A_eus-gaap--InventoryGross_iI_dm_c20230630_zDf0MrE27rMj">1.4 million</span>. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. No inventory reserve was required as of March 31, 2024 and June 30, 2023. The following table presents the components of inventory as of March 31, 2024 and June 30, 2023:</p> <p id="xdx_896_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zkG6WODrS0xa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 79%; margin-right: auto"> <tr style="vertical-align: bottom"> <td id="xdx_8B1_zi3HkMK3EIv8"> <b style="display: none">Schedule of inventory</b></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20240331_zKCZtzMq0xw8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20230630_zjZTPc72Kz1f" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--InventoryRawMaterials_iI_zdIRPVkFwaRf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 45%; text-align: left">Raw materials, consisting of assembly parts, <span style="font-size: 10pt">batteries and inverters</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,502,119</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,353,055</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InventoryFinishedGoods_iI_zywTPfNsFHmi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">634,828</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">227,516</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryNet_iI_z8D0sfn1NOr" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,136,947</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,580,571</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_z9fiB5JoKWj7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p id="xdx_842_eus-gaap--RevenueRecognitionPolicyTextBlock_zlLaZjc1K7Wh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_869_zkTBYATi921f">Revenue Recognition</span></i> – The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Identification of the contract with a customer</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Identification of the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Determination of the transaction price</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three dealers represented approximately <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDealerMember_zU8sNztBiJa7" title="Concentration Risk, Percentage">25</span>%, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SecondDealerMember_z4AqW1MRrI08" title="Concentration Risk, Percentage">17</span>% and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThirdDealerMember_zK3rZU5ZGDr8" title="Concentration Risk, Percentage">11</span>% of the Company’s revenues in the nine months ended March 31, 2024, however, no other dealers accounted for more than 10% of the revenues in such period. Four dealers represented approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDealerMember_zXWPgrQpCtPk" title="Concentration Risk, Percentage">22</span>%, <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SecondDealerMember_z9bEXopFTyI1" title="Concentration Risk, Percentage">20</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThirdDealerMember_zHV0L9F6N6H9" title="Concentration Risk, Percentage">17</span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourthDealerMember_zZknxk77FE1j" title="Concentration Risk, Percentage">13</span>% of the Company’s gross accounts receivable as of March 31, 2024. Three such dealers represented approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDealerMember_zpCH7lO2gse2" title="Concentration Risk, Percentage">21</span>%, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SecondDealerMember_zyyom5plGb84" title="Concentration Risk, Percentage">18</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThirdDealerMember_zECy5mBo8mT8" title="Concentration Risk, Percentage">16</span>% of the Company’s revenues in the nine months ended March 31, 2023. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the nine months ended March 31, 2024 and 2023 is provided.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_844_ecustom--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy1_z2D9dgDDTgaa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_860_zSL3B8i6JK17">Allowance for Expected Credit Losses</span></i> – The Company recognizes an allowance for expected credit losses whenever a loss is expected to be incurred in the realization of a customer’s account. As of March 31, 2024 and June 30, 2023, our allowance for expected credit losses was $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20240331_zwwdRfqTcT5g">1,160,000</span> and $<span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20230630_zkgFih1v4CPg">490,000</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_zf1vFirdjmQj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_863_zuoQGrNE4Ch">Income Taxes</span></i> – The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of reported assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for uncertain tax positions in accordance with the provisions of Accounting Standards Codification (“ASC”) 740-10 which prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken, or expected to be taken, on its tax return. The Company evaluates and records any uncertain tax positions based on the amount that management deems is more likely than not to be sustained upon examination and ultimate settlement with the tax authorities in the tax jurisdictions in which it operates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_840_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zdyOvw46krah" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_865_zwAhkHLwG5Eb">Stock Compensation Expense</span></i> – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zRWmSuPn3twa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86C_zcuulCQPGuG7">Loss Per Common Share</span></i> – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of March 31, 2024, the Company had total outstanding common stock equivalents of <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230701__20240331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_zVyJ5Lwpustb" title="Antidilutive shares">1,229,750</span> shares as follows: (i) <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230701__20240331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--InvestorWarrantsMember_zzZPRuj1KCu7">1,121,250</span> shares related to warrants issued to investors in the public offering completed in August 2022; (ii) <span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230701__20240331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnderwriterWarrantsMember_zaTZHMfHFnTg">58,500</span> shares related to warrants issued to the underwriters in that same offering, and (iii) <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230701__20240331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnitsMember_zOoxp9LJ7fi8">50,000</span> shares related to restricted stock units granted to two officers in March 2022 (see Note 2).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_zZ80s42FehU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86A_zY9mREBXGSn2">Research and Development Costs</span></i> – Research and development costs are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_840_eus-gaap--UseOfEstimates_zNY0kC3J2fda" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_860_z7kKJbOF526i">Use of Estimates</span></i> – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates. As a result of the continued spread of the COVID-19 coronavirus since early 2020, economic uncertainties have arisen which could impact business operations, supply chains, energy demand, and commodity prices that are beyond our control. Overall, we have not experienced a material adverse impact to our economic performance or ability to continue our business operations as a result of COVID-19. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84B_ecustom--RelatedPartiesPolicyTextBlock_zXbNr57HnTP7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86F_zbU6KTPoGvPk">Related Parties</span></i> – The Company accounts for related party transactions in accordance with ASC 850. A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that it might be prevented from fully pursuing its own separate interests is also a related party.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <p id="xdx_84C_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zSFcD9Qsf1ba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i><span id="xdx_86B_zMFthrUcEBEk">Fair Value Measurements and Financial Instruments</span></i> – ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). <span style="background-color: white">The three levels of the fair value hierarchy are described below: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Level 3 - Inputs that are both significant to the fair value measurement and unobservable.  The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, and accounts payable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At March 31, 2024 and June 30, 2023, the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z63rFXIBsQZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86B_zDqGULzyeNde">Recent Accounting Pronouncements</span></i> – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements. Effective July 1, 2023, the Company adopted the provisions of ASC 326 (<i>Financial Instruments – Credit Losses</i>) pertaining to “current expected credit losses,” which had no material impact on the Company’s financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p id="xdx_846_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zq4gGg38qGyj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_866_zgRS5OwFRn8f">Liquidity</span></i> – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary equity financing to continue operations and the attainment of profitable operations. As disclosed in Note 2, we completed a public offering of our equity securities in August 2022 that raised total net proceeds of approximately $3,780,000. As of March 31, 2024, we had a cash balance of $<span id="xdx_906_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20240331_zwkqEqJs1pQb">1,013,962</span> and net working capital of $<span id="xdx_900_ecustom--WorkingCapital_iI_c20240331_zbuJAewqJrq8">5,137,637</span>. We anticipate that we will have sufficient cash resources in order to operate our business for at least the next 12 months from the date these financial statements are issued, without new sources of capital.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84C_ecustom--DescriptionOfBusinessPolicyTextBlock_zLKRItJoJrh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_866_zk0vaxMRtknl">Description of Business</span></i> – NeoVolta Inc. (“we”, “our” or the “Company”) is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 2).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84D_ecustom--InterimFinancialInformationPolicyPolicyTextBlock_z9UKahfOq4nk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86E_zBeCrCZEahPk">Interim Financial Information</span> </i>– The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of March 31, 2024, the results of its operations for the three and nine month periods ended March 31, 2024 and 2023, the changes in its stockholders’ equity for the nine month periods ended March 31, 2024 and 2023, and cash flows for the nine month periods ended March 31, 2024 and 2023. The balance sheet as of June 30, 2023 has been derived from the Company’s June 30, 2023 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2023, as filed with the SEC on September 22, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zzhCG8QJX7k8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_860_zEQfYQAcriDb">Cash and Cash Equivalents</span></i> – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents. Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000, per bank. At March 31, 2024, the Company maintained accounts at two different banks, of which the combined balances of the accounts at the two banks were in excess of the combined FDIC insurance limits by $<span id="xdx_90D_eus-gaap--CashUninsuredAmount_iI_c20240331_z0UmnpB7BPCe">513,962</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 513962 <p id="xdx_840_eus-gaap--InventoryPolicyTextBlock_zJ11QUNnouW4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_860_zN0JjXI1dhTk">Inventory</span></i> – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Additionally, we made a bulk purchase of raw materials consisting of assembly parts from our former contract manufacturer in April 2023, for a gross amount of $<span id="xdx_90A_eus-gaap--InventoryGross_iI_dm_c20230630_zDf0MrE27rMj">1.4 million</span>. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. No inventory reserve was required as of March 31, 2024 and June 30, 2023. The following table presents the components of inventory as of March 31, 2024 and June 30, 2023:</p> <p id="xdx_896_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zkG6WODrS0xa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 79%; margin-right: auto"> <tr style="vertical-align: bottom"> <td id="xdx_8B1_zi3HkMK3EIv8"> <b style="display: none">Schedule of inventory</b></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20240331_zKCZtzMq0xw8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20230630_zjZTPc72Kz1f" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--InventoryRawMaterials_iI_zdIRPVkFwaRf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 45%; text-align: left">Raw materials, consisting of assembly parts, <span style="font-size: 10pt">batteries and inverters</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,502,119</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,353,055</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InventoryFinishedGoods_iI_zywTPfNsFHmi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">634,828</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">227,516</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryNet_iI_z8D0sfn1NOr" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,136,947</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,580,571</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_z9fiB5JoKWj7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> 1400000 <p id="xdx_896_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zkG6WODrS0xa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 79%; margin-right: auto"> <tr style="vertical-align: bottom"> <td id="xdx_8B1_zi3HkMK3EIv8"> <b style="display: none">Schedule of inventory</b></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20240331_zKCZtzMq0xw8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20230630_zjZTPc72Kz1f" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--InventoryRawMaterials_iI_zdIRPVkFwaRf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 45%; text-align: left">Raw materials, consisting of assembly parts, <span style="font-size: 10pt">batteries and inverters</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,502,119</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,353,055</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InventoryFinishedGoods_iI_zywTPfNsFHmi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">634,828</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">227,516</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryNet_iI_z8D0sfn1NOr" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,136,947</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,580,571</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1502119 2353055 634828 227516 2136947 2580571 <p id="xdx_842_eus-gaap--RevenueRecognitionPolicyTextBlock_zlLaZjc1K7Wh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_869_zkTBYATi921f">Revenue Recognition</span></i> – The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Identification of the contract with a customer</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Identification of the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Determination of the transaction price</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three dealers represented approximately <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDealerMember_zU8sNztBiJa7" title="Concentration Risk, Percentage">25</span>%, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SecondDealerMember_z4AqW1MRrI08" title="Concentration Risk, Percentage">17</span>% and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThirdDealerMember_zK3rZU5ZGDr8" title="Concentration Risk, Percentage">11</span>% of the Company’s revenues in the nine months ended March 31, 2024, however, no other dealers accounted for more than 10% of the revenues in such period. Four dealers represented approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDealerMember_zXWPgrQpCtPk" title="Concentration Risk, Percentage">22</span>%, <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SecondDealerMember_z9bEXopFTyI1" title="Concentration Risk, Percentage">20</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThirdDealerMember_zHV0L9F6N6H9" title="Concentration Risk, Percentage">17</span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourthDealerMember_zZknxk77FE1j" title="Concentration Risk, Percentage">13</span>% of the Company’s gross accounts receivable as of March 31, 2024. Three such dealers represented approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDealerMember_zpCH7lO2gse2" title="Concentration Risk, Percentage">21</span>%, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SecondDealerMember_zyyom5plGb84" title="Concentration Risk, Percentage">18</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThirdDealerMember_zECy5mBo8mT8" title="Concentration Risk, Percentage">16</span>% of the Company’s revenues in the nine months ended March 31, 2023. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the nine months ended March 31, 2024 and 2023 is provided.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.25 0.17 0.11 0.22 0.20 0.17 0.13 0.21 0.18 0.16 <p id="xdx_844_ecustom--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy1_z2D9dgDDTgaa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_860_zSL3B8i6JK17">Allowance for Expected Credit Losses</span></i> – The Company recognizes an allowance for expected credit losses whenever a loss is expected to be incurred in the realization of a customer’s account. As of March 31, 2024 and June 30, 2023, our allowance for expected credit losses was $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20240331_zwwdRfqTcT5g">1,160,000</span> and $<span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20230630_zkgFih1v4CPg">490,000</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 1160000 490000 <p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_zf1vFirdjmQj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_863_zuoQGrNE4Ch">Income Taxes</span></i> – The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of reported assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for uncertain tax positions in accordance with the provisions of Accounting Standards Codification (“ASC”) 740-10 which prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken, or expected to be taken, on its tax return. The Company evaluates and records any uncertain tax positions based on the amount that management deems is more likely than not to be sustained upon examination and ultimate settlement with the tax authorities in the tax jurisdictions in which it operates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_840_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zdyOvw46krah" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_865_zwAhkHLwG5Eb">Stock Compensation Expense</span></i> – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zRWmSuPn3twa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86C_zcuulCQPGuG7">Loss Per Common Share</span></i> – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of March 31, 2024, the Company had total outstanding common stock equivalents of <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230701__20240331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_zVyJ5Lwpustb" title="Antidilutive shares">1,229,750</span> shares as follows: (i) <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230701__20240331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--InvestorWarrantsMember_zzZPRuj1KCu7">1,121,250</span> shares related to warrants issued to investors in the public offering completed in August 2022; (ii) <span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230701__20240331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnderwriterWarrantsMember_zaTZHMfHFnTg">58,500</span> shares related to warrants issued to the underwriters in that same offering, and (iii) <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230701__20240331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnitsMember_zOoxp9LJ7fi8">50,000</span> shares related to restricted stock units granted to two officers in March 2022 (see Note 2).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> 1229750 1121250 58500 50000 <p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_zZ80s42FehU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86A_zY9mREBXGSn2">Research and Development Costs</span></i> – Research and development costs are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_840_eus-gaap--UseOfEstimates_zNY0kC3J2fda" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_860_z7kKJbOF526i">Use of Estimates</span></i> – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates. As a result of the continued spread of the COVID-19 coronavirus since early 2020, economic uncertainties have arisen which could impact business operations, supply chains, energy demand, and commodity prices that are beyond our control. Overall, we have not experienced a material adverse impact to our economic performance or ability to continue our business operations as a result of COVID-19. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84B_ecustom--RelatedPartiesPolicyTextBlock_zXbNr57HnTP7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86F_zbU6KTPoGvPk">Related Parties</span></i> – The Company accounts for related party transactions in accordance with ASC 850. A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that it might be prevented from fully pursuing its own separate interests is also a related party.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <p id="xdx_84C_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zSFcD9Qsf1ba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i><span id="xdx_86B_zMFthrUcEBEk">Fair Value Measurements and Financial Instruments</span></i> – ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). <span style="background-color: white">The three levels of the fair value hierarchy are described below: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Level 3 - Inputs that are both significant to the fair value measurement and unobservable.  The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, and accounts payable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At March 31, 2024 and June 30, 2023, the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z63rFXIBsQZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86B_zDqGULzyeNde">Recent Accounting Pronouncements</span></i> – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements. Effective July 1, 2023, the Company adopted the provisions of ASC 326 (<i>Financial Instruments – Credit Losses</i>) pertaining to “current expected credit losses,” which had no material impact on the Company’s financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p id="xdx_846_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zq4gGg38qGyj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_866_zgRS5OwFRn8f">Liquidity</span></i> – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary equity financing to continue operations and the attainment of profitable operations. As disclosed in Note 2, we completed a public offering of our equity securities in August 2022 that raised total net proceeds of approximately $3,780,000. As of March 31, 2024, we had a cash balance of $<span id="xdx_906_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20240331_zwkqEqJs1pQb">1,013,962</span> and net working capital of $<span id="xdx_900_ecustom--WorkingCapital_iI_c20240331_zbuJAewqJrq8">5,137,637</span>. We anticipate that we will have sufficient cash resources in order to operate our business for at least the next 12 months from the date these financial statements are issued, without new sources of capital.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 1013962 5137637 <p id="xdx_809_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z02DDI2OxnKk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(2)       <span id="xdx_824_zNrM2FWbyqDg">Equity</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Common Stock</i> – In August 2022, the Company completed an underwritten public offering of its equity securities in the form of Units with<span id="xdx_906_ecustom--UnitDescription_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zOUae58GoMvj" title="Unit description"> each Unit consisting of one share of common stock and one warrant (each, a “Warrant” and collectively, the “Warrants”)</span> to purchase one share of common stock at an exercise price of $4.00 per share. The shares of common stock and the Warrants comprising the Units were immediately separated at closing of the offering and each is now independently listed on the NASDAQ Capital Market. Each Warrant became exercisable on the date of issuance and will expire five years from the date of issuance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the underwritten public offering, a total of <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zs1F40kgwfmg" title="Shares issued new, units issued">1,121,250</span> Units, including exercise of the underwriter’s overallotment option, were sold at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $<span id="xdx_90C_ecustom--GrossProceedsFromIssuanceOrSaleOfEquity_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zROkNvYmoZ" title="Gross proceeds from sale of equity">4,485,000</span> and the net proceeds, after deduction of underwriting discounts and other offering costs were approximately $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zvsEmeZ8NU1c" title="Net proceeds from sale of equity">3,780,000</span>. The Company also granted the underwriter non-tradeable warrants to purchase a total of <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__srt--CounterpartyNameAxis__custom--UnderwriterMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonTradeableWarrantsMember_z7otwTrgBGi4" title="Warrants granted">58,500</span> shares of common stock at an exercise price of $4.40 per share for a period of five years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In conjunction with the public offering, all holders of the Company’s 2018 convertible notes in the total amount of $<span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--AugustPublicOfferingMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--May2018NotesPayableMember_zxHfS0iXnWx" title="Debt converted, amount converted">59,251</span>, including accrued interest, converted their debt into a total of <span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--AugustPublicOfferingMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--May2018NotesPayableMember_zxSn1mbwur93" title="Debt converted, shares issued">9,404,867</span> shares of common stock at the stated conversion rate, and all holders of the Company’s 2021 convertible notes in the total amount of $<span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--AugustPublicOfferingMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--October2021NotesPayableMember_zhMJeyaAeEll" title="Debt converted, amount converted">1,120,035</span>, including accrued interest, automatically converted their debt into a total of <span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--AugustPublicOfferingMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--October2021NotesPayableMember_z9ztjJuwEXAk" title="Debt converted, shares issued">267,000</span> shares of common stock at the stated conversion rate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Warrants</i> – The Warrants for a total of <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230630_z2Nbr5PPwdc">1,179,750</span> shares of common stock issued to investors and the underwriters are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance, or August 1, 2027. The Warrants may be exercised upon payment of the exercise price in cash on or prior to the expiration date. Under the terms of the Warrant Agreement, we must use our best efforts to maintain the effectiveness of the registration statement and current prospectus relating to common stock issuable upon exercise of the Warrants until the expiration of the Warrants. If we fail to maintain the effectiveness of the registration statement and current prospectus relating to the common stock issuable upon exercise of the Warrants, the holders of the Warrants shall have the right to exercise the Warrants solely via a cashless exercise feature provided for in the Warrants, until such time as there is an effective registration statement and current prospectus. As of the date of this report, the Company has not maintained the effectiveness of the registration statement and the Warrants may be exercised on a cashless basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table presents activity with respect to the Company’s warrants <span style="font-family: Times New Roman, Times, Serif">for the nine months ended March 31, 2024</span>:</p> <table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z9pBwK2qADyk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Equity (Details - Warrant activity)"> <tr style="vertical-align: bottom"> <td id="xdx_8BD_zH7fujmgzFn8"><b style="display: none">Schedule of warrant activity</b></td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Wtd. Avg.</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Wtd. Avg.</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Aggregate</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Intrinsic</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term (Yrs.)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 32%">Outstanding at June 30, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20230701__20240331_zgtT2k3yrsU7" style="width: 13%; text-align: right" title="Warrants outstanding, beginning">1,179,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20230701__20240331_zwffAEVhxBS3" style="width: 13%; text-align: right" title="Weighted Average Exercise Price, Beginning">4.02</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230701__20231231_zzGLD2zkF8Wf" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0542">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Warrants exercised/forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20230701__20231231_zlWsg7XZSFph" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0543">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding at March 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20230701__20240331_z5k4VwWW9ljf" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, beginning">1,179,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20230701__20240331_zj5RBGRi6S09" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Beginning">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYp_c20240331_zwgVyPNAVNr5" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants and Rights Outstanding, Term">3.3</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_d0_c20240331_z25kSopRPPh3" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at March 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20230701__20240331_z8VN2HeX9cl6" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, beginning">1,179,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--WarrantsExercisableWeightedAverageExercisePrice_iI_c20240331_zI71t135BoR8" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable, weighted average exercise price">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_ecustom--WarrantsAndRightsOutstandingTermExercisable_dtY_c20230701__20240331_z54vU3IZdH7k" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants term, exercisable">3.3</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable_iI_d0_c20240331_z33XZCTtvx25" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Exercisable">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These warrants were issued in conjunction with an underwritten public equity offering, therefore, there was no employee or non-employee compensation expense recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Stock Compensation Expense </i>– In February 2022, we entered into a new employment agreement with our Chief Executive Officer (“CEO”), effective April 1, 2022. The initial term of the employment agreement was one year and is automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. The agreement provides for an initial annual salary of $165,000. Pursuant to the agreement, we issued our CEO a restricted stock unit (“RSU”) award for up to 150,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 50,000 shares; and (ii) Milestone 2 - Produce 2,000 ESSs in 2022 and continue his employment with our company until January 1, 2023: 100,000 shares. As of December 31, 2023, Milestone 1 was achieved, however, Milestone 2 was not achieved. The underlying <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20220701__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TransactionTypeAxis__custom--Milestone1Member_zuwgo7yD07r" title="Restricted stock granted, shares">50,000</span> shares of common stock earned under Milestone 1 were issued to our CEO as of January 1, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In February 2022, we entered into a new employment agreement with our Chief Financial Officer (“CFO”), effective March 1, 2022. The initial term of the employment agreement is one year and is automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. The agreement provides for an initial annual salary of $125,000. Pursuant to the agreement, we issued our CFO an RSU award for up to 300,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 250,000 shares; and (ii) Milestone 2 - successfully complete and file the Company’s Form 10-K for the year ended June 30, 2023 no later than September 29, 2023 and continue his employment with our company until January 1, 2024: 50,000 shares. Milestone 1 was achieved as of January 1, 2023, and the underlying <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20220701__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--TransactionTypeAxis__custom--Milestone1Member_z6YIW9gFbr78">250,000</span> shares of common stock earned under Milestone 1 were issued to our CFO as of that date. Milestone 2 was achieved as of January 1, 2024, and the underlying 50,000 shares of common stock earned under Milestone 2 are expected to be issued to our CFO in May 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based upon management’s assessment of the probability of our CEO and CFO ultimately achieving each milestone specified under the RSU awards indicated above, we calculated the grant date value of such awards and are amortizing it as stock compensation expense over the underlying performance periods. We have recognized stock compensation expense applicable to such RSU awards in the nine months ended March 31, 2024 and 2023 in the amounts of $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20230701__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zlvPxf5vHGD3">81,683</span> and $<span id="xdx_903_eus-gaap--ShareBasedCompensation_c20220701__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zjKFoaW1J9Ma">1,200,723</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In conjunction with our public offering in August 2022, we appointed two new independent directors and adopted a new compensation plan for all independent directors based on an annual compensation amount of $65,000 with not less than 70% of such amount paid in shares of our common stock, calculated based on the share price at the end of such prior fiscal quarter, and up to 30% paid in cash, with such final amounts to be determined by each director. As of March 31, 2024, we booked an accrual of $<span id="xdx_905_eus-gaap--DeferredCompensationLiabilityCurrentAndNoncurrent_iI_c20240331__srt--CounterpartyNameAxis__custom--ThreeIndependentDirectorsMember_zTKTkS1qQNKj" title="Accrued compensation expenses">146,250</span> of compensation expense (of which $131,625 will be settled through the issuance of shares) for our three independent directors under this plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the nine months ended March 31, 2024, we recognized total non-cash stock compensation expense of $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20230701__20240331_z3VkDrtb81c5">245,496</span> as follows: (i) $<span id="xdx_907_eus-gaap--ShareBasedCompensation_c20230701__20240331__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfRSUsGrantedMember_zw52X4W7r6a7">81,683</span> for the amortized value of the RSUs granted to our two executive officers, as previously described; (ii) $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20230701__20240331__us-gaap--TransactionTypeAxis__custom--IndependentDirectorsMember_zQ0qjZjJ5o57">131,625</span> for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock; (iii) $<span id="xdx_909_eus-gaap--ShareBasedCompensation_c20230701__20240331__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfSharesGrantedToVariousAdvisorsMember_z7uv9FEJIcrb">19,763</span> for the amortized value of the shares granted to various advisors under their annual service contracts; and (iv) $<span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20230701__20240331__us-gaap--TransactionTypeAxis__custom--FairValueOfIncentiveSharesWholesaleDealerMember_z4KCSKlfXSVi">12,425</span> for the fair value of incentive shares earned by a wholesale dealer as of December 31, 2023 (see Note 3). There was a total of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20231001__20240331__srt--CounterpartyNameAxis__custom--IndependentDirectorsMember_zlLhKyBiKtD7" title="Stock issued for compensation, shares">80,964</span> shares of common stock that were issued to our independent directors in the nine months ended March 31, 2024, which were previously expensed in the year ended June 30, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the nine months ended March 31, 2023, we recognized total non-cash stock compensation expense of $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20220701__20230331_zzcxykcCaCE9">1,420,201</span> as follows: (i) $<span id="xdx_90F_eus-gaap--ShareBasedCompensation_c20220701__20230331__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfRSUsGrantedMember_zuRfCCl0zMV3">1,200,723</span> for the amortized value of the RSUs granted to our two executive officers, as previously described; (ii) $<span id="xdx_905_eus-gaap--ShareBasedCompensation_c20220701__20230331__us-gaap--TransactionTypeAxis__custom--IndependentDirectorsMember_zlSaDrogNfAh">131,625</span> for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock; (iii) $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20220701__20230331__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfSharesGrantedToVariousAdvisorsMember_z81cgLyPAdIa">60,625</span> for the net amortized value of the shares granted to various advisors under their annual service contracts; and (iv) $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20220701__20230331__us-gaap--TransactionTypeAxis__custom--FairValueOfIncentiveSharesTwoWholesaleDealerMember_zzPr1czxWyFh">27,228</span> for the fair value of incentive shares earned by two wholesale dealers as of December 31, 2022 (see Note 3). There was a total of 384,759 shares of common stock that were issued to various grantees, including our two executive officers, in the nine months ended March 31, 2023, of which 75,000 shares were previously expensed in the year ended June 30, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Other Matters</i> – In February 2019, the Company’s Board of Directors approved the establishment of a new 2019 Stock Plan (“Plan”) with an authorization for the issuance of up to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20190228__us-gaap--PlanNameAxis__custom--StockOptionPlan2019Member_zZCVowvIH3ak" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized">2,500,000</span> shares of common stock. The Plan is designed to provide for future discretionary grants of stock options, stock awards and stock unit awards to key employees, consultants, advisors, and non-employee directors. As of March 31, 2024, the Company has made awards under the Plan as follows: (i) <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20220701__20230630__us-gaap--PlanNameAxis__custom--StockOptionPlan2019Member__srt--CounterpartyNameAxis__custom--TwoExecutivesMember_zgS5jBAjW2Nh">450,000</span> shares for the RSUs granted to our two executive officers, as noted above; (ii) <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20220701__20230630__us-gaap--PlanNameAxis__custom--StockOptionPlan2019Member__srt--CounterpartyNameAxis__custom--ThreeIndependentDirectorsMember_zZrRdkgvEUv1">54,964</span> shares for the initial services of our three independent directors in the year ended June 30, 2023, pursuant to the new compensation plan adopted in August 2022 for independent directors; and (iii) 32,858 shares granted to several wholesale dealers under an incentive sales program.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"> </p> each Unit consisting of one share of common stock and one warrant (each, a “Warrant” and collectively, the “Warrants”) 1121250 4485000 3780000 58500 59251 9404867 1120035 267000 1179750 <table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z9pBwK2qADyk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Equity (Details - Warrant activity)"> <tr style="vertical-align: bottom"> <td id="xdx_8BD_zH7fujmgzFn8"><b style="display: none">Schedule of warrant activity</b></td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Wtd. Avg.</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Wtd. Avg.</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Aggregate</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Intrinsic</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term (Yrs.)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 32%">Outstanding at June 30, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20230701__20240331_zgtT2k3yrsU7" style="width: 13%; text-align: right" title="Warrants outstanding, beginning">1,179,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20230701__20240331_zwffAEVhxBS3" style="width: 13%; text-align: right" title="Weighted Average Exercise Price, Beginning">4.02</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230701__20231231_zzGLD2zkF8Wf" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0542">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Warrants exercised/forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20230701__20231231_zlWsg7XZSFph" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0543">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding at March 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20230701__20240331_z5k4VwWW9ljf" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, beginning">1,179,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20230701__20240331_zj5RBGRi6S09" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Beginning">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYp_c20240331_zwgVyPNAVNr5" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants and Rights Outstanding, Term">3.3</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_d0_c20240331_z25kSopRPPh3" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at March 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20230701__20240331_z8VN2HeX9cl6" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, beginning">1,179,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--WarrantsExercisableWeightedAverageExercisePrice_iI_c20240331_zI71t135BoR8" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable, weighted average exercise price">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_ecustom--WarrantsAndRightsOutstandingTermExercisable_dtY_c20230701__20240331_z54vU3IZdH7k" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants term, exercisable">3.3</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable_iI_d0_c20240331_z33XZCTtvx25" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Exercisable">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1179750 4.02 1179750 4.02 P3Y3M18D 0 1179750 4.02 P3Y3M18D 0 50000 250000 81683 1200723 146250 245496 81683 131625 19763 12425 80964 1420201 1200723 131625 60625 27228 2500000 450000 54964 <p id="xdx_80B_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zuf5U9iJDUZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(3)       <span id="xdx_829_zPevQtqZN6hk">Commitments and Contingencies</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective January 1, 2021, we secured new corporate and manufacturing office space under a sublease agreement with a company that served as our contract manufacturer at that time. Under the terms of the sublease agreement, we were required to make rental payments of $10,350 per month during the initial one-year term of the agreement. Further, under the terms of the sublease agreement, we were granted the right to renew the sublease for additional terms of 12 months each upon mutual agreement of both parties, provided thirty days’ notice is given for each subsequent term, at a modest increase in the monthly rent, through February 28, 2025. However, we were under no obligation to renew it. At inception of the sublease, management determined that exercise of the renewal option was not reasonably certain and, notwithstanding that the Company elected to renew the agreement for additional one year periods as of January 1, 2022, 2023 and 2024, continues to believe that is the case. Accordingly, we have accounted for it as a short-term lease under ASC 842, <i>Leases</i>. Under an amendment to our supply agreement with our former contract manufacturer in April 2023, we took over direct responsibility for the manufacturing process surrounding our ESS units on June 1, 2023, however, that amendment had no effect on the sublease agreement with our former contract manufacturer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As indicated in Note 1, we sell our proprietary ESS units through wholesale dealers, primarily in California. In that regard, we have entered into agreements with several wholesale dealers operating in California and other states under which we have incentivized the dealers to achieve quarterly sales above targeted levels by agreeing to grant them shares of our common stock for exceeding such quarterly sales targets, determined as of the calendar year end, subject to defined maximums.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time in the ordinary course of our business, the Company may be involved in legal proceedings, the outcomes of which may not be determinable. The Company is not involved in any legal proceedings at this time. The results of litigation are inherently unpredictable. Any claims against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"> </p> <p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_z1eO5uqNO8nf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(4)        <span id="xdx_82A_z1gTM248GGSi">Subsequent Events</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective April 29, 2024, the Company engaged a new Chief Executive Officer (“CEO”), replacing the Company’s former chief executive officer and founder who remains as Chairman of the Board and chief technology officer. The Company has entered into an employment agreement with the new CEO providing for an initial term extending through June 30, 2027, which will be automatically renewed for additional one-year terms unless either party chooses not to renew it. Pursuant to the agreement, the new CEO received an initial equity grant equal to 1,280,000 RSUs, <span style="font-family: Times New Roman, Times, Serif">which will vest over a four-year period, subject to his continued employment with the Company, </span>and will be entitled to earn additional RSU’s in the form of <span style="font-family: Times New Roman, Times, Serif">three annual performance-based equity grants, beginning in the</span> year ending June 30, 2025, <span style="font-family: Times New Roman, Times, Serif">with a target value of up to $660,000 each.</span></p> false false false false